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"From the standpoint of daily life, however, there is one thing we do know: that we 
are here for the sake of each other - above all for those upon whose smile and well-
being our own happiness depends, and also for the countless unknown souls with 
whose fate we are connected by a bond of sympathy. Many times a day I realize 
how much my own outer and inner life is built upon the labors of my fellow men, 
both living and dead, and how earnestly I must exert myself in order to give in 
return as much as I have received." 
 
-Albert Einstein 
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Summary 
 
With the dawn of the „omics‟ era, bioinformatics has been catapulted from being a passive 
service component of molecular biology to a multifaceted scientific discipline that now actively 
drives major biomedical endeavors. In the past decade bioinformatics has played key roles in the 
success of genomics and seamlessly integrated itself into the fabric of contemporary biology. 
Owing to recent advances in mass spectrometry (MS) instrumentation, proteomics too has joined 
in the league of high throughput technologies
1,2
. Modern proteomics experiments generate 
massive amount of data of complex structure and high dimensionality. Analysis of such datasets 
presents many novel challenges hitherto unknown to proteomics researchers, therefore 
bioinformatics is gaining wider acceptance in proteomics research. This thesis applies 
bioinformatics to systematic knowledge mining and comprehensive functional analysis of mass 
spectrometry based proteomics datasets.  
 
Proteomics in itself builds upon an arsenal of innovative analytical, technological and molecular 
biology methodologies. It is important to appreciate how these diverse technologies and 
methodologies coexist and co-operate to facilitate high throughput investigations at the protein 
level. Breakthroughs in mass spectrometric instrumentation and protein ionization techniques 
have played pivotal roles in the advancement of proteomics, which has been timely supported by 
innovations in experimental strategies. With the introduction of various quantitation methods, 
mass spectrometry based proteomics is now ready for systems-wide measurement of cellular 
protein expression levels
2
.  Chapters 1 through 3 of the thesis provide a brief introduction to 
these aspects of proteomics, namely mass spectrometry instrumentation, ionization techniques 
and quantitative proteomics techniques.  
 
The data structures generated by mass spectrometers are a collection of mass spectra, which form 
a three dimensional space of mass-to-charge ratio (m/z), time (t) and intensity (I). In simpler 
terms these mass spectra are the signal generated by the ionized peptides from digested proteins 
and contain peptide identification and quantitation information.  The process of decoding peptide 
identity and quantity from collection of mass spectra is an intensive multi-level algorithmic 
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exercise, now widely studied in the sub-discipline of Computational Proteomics. Computational 
proteomics spans a gamut of computational, statistical and machine learning methods and 
algorithms especially dedicated for peptide (and protein) identification and quantitation. 
Moreover, it harbors a few of the most exciting algorithmic research problems in biology for data 
disambiguation, interpretation and presentation, and is essentially the cornerstone of proteome 
informatics
3
. Chapter 4 of the thesis briefly discusses this very important facet of the proteomics 
workflow. 
 
The analysis of raw mass spectrums by computational proteomics algorithms and applications 
usually generate a data matrix containing protein identity and quantity information for different 
biological conditions or samples. Essentially, this inventory of identified proteins and their 
quantitative map (if present) contain a wealth of information that needs to be mapped onto 
biological knowledge and insights. This transformation from the data to the knowledge domain is 
facilitated by bioinformatics. Bioinformatics itself has come to prominence in the last decade due 
to the large scale genome sequencing projects. But application of bioinformatics to solve 
biological problems is not a recent trend and can be traced back to the earliest days of the 
computing revolution
4,5
. As this thesis primarily centers on bioinformatics application, an 
understanding of current state-of-the-art in this field will help put proteomics related 
bioinformatics activities in broader context of integrative systems biology. Chapter 5 discusses 
some of the major research directions in bioinformatics which is now also becoming an integral 
part of the regular proteomics workflow. 
 
This thesis discusses four projects illustrating wide-ranging functional analysis of mass 
spectrometry based proteomics datasets by bioinformatics. The data generated by current 
proteomics research endeavors are mainly of two types - qualitative whereby only the qualitative 
aspect of the constituent proteome is studied, and quantitative where in addition to cataloguing 
proteins the quantitative information of their changes across conditions are also reported. The 
scope of functional analysis and the analytical directions that can be taken are largely dependent 
on the type of data generated. In qualitative proteomics most of the bioinformatics activities are 
focused on functional data mining by integration of various annotational data sources - to extract 
the global biological theme underlying the proteome. Additionally, in quantitative proteomics 
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machine and statistical learning approaches can be employed to explore quantitative dimensions 
of the proteome datasets that are not initially obvious to humans.  
 
The first project of this thesis showcases the breadth of biological knowledge that can be 
extracted from a proteome inventory by applying an array of bioinformatics tools and algorithms. 
In this project the proteome of the 3T3-L1 adipocyte (a fat cell line) was studied in-depth after 
fractionation into four sub-cellular fractions, namely cytosol, nuclei, mitochondria and 
membrane. State-of-the-art MS-based protein identification technology developed recently in our 
laboratory allowed us to identify more than 3,200 proteins with essentially no false positives.  
Extensive bioinformatics analysis and comparison with transcriptome data revealed several 
layers of information related to the adipocytes proteome that were in turn mapped to an ensemble 
of interesting biological processes, functions and pathways. Our findings concur with recent 
scientific re-evaluation of adipocytes function and pathophysiology, which renounces the view 
that they are mere lipid depots and implicates them in myriad cellular and organismal 
processes
6,7
. Additionally, by using a systemic protein prioritization methodology described 
recently for functional genomics
8
 we predicted candidate proteins hitherto not known to be 
involved in insulin-dependent vesicular trafficking. Chapter 6 discusses the proteomics and 
bioinformatics analysis of the 3T3-L1 adipocyte along with key findings in detail. 
 
The second project relates to systems level quantitative proteomic comparison of the mouse 
hepatoma cell line Hepa1-6 with the non-transformed mouse primary hepatocytes. The 
experiment was performed by employing the Stable Isotope Labeling by Amino Acids in Cell 
culture (SILAC) approach
9
, whereby Hepa1-6 was completely labeled by the „heavy‟ 13C6-forms 
of arginine and lysine and combined with the primary hepatocytes. To characterize the features 
of these two proteomes, quantitation information (i.e. protein ratios between the two cell types) 
was used to divide all proteins into five quantiles. Each quantile was clustered according to the 
Gene Ontology (GO) and KEGG pathway database information to assess their enriched 
functional groups and signaling pathways. To integrate this information at the systems level, 
hierarchical clustering based on the enrichment p-value obtained from GO and KEGG clustering 
was performed. Using this novel bioinformatics algorithm for functional data mining, the 
proteomic phenotypes of the primary cells and transformed cells are immediately apparent. 
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Primary hepatocytes are enriched in mitochondrial functions such as metabolic regulation and 
detoxification, as well as liver functions with tissue context such as secretion of plasma and low-
density lipoprotein (LDL). In contrast, the transformed cancer cell line Hepa1-6 is enriched in 
cell cycle and growth related functions. Interestingly, several aspects of the molecular basis of 
the “Warburg effect” described in many cancer cells became apparent in Hepa1-6, such as 
increased expression of glycolysis markers and decreased expression of markers for tricarboxylic 
acid (TCA) cycle
10
. Many of these bioinformatics findings could directly be verified at cellular 
compartment level by light microscopic comparison of the cell types. This is the first systematic 
proteome level evaluation of a cell line model against its cognate in vivo cell counterpart and 
chapter 7 discusses the experimental procedure, bioinformatics steps and results obtained. 
 
The third project banks on bioinformatics analysis of one of the most important aspects of any 
biological process, which is time course progression through a cellular event. In this project the 
SILAC approach was combined with latest MS technology, large scale phosphopeptide 
enrichment, sophisticated computational proteomics and novel bioinformatics - to study time 
course progression of cell cycle in HeLa cell line at the proteome and phosphoproteome level. 
The dataset comprised of 6 time points capturing different temporal stages of cell cycle and was 
analyzed separately by a novel time course guided supervised clustering approach. The clusters 
recapitulated known behavior of key cell cycle players but also revealed interesting patterns of 
biological functions when analyzed by an extended version of the proteomic phenotypic method 
described in chapter 7. Moreover, we used directional statistics methods to reveal the cellular 
component level organization of the proteome during the course of cell cycle progression. 
Comparison of proteome changes with transcriptome showed interesting regulatory aspects 
wherein proteins regulated at both the mRNA and the protein level showed an enrichment of cell 
cycle related functions, whereas proteins regulated at neither of the levels were preferentially 
involved in homeostatic and basic metabolic processes. Additionally, analysis of 
phosphoproteome showed time dependent regulation of cell cycle regulated kinase substrates, 
and in particular identified MCM6 protein as a substrate for the DNA damage response network.  
More interestingly, systems level integration of proteome, transcriptome and phosphoproteome 
revealed that E2F transcriptional targets are regulated during the cell cycle through lamina 
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association. Chapter 8 discusses the experimental protocols, bioinformatics analysis and results 
obtained from this global cell cycle phosphoproteomics study. 
 
The fourth project explores the spatial aspect of cellular proteomes to elucidate the mitochondrial 
proteome of mouse brown adipose tissue (BAT) and white adipose tissue (WAT). Here we build 
on the strength of quantitative proteomics by SILAC and complement it by a novel 
bioinformatics approach for sub-cellular localization prediction.  In a set of two parallel 
experiments we mix mitochondrial fraction from each of the adipose tissue subtypes (brown and  
white) with either SILAC labeled nuclear or SILAC labeled post mitochondrial fraction from the 
cognate cell types (brown adipocyte, 3T3-L1 adipocyte).  The resultant relative quantitative 
ratios were then modeled as bimodal Gaussian distributions, and subsequently used to assign 
localization probability to the proteins based on their quantitative ratios using Bayesian 
framework. This enabled us to disentangle the mitochondrial proteome from nuclear or post 
mitochondrial populations. Our prediction results concurred very well with known Gene 
Ontology mitochondrial annotations – 94% of those proteins were sorted correctly.  We then 
used this compendium of mitochondrial proteins to filter a separate in vivo quantitative 
mitochondrial proteome of BAT versus WAT. This quantitative proteomic map of adipose tissue 
mitochondria provided interesting insights into the divergence of key metabolic processes and 
pathways. For instance, strongly up-regulated pathways in BAT mitochondria were ubiquinone 
biosynthesis, oxidative phosphorylation, and citrate cycle. In WAT mitochondria systemic up-
regulation of pathways was less pronounced, and significantly up-regulated pathways were 
androgen/estrogen metabolism, fatty acid synthesis, pyruvate metabolism, and – interestingly - 
metabolism of xenobiotics. Chapter 9 discusses the experimental protocols, bioinformatics 
analysis and results obtained from this mitochondrial organellar proteomics study. In addition to 
the work discussed here, I contributed bioinformatics expertise and analysis to several projects in 
the Department of Proteomics and Signal Transduction at the Max Planck Institute for 
Biochemistry. The list of publication generated in my thesis‟s work so far can be found at the 
end of this summary.  
 
The studies reported in this thesis exemplify extensive applications of bioinformatics tools and 
algorithms for analysis of high throughput proteomics data. The work presented here samples 
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important directions in proteomics related bioinformatics research. There are other analytical 
directions and applications that are currently being reported in the literature and they have been 
cited at appropriate places throughout the thesis. Extensive application of bioinformatics to 
proteomics is a relatively recent development, and has been particularly driven by the very large 
amount of data that is being generated by current proteomics studies. This on one hand has 
opened newer vistas for data analysis and knowledge mining, and on another presented novel 
challenges to biomedical informatics researchers. It is rapidly becoming apparent that 
bioinformatics is indispensable part of the contemporary high throughput proteomics workflows, 
and that it will continue to play an integral role in proteomics research. We envisage that the role 
of bioinformatics in proteomics will evolve where not only it will be at the core of functional 
analysis, but will also provide important pointers for hypothesis generation and testing. 
Concurrent to developments in bioinformatics, proteomics will also advance to generate fine 
grained and comprehensive data, amenable for integrative systems level analysis and 
exploration. Proteomics equipped with bioinformatics is poised to change the outlook of systems 
biology and is now ready to engender profound changes in biomedical and translational research. 
Chapter 10 discusses some of the current challenges for bioinformatics research especially in 
context of its applications to proteomics, and provides perspectives for its symbiosis with mass 
spectrometry based proteomics in future. 
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1. Mass spectrometry-based proteomics 
 
The „central dogma‟ of molecular biology is that biological information flows from DNA to 
RNA to protein by well defined molecular processes or „algorithms‟, whereas proteins do not 
change the genetic code. With some notable exceptions, all living cells conform to this rule. 
DNA, the genetic material, also termed the “book of life” contains all necessary information for 
RNA (and consequently protein) production, and hence serves as the blueprint for building the 
entire cellular machinery. Therefore, the beginning of the twenty first century witnessed a 
remarkable scientific project towards deciphering the genetic constitution of organisms. The 
sequencing of the complete genome of an organism has been a landmark in the history of 
biomedical research, which was the result of concerted scientific and technological orchestration 
between various disciplines of biomedical, physical and material sciences.  
 
 The efforts and advances made in large-scale sequencing of a large number of genomes, 
including the human genome, have generated a wealth of useful information, which is 
revolutionizing our understanding of the complex molecular biology responsible for different 
physiological processes. Genomics has undoubtedly furthered the human race‟s endeavors 
towards global and holistic understanding of organismal function, evolution and disease 
pathophysiology. However, detailed study of genomes at DNA and RNA levels have also 
revealed that these digital pieces of information are just one part of the immense and very 
intriguing scientific puzzle called “life”11, and may a times not be sufficient to answer many 
fundamental questions - like the apparent differences between two very closely related species. 
For instance, when comparing the chimpanzee genome to the human one, focusing on base pair 
substitutions, more than 98.5 percent of our DNA sequence is identical between the two 
species
12
. Since the human genome is not very different from that of a chimpanzee, or even a 
mouse, there must be something else explaining the complexity of the human body and brain. 
This explanation may largely lie in the gene products, the proteins, which are the active players 
in living cells in contrast to the static DNA. Supporting this notion, it turns out that the 
transcriptome and the proteome (especially in the brain) is significantly different between 
humans and chimpanzees
13
. A similarly interesting example is the discovery that humans have 
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fewer proteins-coding genes (~ 20,500 ref
14
) than many plants, again adding to the growing body 
of evidence that the complexity of human species is largely due to multiple protein forms that 
result from alternative splicing of RNAs
15
 and post translational modifications such as 
phosphorylation, methylation and glycosylation.  
 
With growing appreciation of the dynamic role of proteins in almost every cellular process and 
direct implication of their altered behavior or malfunctioning in myriad disease pathologies, the 
task of mapping the protein repertoire of an organism figures prominently on the agenda of 
twenty first century biomedical science
16,17
. For this reason as well as many others, one of the 
major challenges in the post-genomic era is to understand the structure, dynamics and 
interactions of proteins
18
. This knowledge can be acquired in a large-scale fashion by a relatively 
new “omics”-discipline; namely proteomics19. While the origin of proteomics can be traced back 
to the 1970-80s, it was named by Marc Wilkins in 1994 when he was searching for an alternative 
to the phrase “the protein complement of the genome”20, 21. 
 
Proteomics is now broadly defined by the range of technologies that allow large-scale 
investigation of genetic and cellular function directly at the protein level. Although the field of 
proteomics builds on an array of analytical, technical and molecular biology methodologies - 
including protein microarrays
22
, global two hybrid analyses
23
, and high throughput protein 
production and crystallization
24
, it has in the past decade been particularly driven by the rapid 
advances made in instrumental technologies, mainly mass spectrometry (MS)
1,25
. 
 
1.1 Generic Workflow of MS-based Proteomics  
Mass spectrometry is an analytical technique that characterizes a molecule on the basis of the 
mass to charge ratio (m/z) of its charged gas-phase particles (ions). MS-based proteomics refers 
to the application of mass spectrometry to the study of proteins. In MS-based proteomics, the 
m/z values of peptides or intact proteins are measured, which can provide their added amino acid 
molecular weight and as well as the weight of potential post-translational modifications. 
Currently, two complementary strategies are commonly employed for characterizing proteins - 
bottom-up proteomics and top-down proteomics. 
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The bottom-up approach is the most pervasive and by far the most successful method in 
proteomics (Figure 1.1). Proteins of interest are enzymatically cleaved at specific sites to yield 
short peptides of typically 6-20 amino acid residues. The resulting peptide mixture is analyzed in 
a mass spectrometer in two stages. In the first (survey scans or MS
1
 scans), the masses of the 
intact peptides are determined; in the second, these peptide ions are fragmented by low energy 
collision with an inert gas (MS/MS fragmentation) to produce amino acid sequence related 
information. Taking a protein database as a reference, mass spectra are correlated to amino acid 
sequences with the aid of computational algorithms. The assigned peptide sequences are then 
mapped to parent proteins, which ultimately leads to protein identification. 
 
Figure 1.1 General workflow for bottom-up MS-based proteomics. Proteomics samples come from 
tissues, cell lines, body fluids etc. Protein or peptide samples can be fractionated by different means to 
reduce complexity and subsequently separated by HPLC. This separated peptide mixture is then 
introduced into a mass spectrometer for MS and MS/MS analysis thereby generating mass spectra read 
outs. Computer algorithms match mass spectra to amino acid sequences. The outcome of the 
experiment is a list of identified proteins which are then used for functional proteomics analysis. 
 
In the top-down approach, intact proteins are ionized and sprayed into mass spectrometers where 
peptide fragments are subsequently generated using one of a variety of activation methods such 
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as CID, ECD, ETD, and IRMPD methods (see abbreviation page). Top-down proteomics 
consists of fragmenting intact proteins in the mass spectrometer, without prior enzymatic 
digestion. It provides an alternative approach in proteomics to peptide based approaches. It 
obtains better sequence coverage of protein identifications and is especially suited for elucidating 
the primary structure, splice variants, and post translational modification (PTM) of whole 
proteins
26
. So far, the applicability and throughput of this method has been limited, because of its 
limited sensitivity, the heterogeneity of most proteins and the difficulty of fragmenting proteins 
efficiently, resulting in prolonged acquisition times and necessitating a combination of different 
fragmentation techniques. It has also been difficult to combine this methodology with online LC-
MS analysis. However, with recent advances in mass spectrometric instrumentation, top-down 
MS could become a powerful and practical addition to bottom-up in the future
27,28
. 
 
Proteomics frequently deals with complex protein or peptide mixtures. As dynamic range and 
sequencing speed are the limiting factors in current MS technology
29
 for dealing with these 
mixtures.  To reduce the complexity of a biological sample (cell lysate, purified organelle, body 
fluid) it is often desirable to fractionate and separate the proteins or peptides by at least two 
orthogonal separation techniques before MS analysis. Separation with reversed phase 
chromatography (HPLC) connected on-line to the mass spectrometer has proven to be a useful 
method (Figure 1.1).The C18 reversed phase HPLC column elutes peptide mixtures with linearly 
increasing organic solvent, e.g. acetonitrile (MeCN). The gradual elution (typically at a few 
hundred nanoliter per minute) with shallow gradients increases available sequencing time in the 
MS. Prior to this hydrophobicity-based peptide separation, complex samples can be separated by 
one dimensional gel
1
, isoelectric focusing
30
, ion-exchange
31,32
, molecular size
33
, and affinity 
binding such as immunoprecipitation
34,35
, IMAC
36,37
 and TiO2 enrichment
29,38,39
. For less 
complex samples, static electrospray – called nanoelectrospray –can be used which often yields 
better identification results. In particular static spray is beneficial for targeted modification 
studies
40
. 
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1.2 Computational and Functional Proteomics  
 
One of the primary goals of any MS-based proteomics experiment is to identify and quantify 
proteins in a biological sample of interest. This task is performed in the penultimate step of the 
MS-based proteomics workflow, now widely recognized as “Computational Proteomics”41. A 
large number of computational and algorithmic approaches are now available for identification 
of proteins and their post translational modifications
42-44
 as well as for their quantitation
45
. As 
further functional analyses rely on the accuracy of protein identification and quantitation, a range 
of research activities have emerged for accessing the quality of identification and 
quantitation
46,47
. 
The ultimate goal of any proteomics endeavor is to gain important insights into the physiology of 
the biological system under study. Functional proteomics analysis therefore forms the 
cornerstone of such an enterprise. Data analysis and mining takes place at the end of the work 
flow and comes under the auspices of “Bioinformatics”. Depending upon the nature of the data 
(qualitative or quantitative) specialized analytical directions are undertaken. Annotation 
databases such as Gene Ontology
48
, pathway resources like KEGG
49
, disease databases like 
OMIM are frequently used to group proteins according to their common biological themes
50-52
. 
Various statistical and machine learning methods have been employed to analyze proteomics 
datasets
53-55
. Additionally, integration of other “omics” datasets (genome, transcriptome, 
epigenome and interactome) can complement the analysis and provide deeper insights into 
proteome organization, function and dynamics
30,56-60
. The amalgamation of proteomics with 
other contemporary “omics” disciplines heralds the beginning of a concerted scientific effort by 
which the future promises of “systems biology” will be realized and delivered61-63.  
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2. Mass spectrometry 
 
Mass spectrometry (MS) has become the most important technology in proteomics today
1
 
because it is a versatile tool that encompasses several unique features at once, such as 
identification of individual proteins in a complex mixture
51
, quantification of proteins in a cell or 
organism
64
 and characterization of important post-translational modifications (PTMs) of proteins 
(e.g. phosphorylation, methylation, acetylation)
65
.  
MS is essentially a technique for weighing molecules, but the measurements are obviously not 
performed with a conventional balance or scale. Instead, the basis of MS is the production of 
gas-phase ions, which are subsequently separated or filtered according to their mass-to-charge 
(m/z) ratio in a magnetic or electrostatic field and finally recorded by a detector. The resulting 
mass spectrum is a plot of the relative abundances of the produced ions as a function of their m/z 
ratio (Figure 1.1).  
Because every peptide molecule and modification has a characteristic mass, MS in proteomics is 
a very useful and nearly universal tool for analysis, which can provide a nearly unique feature of 
the molecule. Peptides furthermore have distinct fragmentation patterns that provide structural 
information to identify their amino acid sequences and modifications. 
 
2.1 Types of ionization and Mass Spectrometers used in proteomics  
 
2.1.1 Electrospray Ionization - ESI (2+, 3+)  
In the early 1980s John Fenn and coworkers reported a significant refinement of an ionization 
principle, originally reported by Malcolm Dole
66
 almost two decades earlier. He developed the 
electrospray ionization (ESI) method as a mass spectrometric technique
67
 (Figure 2.1). ESI 
allows for large, non-volatile molecules (such as peptides and proteins) to be non-destructively 
ionized directly from a liquid phase (usually a mixture of volatile organic solvent and acidified 
water).  In electrospray, a liquid is passed through a needle to which a high voltage is applied. 
The charged liquid becomes unstable as it is forced to hold more and more charges. Soon the 
liquid reaches a critical point and at the tip of the liquid stream in front of the needle it blows 
apart into a cloud of tiny, highly charged droplets. These droplets rapidly shrink as solvent 
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molecules evaporate from their surface increasing the electric field at the droplet surface. By a 
process of „ion evaporation‟ (Iribarne and Thomson model) or simple solvent evaporation 
(charged residue model), the “naked” biomolecule becomes a gas-phase ion.  
 
Figure 2.1 Electrospray ionization process schematic (adapted from ref68 ) 
  
2.1.2 Matrix-assisted laser desorption ionization –MALDI(1+) 
Another “mild” ionization technique for biomolecules is named Matrix-assisted laser desorption 
ionization (MALDI) and was also developed in the late 1980s (by Franz Hillenkamp and 
Michael Karas at the University of Münster in Germany)
69
(Figure 2.2).  In this technique, 
analyte molecules are co-crystallized with an UV- or IR-absorbing substance termed the matrix, 
which is usually an organic carboxylic acid such as 2,5-dihydroxybenzoic acid (UV-absorbing) 
or succinic acid (infrared absorbing). The analytes are desorbed and ionized by a laser beam 
(pulsed laser irradiation) from the solid surface containing the organic matrix compound in 
approximately thousand-fold excess. Although the exact ionization process of MALDI, like that 
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of electrospray, is still not entirely clear, the matrix plays a key role in this technique by 
absorbing the laser light energy and causing a small part of the target substrate to vaporize. A 
widely accepted view is that, following their desorption as neutrals, the sample molecules are 
ionized by acid-base proton transfer reactions with the protonated carboxylic acid matrix ions in 
a dense „selvage‟ phase just above the surface of the matrix.  
 
Figure 2.2  MALDI ionization process 
 
The MALDI technique has some similarities with the soft laser desorption (SLD) technique 
described by Koichi Tanaka in 1987
70
. Tanaka discovered that by mixing ultra fine metal powder 
in a glycerol matrix an analyte molecule can be ionized resulting in stable gas-phase ions with 
intact primary structure. Tanaka was awarded the Nobel Prize in Chemistry in 2002 for his work, 
although this raised a major controversy in the MS community, because most mass 
spectrometrists felt that the award should have been given to Hillenkamp instead.  
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Like ESI, MALDI is capable of efficiently ionizing large biomolecules such as peptides and 
proteins and is often used with time-of-flight (TOF) mass spectrometers due to the vacuum-
compatibility and pulsing nature of the technique (the laser frequency can easily be synchronized 
with the TOF extraction pulse). Both the ESI and MALDI techniques have enabled biological 
molecules exceeding one million Daltons to be introduced into mass spectrometers
71
. 
For peptide analysis, the main difference between the two ionization methods is that ESI 
predominately produces multiply charged ions, MHn
n+
, whereas MALDI almost exclusively 
generates singly-charged peptide ions, MH
+
, which can be difficult to sequence by the low-
energy dissociation methods available on most proteomic mass analyzers. 2D-gel based 
proteomics is almost exclusively driven by MALDI-TOF MS analysis, whereas many other areas 
of proteomics are mainly based on ESI, because of the possibility to couple ESI directly with 
online LC-MS/MS.  
 
2.2 Traditional mass analyzers in proteomics: TOF, quadrupoles and ion 
traps 
 
2.2.1 Time-of-flight mass spectrometry 
A time-of-flight mass spectrometer (TOF-MS) measures the (mass-to-charge dependent) time it 
needed for ions of different masses to travel from the ion source region to reach the detector
72
. 
This requires that the starting time (the time at which the ions leave the ion source) is well 
defined. Therefore, ions are either formed by a pulsed ionization method such as MALDI or 
various kinds of rapid electric field switching which are used as a 'gate' to release the ions from 
the ion source in a very short time interval.   
 
An electric field accelerates all ions into a field-free drift region with a kinetic energy of:  
 
Where, q is the ion charge and U is the applied voltage. Since the ion kinetic energy is equal to 
, lighter ions have a higher velocity than heavier ions and reach the 
detector at the end of the drift region sooner;  
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 Since the transit time (t) through the drift tube is  , where d is the length of the drift tube 
the following equations are used to produce and calibrate a mass spectrum from the signal 
produce at the detector:        
 
Figure 2.3 Reflectron time-of-flight mass analyser with a dual stage ion extraction source 
 
The ions leaving the ion source of a TOF mass spectrometer have neither exactly the same 
starting times nor exactly the same kinetic energies, which results in peak broadening and 
decreased mass accuracy. Various time-of-flight mass spectrometric designs have been 
developed to compensate for these differences. A reflectron is an ion optic device in which ions 
in a time-of-flight mass spectrometer pass through a "mirror" or "reflectron" and their flight 
direction is reversed (Figure 2.3). The reflectron is composed of a series of rings or grids that act 
as an ion mirror. This mirror compensates for the spread in kinetic energies of the ions as they 
enter the drift region and improves the resolution of the instrument. The output of an ion detector 
is measured as a function of time to produce the mass spectrum. Reflector TOF analyzers can 
easily baseline resolve multiply-charged peptide ions and current instruments used in proteomics 
usually provide mass accuracy measurements of better than 50 ppm. 
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2.2.2 Quadrupole ion trap MS 
There are two types of ion trap mass analyzers; dynamic and static ion traps. 3-dimensional 
quadrupole ion traps (QIT) are dynamic traps and Fourier transform ion cyclotron resonance 
(FT-ICR) mass spectrometers contain static traps. Both types of instruments work by trapping 
ions in electric or magnetic field, respectively, and by manipulating the ions through DC or DC 
and RF electric fields in a series of carefully timed events. The 3D-ion trap mass spectrometer 
(also know as the Paul trap, Figure 2.4) was the first integrated and easy to use proteomic 
analyzer that combined online HPLC with fast scanning tandem MS. 
 
Figure 2.4 Quadrupole ion trap (Paul trap) 
 
The quadrupole ion trap is based on the same principle as a quadrupole mass filter, except that 
the quadrupole field is generated within a three-dimensional trap. The 3D ion trap consists of a 
ring electrode and two end caps (Figure 2.5). Ions are formed within the ion trap or (in 
proteomics) injected into the trap from an external source. The ions are dynamically trapped by 
the applied RF potentials with the help of a "bath gas" which confines them in the trap. The 
trapped ions can be manipulated by RF fields analogous to a quadrupole mass spectrometer. A 
mass spectrum is obtained by changing the electrode voltages to eject the ions from the trap in 
turn (i.e. scanning the ions out to the detector).  
Mass spectrometry 
     
 
21 
 
 
 
 
Figure 2.5 Linear ion trap 
 
The Paul trap has very high sensitivity (sub-femtomole) and fast sequencing speed (msec 
timescale), but large-scale proteomic analysis can be severely hampered by the low mass 
accuracy and dynamic range of this instrument. The main weakness of Paul traps is their limited 
dynamic range, which is due to a low trapping and storage capacity (in a point-like three 
dimensional volume in the middle of the trap) holding less than 10,000 ions before the onset of 
space-charge distortions.  
To overcome these drawbacks of conventional 3D-ion traps, a new generation of ion traps with 
superior ion capacity, dynamic range, scan speed and sensitive has been introduced
73,74
 These are 
the linear ion traps (or 2D ion traps); essentially segmented rf/dc-quadrupole mass filters, 
capable of trapping and detecting a factor hundred more ions than traditional 3D-ion traps.  
 
2.3 Hybrid instruments - State-of-the-art MS analyzers 
 
The term hybrid mass spectrometer refers to a combination of two MS analyzer types. In 
proteomics, the term was originally given to the combination of a quadrupole analyzer with a 
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time-of-flight detector, namely the qTOF type instruments (Q-TOF and QSTAR
75,76
. The idea is 
that a hybrid instrument combines the strengths of each analyzer type while minimizing the 
compromises that might result from interfacing the two or more MS technologies.  
 
In a quadrupole time-of-flight instrument, the high-resolution and sensitivity of the reflector TOF 
are combined with the tandem MS capabilities of an electrospray quadrupole instrument. This 
combination represents an instrument that is very well suited for large-scale proteomics projects, 
and which can easily be coupled to online nano-HPLC for high-throughput analyses. This 
instrument was a real boost to proteomics when it was introduced in the 1990s. However, today 
it has been somewhat eclipsed by the latest generation of hybrid mass spectrometers, the linear 
ion trap – Fourier transform instrument combinations described below. 
 
2.3.1 LTQ-FT - a linear quadrupole ion trap – 7T-FTICR mass spectrometer  
Although Fourier transform ion cyclotron resonance mass spectrometry (FTICR-MS) has shown 
great promise and potential in proteomics research for more than a decade
77,78,79
 it was not until 
recently, with the introduction of a linear ion trap - Fourier transform mass spectrometer (the 
LTQ-FT
80
), that FTICR mass spectrometry really became practical and offered adequate 
sensitivity and speed for large-scale proteomics research (Figure 2.6).  
 
Figure 2.6 High-resolution analyzer: Linear ion trap – FTICR mass spectrometer 
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The LTQ-FT is a hybrid instrument that can provide sub-ppm mass accuracy with acquisition 
speed of less than one second per scan. The FTICR-detection (Figure 2.7) combined with 
automatic-gain control; AGC in the ion trap mass spectrometer allows for controlling the number 
of ions in the ICR cell during nanoLC-MS measurements, and hence provides high-mass 
accuracy measurements of peptide ions of less than 2 ppm root-mean-square (RMS) across LC 
elution profiles. This feature together with its high dynamic range and comparative ease of use 
makes the hybrid instrument very powerful in identifying peptides via database search 
algorithms with very high confidence.  
 
 
Figure 2.7 Detection principle of an ICR instrument (adapted from ref81 ). The ion cyclotron frequency is 
directly proportional to the magnetic field and inversely proportional to the mass to charge of the 
detected ion.  Fourier transformation generates a mass spectrum from the overlapping frequency 
spectrum of several compounds.  
 
In order to maximize the dynamic range and sensitivity of the FT-detector for complex mixture 
analysis, we and others
82,83
 have injected very high numbers of ions into the FT part of the hybrid 
instrument for FT survey scans. These ion target values are close to the maximum ion capacity of 
the upstream ion trap of 5-10 E6. However, at high-target values (ACG > 1,000,000) the mass 
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measurement accuracy of LTQ-FT-MS is greatly affected by space-charge effects in the ICR 
cell. Space-charging gives rise to a non-linear ion intensity-dependent cyclotron frequency-shift 
of the ions and as a consequence of the mass measurement accuracy fluctuates 25 ppm or more. 
This presents a problem for confident peptide identification. To minimize this effect we have 
developed an acquisition method that utilizes the fast and very sensitive selected ion monitoring 
(SIM) scan capabilities of the LTQ-FT
84
. Briefly, by accumulating only a small mass range and a 
limited and defined ion population, space charge effects are eliminated allowing very high mass 
accuracy and better quantitative accuracy. By employing FT-SIM scans for all parent ions 
selected for sequencing we have shown that it is possible to measure peptide ions with mass 
errors less than 2 ppm. On the downside, although the LTQ-FT allows for parallel detection by 
both ion trap and FT-detectors simultaneously, the SIM scans still takes away valuable analysis 
time during an online LC-MS/MS experiment.  
 
2.3.2 LTQ-Orbitrap 
A major breakthrough in proteomics came very recently with the introduction of a novel mass 
spectrometer, the LTQ-Orbitrap
85
. The Orbitrap is the first fundamentally new mass analyzer in 
more than 20 years (Figure 2.8). 
Figure 2.8 LTQ-Orbitrap mass spectrometer 
 
 The instrument contains three components. Like the LTQ-FT it has a linear quadrupole ion trap 
(LTQ), in which it is possible to control and manipulate (e.g. accumulate and collisionally 
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activate) ions in the sub-second time-scale. Detection can be achieved in two ways. In the linear 
ion trap ions can be ejected radially through slots (holes) in the quadrupole-rods and detected by 
two electron multiplier detectors. Alternatively, ions are ejected axially from the ion trap and 
transferred via octopole-ion guides into another ion trap (the C-trap) were they are collisionally 
cooled and focused, before they are orthogonally injected into the third component of the 
instrument, the high-vacuum Orbitrap FT-MS analyzer.  
 
This hybrid instrument exhibits a several-fold increase in sensitivity and dynamic range as 
compared to a state-of-the-art hybrid ICR mass spectrometer (LTQ-FT). Based on the highly 
accurate mass determination combined with high resolution and sensitivity, the novel instrument 
not only allows for routine analysis in a high throughput manner, but also for the straightforward 
analysis of intact proteins without chemical or enzymatic digestion. Since it is easier to stabilize 
a magnetic field than an electric field, the LTQ-FT is expected to achieve higher mass accuracies 
than the LTQ-Orbitrap. However, we developed an internal recalibration method for the LTQ-
Orbitrap that offers sub-ppm mass measurement accuracies of peptide ions throughout an online 
LC-MS/MS experiment even when operating the orbitrap analyzer at high target values
86
. 
Utilizing a special lock-mass recalibration feature that this hybrid triple-MS instrument provides 
we are able to recalibrate all ions in FT-MS and MS
n
 to better than 2 ppm mass error. Briefly, 
because the C-trap is a second ion trap we can perform multiple ion fillings in this trap and store 
several “different” ion populations that have been accumulated and axially ejected from the 
linear ion trap before injecting them into the Orbitrap. The lock-mass recalibration approach 
takes advantage of this unique feature providing an opportunity to do internal recalibration of all 
ions by introducing a small number of known recalibration mass ions into every ion population 
that is filled into and stored in the C-trap. During online nanoLC-MS/MS measurements we 
chose to make use of a polycyclodimethylsiloxane (PCM) ion as our lock-mass. PCMs are 
contaminants from ambient air that easily ionize by electrospray ionization and are therefore 
present throughout the whole chromatographic run. The LTQ-Orbitrap instrument is particularly 
suitable for both qualitative and quantitative analysis of complex peptide mixtures, because of 
the high dynamic range and sequencing speed. This allow for sequencing of thousands of 
peptides by tandem MS in less than one hour of LC-MS/MS analysis. Clearly, the new 
generation hybrid instruments already have and will continue to set the standards for large-scale 
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proteomic analyses. Especially the demands for faster sequencing abilities, higher dynamic 
range, and sensitivity and mass accuracy will be met by these hybrid instruments. 
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3. Quantitative Proteomics 
 
Any study of biological processes benefits immensely from the knowledge of quantitative 
change of the entities that form the components of that process. As proteins are the key 
mediators and final effectors in most of the cellular processes, the study of protein amounts and 
their quantitative changes has always been an important task in biomedical research. In that 
context various protein quantitation methods have been developed in the past decades. The 
emergence of mass spectrometry (MS) as a tool for protein quantitation is a recent development. 
Protein quantitation by MS depends on measurement of peptide signal intensities and has been 
mostly done by metabolic incorporation of stable isotopes in proteins or by stable isotope tagging 
of peptides. Recently comparison of signal intensity of unlabeled peptides by advanced machine 
learning and statistical models has been developed and is termed label free quantitation
47
. In this 
chapter we briefly review these methods which are at the core of proteomics workflows.  
 
3.1 Stable isotope dilution 
Although mass spectrometry has proven itself as an extraordinary tool for protein 
characterization, peptides and proteins cannot be directly quantified by MS analysis alone
87
. The 
reason for this is that peptide responses (signals) in the mass spectrometer are extremely 
variable, because the ionization efficiency is highly dependent on their chemical structure.  
To overcome this problem, proteomic investigators have adapted a quantitative method that has 
been employed for many years in small-molecule MS, stable isotope dilution
88
. In this procedure 
heavy stable isotope atom(s), such as deuterium (D), carbon-13 (
13
C), nitrogen-15 (
15
N) or 
oxygen-18 (
18
O), is covalently incorporated into peptides derived from one of the proteomes to 
be analyzed by MS. The physical characteristics and properties of the “heavy” stable isotope 
labeled peptides remain essentially the same as the corresponding “light” versions. When 
peptides from two cell states are analyzed concurrently (after mixing), they will appear as pairs 
in the spectrum - spaced by the mass-shift introduced by the isotopic labeling. Relative 
quantitation is measured by comparing
 
the intensity of the signals of the identical, however 
isotopically distinct,
 
peptides. 
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In the last decade several techniques based on stable isotope dilution for protein quantitation by 
mass spectrometry have emerged. They all enable peptides derived from two or more samples to 
be distinguished in the mass spectrometer. Many different isotope tag techniques have been 
described but a few have attracted most of the attention. These include isotope-coded affinity 
tags (ICAT), metabolic labeling by 
15
N-incorporation, stable isotope labeling of amino acids in 
culture (SILAC), enzymatic 
18
O-labeling and the very recently introduced chemical labeling by 
tandem mass tags iTRAQ
9, 89-92
.  
 
3.2 Isotope coded affinity tags (ICAT) 
ICAT
™
 was the first real breakthrough approach to quantitative expression analysis of complex 
protein mixtures (Figure 3.1). It was developed in Ruedi Aebersold‟s laboratory at the University 
of Washington
89
. ICAT was devised as an LC-MS based approach but it also works with 1D- and 
2D-gels.  
 
Figure 3.1 Isotope coded affinity tag (ICAT) 
 
The method uses a cysteine thiol-reactive chemical tag that contains biotin, which is used as an 
affinity tag to specifically isolate the tagged peptides by avidin-affinity chromatography. 
Although this methodology efficiently reduces the complexity of the protein mixture under 
investigation, in its original version it had some severe disadvantages. The isotope-mass shift 
was introduced by the incorporation of eight deuterium atoms in the heavy version of the ICAT -
reagent and this resulted in a quantitation problem arising from the fact that the light and heavy 
labeled version of the same peptide did not co-elute during reversed-phase LC-MS, because of 
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the so-called deuterium-effect. This RP-LC separation effect is due to the different 
hydrophobicity of hydrogen (H) and deuterium (D) atoms covalently bound to carbon-atoms 
(deuterium isotope effects are primarily attributed
 
to the shorter bond length of C-D versus C-H, 
this decreases the hydrophobicity of deuterated peptides). Another problem with the original 
version of the ICAT-reagent was the generation of very abundant fragment ions from the biotin-
group during MS/MS analysis. This made database search identification of ICAT-labeled peptide 
sequences very difficult. As a consequence of these problems, a new and improved version of the 
reagent has been introduced with a 
13
C9-label and an internal acid-cleavable bond, which allows 
removal of the biotin-moiety prior to MS analysis.  
 
3.3 HysTag 
Olsen et al. developed an isotope coded affinity tag called the HysTag93, which is an inexpensive 
and elegant alternative to the ICAT reagent (Figure 3.2). The HysTag reagent is a 10-mer 
derivatized peptide, H2N-(His)6-Ala-Arg-Ala-Cys(2-thiopyridyldisulfide)-CO2H, which consists 
of four functional elements: an affinity ligand (His6-tag), a tryptic cleavage site (-Arg-Ala-), an 
isotope label; Ala-9 residue that contains four (d4) or no (d0) deuterium atoms, as well as a thiol-
reactive group (2-thiopyridyl disulfide). For differential analysis cysteine residues in the samples 
to be compared are modified using either (d4) or (d0) reagent. The HysTag peptide is preserved 
in Lys-C digestion of proteins and allows charge-based selection of cysteine-containing peptides, 
whereas subsequent tryptic digestion reduces the labeling group to a di-peptide (-Cys-Ala), 
which does not hinder effective fragmentation. Surprisingly, it was found that HysTagged 
peptides containing Ala-d4 co-elute with their d0-labeled counterparts during RP-LC-MS/MS 
analysis making the HysTag reagent very economical.  
Figure 3.2 The HysTag reagent 
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The reagent is very easy to manufacture by the well-established solid-phase Fmoc-peptide 
synthesis and by using a deuterium label the cost of the reagent is low.  Olsen et al. have 
successfully studied the plasma membrane proteomes of distinct mouse brain compartments with 
this approach
93
 (Figure 3.3). The HysTag reagent and small scale organellar purification 
protocols allowed, for the first time, quantification of large numbers of membrane proteins in a 
single animal.  
 
Figure 3.3 The HysTag flowchart for differential analysis of membrane proteins from distinct areas of 
mouse brain 
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3.4 Metabolic labeling 
There are several different ways to metabolically isotope label cells during growth. Stable 
isotope incorporation in newly synthesized proteins can be achieved by a stable-isotope labeled 
compound, which represents the sole source of an element, typically nitrogen (
15
N) or carbon 
(
13
C). This methodology is very simple, but requires a well-defined cell culture system, where 
the cells of interest are capable of synthesizing all the necessary amino acids from the isotope 
labeled compound. Hanno Langen introduced this method and applied it to E. coli bacteria and 
yeast cells
94
. Chait and coworkers reported the 
15
N labeling in yeast for protein quantitation and 
phosphorylation study
90
. Heck and coworkers reported a two-step approach to 
15
N-encode 
higher-multicellular organisms. Metabolic labeling of the model organisms C. elegans and D. 
Melanogaster was accomplished by feeding them on completely 15N-labeled E. coli or yeast 
cells
95
. Yates and coworkers even attempted to isotope label an entire mammalian organism, a 
rat, by feeding it a diet consisting of 
15
N as the single source of nitrogen
96
.  
 
3.5 Stable Isotope Labeling by Amino acids in Cell Culture (SILAC) 
Our laboratory described a whole cell metabolic labeling strategy termed stable isotope labeling 
of amino acids in cell culture („SILAC‟)97. SILAC makes proteins from one cell population 
(isotope-encoded with an essential amino acid such as 
13
C6-Arg) distinguishable from proteins 
from another cell population (cultured in media containing „normal‟ 12C6-Arg) (Figure 3.5). 
Unlike 
15
N-labeling, SILAC can directly isotope-label mammalian cell lines. One of the main 
advantages of SILAC over many other labeling approaches is that it allows the total lysates from 
the two SILAC-encoded populations to be combined before any separation or purification steps, 
which minimizes the often dominant quantitation errors that are otherwise introduced in parallel 
purification procedures. In SILAC, the relative protein quantity between samples can be directly 
read-out by measuring the isotopic ratio of peptides by MS after tryptic digestion. Any essential 
amino acid for the cell culture system under investigation can be used for SILAC encoding, and 
from the observed mass-difference between the SILAC pair the total number of labeled amino 
acids in a given peptide sequence can immediately be deduced.  Due to the simplicity, ease-of-
use and accuracy of SILAC, the approach is becoming very popular and has been validated in 
many different areas of cell culture-based quantitative proteomics. Our laboratory has recently 
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established stable isotopic labeling of living model animals like the mouse
98
 thereby facilitating 
proteome comparison in different physiological states. SILAC is particularly well-suited to study 
post-translational modifications (PTMs) such as phosphorylation changes. We have used SILAC 
specifically to study diverse cell signaling systems by quantitatively determining the signaling 
molecules involved and their phosphorylation sites (see refs
82,37
 and below).   
 
Figure 3.5 Quantitative proteomics by Stable isotope labeling of amino acids in cell culture (SILAC). GF, 
growth factor.  
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 3.6 Enzymatic isotope labeling (
18
O)  
Peptides can also be isotope labeled via enzymatic reactions. This approach involves specific 
proteases such as trypsin that incorporate water into the carboxy-termini of peptides during 
proteolysis
76
. The isotope labeling is accomplished by performing digestion in the presence of 
stable isotopically enriched water (H2
18
O). Depending on the protease utilized and duration of 
digestion either one or two 
18
O atoms can be incorporated into a peptide. Endoproteases such as 
trypsin, Lys-C and Glu-C are all capable of incorporating two 
18
O atoms per peptide.  
Trypsin digestion in 
18
O-water therefore results in mass spectra with labeled peptide ion pairs 
spaced by 2 or 4 Da (
18
O-labeled vs. the corresponding analogous peptide digested in natural 
water). Unfortunately, it seems like this methods have some drawbacks that derives from back-
exchange of 
18
O for 
16
O from solvent during storage and handling of sample
99
. They are 
therefore not very frequently used. 
 
3.7 Tandem mass tags - iTRAQ 
As discussed above, proteins can be quantified relative to each other by comparing the intensities 
from MS
1
 mass spectra of isotope label peptides originating from two different cell states 
combined in one sample. Alternatively, quantitative information can also be derived from 
fragment ions in tandem mass spectra. iTRAQ™ is a recently developed protein quantitation 
method that utilizes isobaric amine specific tags
92
 (Figure 3.6).  
 
Figure 3.6 iTRAQ reagent 
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Each tag consists of a reporter and balance group, which is prone to fragmentation, see figure 
3.6. The technique is based on chemically tagging the free N-terminus and lysine- -amino group 
on peptides generated from protein digests that have been isolated from cells in different states. 
The tagged samples are then combined, fractionated by nanoLC and analyzed by tandem MS. In 
MS
1
 spectra the differentially labeled versions of a peptide are indistinguishable. However, in 
MS/MS spectra each tag generates a unique reporter ion (immonium-like ion). Protein 
quantitation is then achieved by comparing the intensities of the reporter ions in the MS/MS 
spectra. There are eight tags available enabling up to eight different conditions to be analyzed in 
one experiment. 
 
3.8 AQUA and Absolute SILAC for absolute quantitation  
In addition to the wealth of isotope labeling strategies that have been developed in proteomics 
for relative quantitation, Gerber et al. have developed a simple approach to measure absolute 
quantity of peptides and proteins called AQUA
100
.  This quantitation technique is based on 
internal peptide standards, which are synthesized using stable isotope (
13
C / 
15
N) labeled amino 
acids. Known amounts of the peptide or peptides of interest are introduced (“spiked”) into the 
sample and the absolute quantity of the endogenous peptide can readily be derived from the 
relative ratio observed by MS.  
 
However, due to the costs associated with synthesis of isotopically labeled peptides this strategy 
has mainly been applied in targeted approaches where a single or few peptides were monitored at 
the same time. Another drawback of the AQUA strategy is that the peptides are introduced after 
the digestion step; therefore strictly speaking the absolute amount of peptide at this purification 
stage rather than in the original sample is determined. Another approach to absolute quantitation 
is QCAT
101
, which is a multiplexed absolute quantitation method using plasmids to synthesize 
isotope-labeled (
15
N) proteins. Recently, we developed a new and more robust method for 
absolute quantitation called “Absolute SILAC”102. In this method SILAC-labeled recombinant 
proteins produced in vivo or in vitro are used as internal standards, which are directly mixed into 
lysates of cells or tissues - thereby minimizing the systematic errors resulting from differences in 
sample processing. Successful application of this approach resulted in precise quantitation of 
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Grb2 copy numbers in HeLa, HepG2 and C2C12 cell lines against the backdrop of whole cell 
lysate. 
 
3.9 Alternative methods – Quantitation without Stable isotopes 
Stable isotope labeling of proteins is not always practical and is relatively expensive. There are 
several alternative methods for MS quantitation. Although these methods are not as precise and 
elegant as isotope-labeling approaches they can be used to extract useful information from MS 
data sets. The most simple and inaccurate approach is called subtractive proteomics, where two 
samples are compared with MS by subtracting all proteins identified in one sample from all those 
identified in the other. This is obviously not a very good approach for quantification, because 
even replicates of the same sample have been shown to have poor overlaps in complex peptide 
mixture analysis.  For example, it has been observed that two replicate MudPIT experiments 
produced two sets of protein identifications with only 65% overlap103.  
 
A more elegant way to quantify proteins between a set of samples is to use the extracted ion 
chromatogram (area under the curve as the peptide elutes from the column), which is in principle 
available for all peptides if the resolution is sufficiently high. Signal-intensity based quantitation 
successfully discriminated between true centrosomal proteins and unspecific ones by “protein 
correlation profiling” of adjacent sucrose fractions104. The accuracy of quantitation in this 
experiment was estimated to be within 30% between peptides derived from the same protein.  
 
Finally, there are of course traditional biochemical methods such as radioactive-labeling, 
differential 2D-gel dyes and western-blotting approaches. However, these methods are only 
useful for quantitation of known proteins or require a difficult extra identification step for 
unknown components. 
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 4. Mass spectrometry data analysis - from ions to protein 
identification and quantitation 
 
The broad application of proteomics in different biological and medical fields, as well as the 
diffusion of high-throughput platforms, leads to increasing volumes of available proteomics data 
requiring efficient algorithms, new data management capabilities and novel analysis, inference 
and visualization techniques. Computational proteomics is an emerging field of biomedical 
informatics research arising from the demand of high throughput analysis in numerous large-
scale experimental proteomics projects
46
. Data analysis in MS based proteomics is a two-tier 
process where the first few steps are related to the identification and quantitation of proteins (and 
their post-translationally modified counterparts) followed by the last step of functional 
proteomics analysis by bioinformatics (Figure 4.1). Computation proteomics mainly deals with 
the first step of this workflow and has evolved as a separate discipline in itself over the past 
decade
41
.  
 
Figure 4.1 Data flow in MS based proteomics(adapted from ref3). PFF, peptide fragmentation 
fingerprinting; PMF, peptide mass fingerprinting 
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In a proteomics experiment different steps can be identified,
 
each one having one or more 
parameters of choice: (i) sample
 
preparation, including separation and labeling; (ii) MS 
experiment,
 
including mass spectrometer choice and configuration; (iii)
 
spectra preprocessing, 
including spectra signal deconvolution, often performed by the spectrometer software, baseline 
subtraction, noise removal, dimension reduction, peak extraction, outlier detection; (iv) 
peptide/protein identification, including database searching, perhaps coupled with de novo 
sequencing or sequence tagging and (v) peptide/protein quantitation, either performed through 
stable isotope labeling or through intensity profiling. Each of these steps has important 
implications on the algorithmic and analytical aspects of computational proteomics. The 
computational facets of all these steps are discussed elaborately in literature and can be found in 
these reviews
3,105
.  
 
4.1 Peptide and Protein identification  
Protein identification by peptide sequencing is at the heart of bottom-up or top-down 
proteomics
42
. The cornerstone in protein identification are peptide database search algorithms 
such as MASCOT and SEQUEST (based on database and signal processing paradigm)
106,107
, 
which allow automatic matching and scoring of peptide fragment ion spectra against protein 
sequence databases. This approach for protein identification is also known as “searching of 
uninterpreted mass spectra” or “probability based scoring”. When a peptide ion is fragmented in 
an MS/MS experiment, there are two pieces of information that are known for each peptide. The 
first is the molecular weight of the peptide and the second is the list of fragment ion masses and 
their intensities. This information is used by the search algorithm in an attempt to identify the 
peptide sequence in a given protein database. All entries in the database are digested “in silico” 
using the appropriate enzyme and possible modification masses are added to the mass of the 
resulting peptides. Every experimentally recorded peptide mass is then compared to all in-silico 
peptides of the same mass, within operator set mass tolerances, and all theoretical peptides with 
other masses are discarded. Then, the calculated fragment ion masses for all of the peptides in 
the selected mass range are compared to the experimentally observed fragment ion masses for 
the peptide - again within operator set mass tolerances - and an peptide score is assigned. The 
output from the search displays the best matching peptide sequence (if any) in the database for 
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each MS/MS spectrum and an associated score that indicates how good the match is. In 
probability based algorithms like MASCOT, the score for an MS/MS match can be given as –
10*Log10(p), where p roughly corresponds to the probability that the observed match between 
the experimental data and the database sequence is a random event. In the result output the 
search-software also groups peptides matching the same protein sequence. 
 
Many more bioinformatics approaches to protein identification have been developed in recent 
years which draw insights from various computational methods, for instance graph theory
108
, 
statistical learning
109
 and machine learning approach
110
. Additionally, the identification of post 
translationally modified peptides and proteins pose formidable computational challenges
111,112
, 
which needs specialized algorithmic treatment 
108,113
. 
 
4.2 Peptide and Protein Quantitation 
Protein quantitation by MS depends on either comparison of labeled (or tagged) peptides or by 
label-free methods for comparison of identical peptides across different biological states
45,114
. 
With advances in MS technology and experimental setups for proteomics, a typical proteomic 
experiment can produce gigabytes of data
115
. Therefore manual analysis of such datasets to 
extract quantitative information is not possible by proteomics researchers and can only be done 
in an automated way by using advanced computational algorithms and analytical pipelines. 
Unlike microarray technology, the lack of standardized and comprehensive quantitation software 
for MS data has been one of the largest challenges and bottlenecks for proteomics
46,116
. To date 
various empirical methods like peptide counting
117
 and spectral counting has been used
118,119
 for 
protein quantitation. The past few years has witnessed application of machine learning and 
mathematical and statistical methods for quantitative proteomics
120
. But most of these methods 
are inherently inaccurate and were developed for low resolution MS data. Therefore they fail to 
deliver when MS data is highly resolved and fine grained as generated by the latest generation of 
mass spectrometers. Our laobratory has recently developed a suite of integrated algorithms 
specifically for high resolution, quantitative MS data based on state-of-the-art data modeling, 
correlation analysis and graph theory
47
. Though still in its infancy, computational proteomics for 
protein quantitation is one of the most exciting area for bioinformatics researchers and it is 
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witnessing rapid developments in computational frameworks, data standardization
121
 and 
software development
3
. 
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5. Bioinformatics for high throughput “omics” sciences 
 
The foundations of modern molecular biology were laid in the early 1950s by pioneering work 
carried out for elucidating the sequence and biomolecular structures of DNA and proteins
122-124
 
(Figure 5.1). Since then this field has caused a paradigm shift in biomedical research, and played 
very instrumental roles in our current understanding of cellular biology.  
 
Figure 5.1 Timeline of solved structures of some key biomolecules (adapted from ref125 ). 
 
One of the most impressive achievements of molecular biology has been that it bridged the gap 
between experimental and computational research thereby transforming biology into a 
quantitative, information driven discipline
126,127
. Some of the most fundamental and scientifically 
significant questions addressed by molecular biology presented novel, interesting and at times 
formidable algorithmic problems, and relied heavily on computational resources
4,5
. For instance, 
the structure of DNA
128
, the encoding of genetic information for proteins
129
, the factors 
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governing protein structure
130,131
, the structural properties of protein molecules
132-135
, the 
evolution of biochemical pathways
136
 and gene regulation
137
, and the chemical basis for 
development
138
 all contain seeds of some of the problems that were only possible to address by 
computation in the ensuing decades.  Application of computer technology and computational 
methods to molecular biology is not a recent trend
5
.  
 
Large scale genome sequencing of model organisms and humans at the beginning of the twenty 
first century
97,139,140
 has been a landmark achievement in biomedical sciences that was fueled by 
extraordinary advances in molecular biology and computer science. This in turn helped in 
redefining the synergy between biology, mathematics and information sciences, thereby leading 
to emergence of bioinformatics as a scientific discipline. Bioinformatics involves the integration 
of computers, computational algorithms, software tools, and databases in an effort to address 
biological questions. Bioinformatics approaches are often used for major initiatives that generate 
large data sets. In the post genomic era bioinformatics has embedded itself into the very fabric of 
contemporary biology and become an indispensable part of any ambitious molecular biology 
enterprise.  
 
5.1 Current state-of-the-art in Bioinformatics 
Initial bioinformatics research and applications were primarily focused on analysis of biological 
sequence data, genome content, and rearrangement, and for prediction of function and structure 
of macromolecules
141-143
(Figure 5.2). With the advent of high throughput “omics” disciplines in 
the past few decades, it is now feasible to systematically profile a biological system at different 
levels of molecular and cellular organization, including its epigenome, transcriptome, 
metabolome, proteome, and interactome
62
. Owing to the largely disparate nature and scale of 
these data types, newer analysis and research directions have spawned from conventional 
bioinformatics, for instance - comparative genomics
144
, functional genomics
145
, network 
biology
146
, and computational proteomics
41
. Moreover, with the further realization that the 
complete understanding of the physiology of biological systems entails an undertaking of multi-
level data integration and analysis, computational systems biology has come into prominence
147
.  
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Figure 5.2 The Use of Computers to Process Biological Information.  
(A) The wealth of genome sequencing information has required the design of software and the use of 
computers to process this information. (Image adapted from Joanne Fox article URL:  
http://bioinformatics.ubc.ca/about/what_is_bioinformatics/). (B) The evolutionary trace (ET)  method 
for identifying specificity residues in proteins (adapted from ref148). An alignment of related sequences 
to a protein of interest is created (left panel). The level of conservation of columns in the alignment is 
calculated (colors represent a sliding scale in which the most conserved residues = red, those with 
intermediate conservation = green and the least conserved = blue) and conserved positions are mapped 
onto the structure or sequence of the unknown protein. In the right panel a comparison of the actual 
substrate-binding residues and predicted residues when the ET method was applied to the ATP-grasp 
domain of a d‑Ala–d-lactate ligase (Protein Data Bank entry 1EHI). It can be seen that the ET method 
achieves a close prediction of the substrate-binding site. 
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The quest for systems level understanding of biological systems has led to evolution of 
bioinformatics as a multifaceted and complex scientific ecosystem, with active research activities 
in each of its sub-disciplines. In this section current state-of-the-art in modern bioinformatics 
research in the context of “omics” disciplines are briefly reviewed, more detailed accounts can 
be found in the huge body of literature published in last decade
149-152
 
 
5.1.1 Bioinformatics for Gene Expression - Functional Genomics 
Microarrays have now permeated literally every field of biology and have found numerous 
applications in applied and translational research
153-155
. Large-scale microarray studies are also 
becoming crucial to a new way of conceiving experimental biology
156
. Since the inception of this 
technology, one of the primary challenges for bioinformatics researchers has been to analyze and 
mine the high-dimensional dataset generated in a typical microarray experiment
157
. Furthermore, 
these challenges are accentuated by the diversity of biological questions being investigated by 
this platform. Microarray data is being used in conjunction with computational algorithms and 
various machine learning paradigms which finds wider application in drug discovery, basic 
research and target discovery, biomarker determination, pharmacology, toxicogenomics, 
development of prognostic tests, population genomics and disease subclass determination. 
Inferential
158,159
 and descriptive statistical
160-162
 methods have been successfully applied to 
microarray data to uncover patterns of gene expression and behavior of genetic markers in 
diseases, especially cancer
163-166
 (Figure 5.3). Reverse engineering of gene networks using gene 
expression data based on Bayesian statistics (probabilistic models)
167
(Figure 5.4) , Boolean 
networks
168
, Relevance Networks
169
, and graph theoretic algorithms
170
 has gained momentum in 
recent years
171-173
.  The diversified field of analysis of microarray data falls under the umbrella of 
Microarray Bioinformatics. 
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Figure 5.3 DNA-microarray analyses can identify relevant clinical subsets of gliomas (adapted from 
ref174). (A) and (B) show that different subtypes of gliomas have distinct gene-expression profiles as 
revealed by multidimensional scaling and hierarchical clustering respectively. (C) and (D) show 
identification of molecular subsets of microscopically identical glioblastomas by hierarchical clustering 
and multidimensional scaling respectively. (E)  Hierarchical clustering of 85 high-grade glioma samples 
on the basis of the expression of 595 genes that are highly differentially expressed in patients with 
relatively good survival times versus those with shorter survival times. Four subsets of patients are 
detected. (F)  Kaplan–Meier survival analysis shows that these genes can identify the subset of patients 
who are most likely to have prolonged survival times (E, cluster 1A, black). 
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Figure 5.4. Regulatory network architecture learnt from microarray data using reverse engineering 
algorithms ( figure adapted from ref173).  Shown is an unconstrained acyclic network where each gene 
can have a different regulator set. This is a fragment of a network learned in the analysis of Pe'er et 
al.175, performed on Rosetta compendium of expression profiles from budding yeast by Hughes et al.156 . 
A summary of direct neighbor relations among the genes is shown based on bootstrap estimates. 
Degrees of confidence are denoted by edge thickness. A sub-network of genes involved in the yeast-
mating pathways was automatically identified with high-confidence relations among them. The colors 
highlight genes with known function in mating, including signal transduction (yellow), transcription 
factors (blue), and downstream effectors (green). 
 
5.1.2 Bioinformatics of Gene Regulation 
The completion of various genome sequencing projects has provided us with the genetic 
blueprint of genomic organization and structure, thereby leading to many intriguing 
observations. Foremost among them is the discovery that cells and organisms devote a 
significant fraction of their DNA to encode cis-regulatory programs that control and coordinate 
gene expression at the transcript level
176
. Trans-acting protein and cis-regulatory sequences are 
the principle components of these molecular programs which act in response to a particular 
cellular context (state) and extra-cellular inputs, and have pivotal role in organismal development 
and evolution
177
. A complete understanding of this molecular algorithm will have profound 
impact on biological research that will be essential for gaining insights into development, cellular 
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responses to environmental and genetic perturbations and the molecular basis of many 
diseases
178
. While the unraveling of the entire network of gene regulation is a distant goal, 
promising results in this direction have started to emerge from diverse studies which include 
bioinformatics approach for identification of cis-regulatory sequences (reviewed in ref179), and 
development of in-silico mathematical models for gene regulatory networks based on 
experimental observations
180-182
. With recent interesting discoveries in transcriptional regulation 
by regulatory RNAs (miRNA,siRNA,piRNA) and current appreciation of the role of epigenetics, 
the bioinformatics research in this domain has gained impetus in computational prediction of the 
key players of gene regulations including various regulatory RNAs and their targets
183-185
 and 
prediction and modeling of epigenetic information and contexts
186
. The bioinformatics of gene 
regulation is currently one of the most exciting areas of computational research. 
 
5.1.3 Network Bioinformatics 
Cells and organisms have evolved amazingly elaborate and intricate mechanisms to carry out 
their basic functions. These functions emerge largely as a result of the dynamic interplay 
between cellular components- genes, proteins, and metabolites, which are further interwoven in 
complex biological networks including webs of protein-protein interactions, regulatory circuits 
linking transcription factors and cis-regulatory targets, signal transduction pathways and 
metabolic pathways. Recent scientific and technological breakthroughs in high-throughput 
genomics
187,188
  and proteomics
189
 are enabling us to discover the molecular programs carried out 
by these networks. But we are still far from a complete understanding of the design principles, 
architecture and dynamics of these networks. Promising results in this direction have started to 
emerge from diverse studies which include mathematical modeling and simulation of pathways, 
graph-theory analysis of global network structure, application of engineering concepts to 
network analysis, partitioning of networks into functionally related modules & motifs, and de 
novo design of networks190-192. Graph-theory analysis proposed by Barabasi et al.146 provides 
details about the static topological properties (degree distribution, clustering coefficient), internal 
organization (hubs, motifs) and evolution of these networks (Figure 5.5). Application of 
engineering concepts to biological network analysis has revealed that biological networks share 
structural principles of modularity, robustness and recurrent circuit elements with their 
engineering counterparts
193-195
.  
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Figure 5.5 A map of protein–protein interactions in Saccharomyces cerevisiae (adapted from Jeong et 
al.196), which is based on early yeast two-hybrid measurements197, illustrates that a few highly connected 
nodes (known as hubs) hold the network together. The largest cluster, which contains 78% of all 
proteins, is shown. The color of a node indicates the phenotypic effect of removing the corresponding 
protein (red = lethal, green = non-lethal, orange = slow growth, yellow = unknown). 
 
Reverse engineering of networks
173,198
 based on machine-learning approach has gained 
momentum in recent years because of the availability of high throughput data, especially from 
microarrays, yeast two-hybrid screens (Y2H) and chromatin immunoprecipitation (ChIP) 
experiments.  Additionally, approaches dealing with dynamics of gene regulatory and protein-
protein interaction networks have been recently reported
199,200
. Integration of phenotypic, drug 
target and disease annotation information with protein interaction and metabolic networks has 
led to interesting insights into disease mechanisms, morbidity and drug actions
201-203
.  
 
Bioinformatics for high throughput “omics” sciences 
     
 
49 
 
Metabolic network analysis spans another dimension of network bioinformatics whereby 
specialized analytical methods based on constraint-based approach such as flux variability 
analysis (FVA) have been popularized by Palsson et al.204-206(Figure 5.6). In recent years 
network bioinformatics has successfully integrated into the theme of wet biology by providing 
testable hypothesis to biologists
207, 208
.  
Figure 5.6 A map of some of the reactions in glycolysis and the pentose phosphate pathway of E. coli 
(adapted from Becker et al.209). Using Flux Variability Analysis (FVA), the minimum (min) and maximum 
(max) allowable flux values for each reaction were determined using the E. coli model iJR904. The values 
shown in the table correspond to the min and max allowable fluxes for each reaction shown in the map 
when the predicted growth rate is constrained to 90% of the optimal value under glucose-limiting 
conditions. The results were further characterized by the direction of predicted flux (bidirectional or  
unidirectional) computed using FVA. The black arrows in the figure show the predicted unidirectional 
direction of flux for reversible reactions that can potentially operate in either direction. 
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5.2 Bioinformatics for high-throughput mass-spectrometry proteomics data 
Mass spectrometry based proteomics has undergone tremendous advances over the past few 
years largely due to technological breakthroughs in instrumentation and state-of-the-art 
innovations in computational proteomics
2
. Proteomics is now a very data intensive discipline that 
requires extensive analytical and data-mining support, and bioinformatics has thus become a 
pivotal constituent of this discipline. Proteomics research endeavors can be classified into two 
broad categories, namely qualitative proteomics and quantitative proteomics. The scope of 
functional proteomics analysis and the analytical direction that can be taken are largely 
dependent on the type of dataset generated by these research endeavors, and are discussed next. 
 
5.2.1 Bioinformatics for Qualitative Proteomics 
In qualitative proteomics the focus is on enumeration of the proteome constitution of a system of 
interest - body fluid, cell type, organelle, tissue or an entire organism
50-52,57,210
. Most of the 
bioinformatics activities therein focus on functional data mining of the dataset to extract the 
global biological theme underlying the proteome. In recent years genome-wide annotational 
datasets like gene ontology (GO)
48
, protein domain organization (PFAM, InterPro)
211,212
, 
pathways (KEGG)
49
, and disease mutations(OMIM) have been successfully used for functional 
grouping of the proteomes
213
. These annotations can be further used in conjunction with 
statistical tests to find over/under-represented functional categories
50,52
. Additionally, integration 
with other high throughput “omics” datasets (microarray, ChIP-chip) and annotations has 
provided valuable insights into proteome expression and turnover, and their role in disease 
mechanisms
30,57,214-216
. In the same vein, augmentation of genome annotation
108,217,218
, and search 
for gene models based on high confidence peptide information has shown interesting results in 
predicting novel genes and splice variants
52,219
. 
  
5.2.2 Bioinformatics for Quantitative Proteomics 
Quantitative mass-spectrometry (MS) adds another dimension to proteomics studies by providing 
quantitative data of proteome changes in the cellular states being investigated
45
. This may be 
either studied on a binary level of protein changes (normal vs. cancer, stimulated with a growth 
factor vs. non-stimulated) or on multiple levels of protein changes (temporal steps of cell cycle, 
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maturation of organelle or differentiation of cells).  Supervised and non-supervised machine 
learning approaches have found wider applications in analyzing such datasets
120
. The 
hierarchical clustering approach has been adopted in various proteomics studies to cluster 
phospho-proteomic and proteomic datasets across multiple conditions or samples
220
. In the first 
global analysis of temporal profile of phosphoproteome dynamics, I used fuzzy k-means 
clustering approach to cluster data across four time points
65
. As part of creating an organelle map 
of mouse liver proteome Foster et al. used a supervised approach to assign organelle localization 
to proteins based on the correlation to organelle specific marker protein dynamics
58
. Dunkley et 
al. used principal component analysis (PCA) methodology to assign organelle localization to 
protein based on their quantitative data across multiple organelles
221
. Rinner et al. employed a 
combinatorial workflow of label-free mass spectrometry and computational analysis based on an 
ensemble of k-means clustering and expectation maximization (EM), to confidently identify 
interaction partners in protein complexes
222
. In clinical applications of proteomics, biomarker 
discovery by comparison of proteome profiles of healthy and disease individuals or cohorts rely 
heavily on pattern mining approaches – using for instance genetic algorithms223, and on building 
classification models for disease predictions
224
.   
 
5.3 Prologue to the thesis work study 
In chapters 6-9 of the thesis I discuss specific projects illustrating applications of bioinformatics 
for the functional and systematic analysis of high throughput proteomics data. The projects will 
be discussed as complete entities with the relevant experimental, computational methods and 
results. The analysis workflow and computational methods for each of them were developed as 
part of my PhD study in Department of Proteomics and Signal Transduction at the Max Planck 
Institute for Biochemistry.  
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6. In-depth Analysis of the Adipocyte Proteome by Mass 
Spectrometry and Bioinformatics 
 
This work is included as a manuscript that has been published with the following citation: 
 
Jun Adachi
φ
, Chanchal Kumar
φ
, Yanling Zhang, Matthias Mann 
In-depth Analysis of the Adipocyte Proteome by Mass Spectrometry and Bioinformatics 
(2007) Mol Cell Proteomics; 6(7):1257-1273 
φ
 These authors contributed equally to this work 
6.1 Introduction 
Obesity has become a global health epidemic, which leads to
 
an increased population risk for 
obesity-related complications
 
such as hypertension, dyslipidemias, type II diabetes mellitus,
 
and 
cardiovascular diseases associated with the onset of insulin
 
resistance
225,226
. Studies in the last 
few years have transformed
 
our thinking about the function of adipocytes (fat cells) in
 
physiology 
in general and obesity in particular
227
. They are
 
no longer regarded just as a passive depot for 
storing excess
 
energy in the form of triglyceride but as endocrine cells
 
that actively regulate the 
pathways responsible for energy
 
balance by the secretion of various bioactive substances termed
 
adipocytokines. Furthermore recent research has highlighted
 
the lipid droplet as a dynamic and 
actively regulated organelle
228,229
. To elucidate the pleiotropic functions of the adipocyte,
 
several 
proteomics studies had been conducted. However, a large scale proteomics
 
study of adipocytes 
has not been reported before and could serve
 
as a useful resource for fundamental biomedical 
research. These considerations
 
as well as our interest in insulin signaling and the metabolic
 
syndrome prompted us to perform an in-depth proteomics analysis
 
of the cellular and organellar 
proteome of adipocytes. We used
 
a combination of one-dimensional gel electrophoresis and on-
line
 
electrospray tandem mass spectrometry with biochemical procedures
 
for sub-fractionation of 
the cellular proteome (Figure 6.1). State
 
of the art protein identification technology recently 
developed
 
in our laboratory, involving a linear ion trap (LTQ) -FTICR
 
mass spectrometer with 
very high mass accuracy
84
, allowed
 
us to identify more than 3,200 proteins with extremely 
stringent
 
identification criteria.  
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Figure 6.1 An overview of the experimental and bioinformatics procedures used for analysis of the 
adipocyte proteome. MAPU database: Max-Planck Unified Proteome database. 
 
Extensive bioinformatics analysis and
 
comparison with transcriptome data revealed
 
several layers 
of information related to the adipocyte proteome
 
that were in turn mapped to an ensemble of 
biological processes,
 
functions, and pathways. Additionally by using a systemic protein
 
In-depth analysis of the adipocyte proteome by mass spectrometry and bioinformatics 
     
 
55 
 
prioritization methodology described recently
8
 we predicted
 
candidate proteins hitherto not 
known to be involved in insulin-dependent
 
vesicular trafficking. 
 
6.2 Materials and Methods 
 
6.2.1 Cell culture 
The maintenance and differentiation of mouse 3T3-L1 preadipocytes were essentially as 
described
230,231
. Briefly, two days after the cells reached confluence, a cocktail of 0.5 mM 3-
isobutyl-1-methyxanthine (mix; Sigma), 1 µM dexamethasone
 
(Sigma), and 167 nM insulin 
(Sigma) was supplied during culture (day 0). After 48 h (day 2), the cocktail was replaced with 
only 167 nM insulin. An additional 48
 
h (day 4) later, insulin was withdrawn, and the medium 
was changed
 
every second day. Fat accumulation was measured by Oil Red O staining and 
differentiated cells at day 9 were used for further experiments.  
 
6.2.2 Subcellular fractionation and western blotting 
Differential centrifugation was used to fractionate adipocytes as described previously 
232,233
. 
Briefly, cells were sheared by 10 passages through a 25-gauge needle and centrifuged at 1,000 g 
for 10 min at 4 °C. The supernatant was called crude cytoplasm and served as the source of 
cytosol, mitochondria and membranes. The pellet contained nuclei. (1) To obtain pure nuclei, the 
pellet was resuspended in sucrose-TKM buffer and overlaid in the 1.6 - 2.3M sucrose gradient. 
After centrifugation at 160,000 g for 1 h (Sorvall surespin 630 rotor), the nuclei settled at the 2.1-
2.3 M interface. This nuclear layer was isolated, diluted and centrifuged at 2,700 g for 10 min. 
The final nuclear pellet was resuspended in 200 μl of HES buffer. (2) To obtain pure 
mitochondria, the crude cytoplasm was centrifuged at 16,000 g for 1 h. The resulting pellet was 
suspended in TES buffer and centrifuged at 16,000 g for 20 min. The pellet was suspended, 
while the supernatant served as the microsomal and cytosolic fraction. This supernatant was 
overlaid with 0.58 - 1.55 M sucrose step gradient and centrifuged at 160,000 g for 1 h.  The 
mitochondrial layer at the 1.29-1.55 M interface were isolated, diluted in 15 ml of 0.25 M HES 
buffer and centrifuged at 16,000 g for 20 min. The purified mitochondrial pellet was resuspended 
in 300 μl of HES buffer. (3) To obtain pure membrane fraction, the post-mitochondrial 
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cytoplasmic fraction was centrifuged at 160,000 g for 1 h. The supernatant served as the 
cytosolic fraction. The pellet was resuspended in HES buffer and centrifuged again at 160,000 g 
for 1 h. The purified membrane pellet was resuspended in 200 μl of HES buffer. (4) To enrich 
proteins in the cytosolic fraction, Centriprep YM-3 membrane concentrators (Millipore, 
Billerica, MA) were used. Total protein in all fractions was then quantified using the Coomassie 
Protein Assay Kit (Pierce, Rockford, IL) and stored at -80 ºC. Equal protein amounts (7 μg) from 
each of the subcellular fractions were loaded onto 10 and 15% SDS-polyacrylamide gels, 
electrophoresed, transferred to nitrocellulose membranes, and immunoblotted with antibodies 
against histone H3 (Cell signaling technology, Beverly, MA), cytochrome C (BD Pharmingen, 
San Diego, CA), insulin receptor β chain (Santacruz Biotechnology, Santacruz, CA) and MEK1 
(upstate, Lake Placid, NY), followed by HRP-conjugated secondary antibodies. The membranes 
were subjected to chemiluminescent detection according to manufacturer's instructions (ECL, 
GE Healthcare, Piscataway, NJ). 
 
6.2.3 1D-SDS-PAGE and in-gel digest  
Proteins (100, 150, 150 and 150 µg) from  each of the subcellular fractions (nuclear, 
mitochondrial, membrane and cytosol fractions, respectively) were separated by one dimensional 
SDS-PAGE, using NuPage
® 
Novex Bis-Tris gels and NuPage
® 
MES SDS running buffer 
(Invitrogen, Carlsbad, CA) according to instructions of the manufacturer. The gel was stained 
with Coomassie using Colloidal Blue Staining Kit (Invitrogen). Protein bands were excised and 
subjected to in-gel tryptic digestion essentially as described
234
. Briefly, the gel pieces were 
destained and washed, and, after dithiothreitol reduction and iodoacetamide alkylation, the 
proteins were digested with porcine trypsin (modified sequencing grade; Promega, Madison, WI) 
overnight at 37 °C. The resulting tryptic peptides were extracted from the gel pieces with 30% 
acetonitrile, 0.3% trifluoroacetic acid and 100% acetonitrile. The extracts were evaporated in a 
vacuum centrifuge to remove organic solvent, then desalted and concentrated on reversed-phase 
C18 StageTips as previously described
235
.  
 
6.2.4 Nanoflow LC- MS
2
 or MS
3 
All nanoflow LC-MS/MS and MS/MS/MS experiments were performed basically as described 
previously
84,236
. All digested peptide mixtures were separated by online reversed-phase (RP) 
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nanoscale capillary liquid chromatography (nanoLC) and analyzed by electrospray mass 
spectrometry (ES MS/MS and MS/MS/MS). The experiments were performed on an Agilent 
1100 nanoflow system connected to an LTQ-FTICR mass spectrometer (Thermo Electron, 
Bremen, Germany) equipped with a nanoelectrospray ion source (Proxeon Biosystems, Odense, 
Denmark). Binding and chromatographic separation of the peptides took place in a 15 cm fused 
silica emitter (75 μm inner diameter) in-house packed with reversed-phase ReproSil-Pur C18-AQ 
3 μm resin (Dr. Maisch GmbH, Ammerbuch-Entringen, Germany). Peptide mixtures were 
injected onto the column with a flow of 500 nl/min and subsequently eluted with a flow of 250 
nl/min from 10% to 64% acetonitrile in 0.5% acetic acid, in a 105 min gradient. Data were 
acquired in data-dependent mode using Xcalibur software. The precursor ion scan MS spectra 
(m/z 300–1575) were acquired in the FT ICR with resolution R = 25000 at m/z 400 (the number 
of accumulated ions 5 × 10
6
). The three most intensive ions were isolated and fragmented in 
linear ion trap by collisionally induced dissociation using 3 × 10
4
 accumulated ions. They were 
simultaneously scanned by FT ICR-selected ion monitoring with 10-Da mass range, R = 50000 
and 5 × 10
4 
accumulated ions for even more accurate molecular mass measurements. For MS
3
, 
most intense ion with m/z > 300 in each MS2 spectra were further isolated and fragmented. In 
data-dependent LC/MS
2
 experiments dynamic exclusion was used with 30-s exclusion duration.   
 
6.2.5 Proteomic data analysis 
Proteins were identified via automated database search (Mascot; Matrix Science, London, United 
Kingdom) of all tandem mass spectra against an in-house curated version of the Mouse 
International Protein Index protein sequence database (IPI, versions 3.07) containing all mouse 
protein entries from Swiss-Prot, TrEMBL, RefSeq and Ensembl as well as frequently observed 
contaminants (porcine trypsin, achromobacter lyticus lysyl endopeptidase and human keratins). 
A „decoy database‟ was prepared by reversing the sequence of each entry and appending this 
database to the forward database. Carbamidomethyl cysteine was set as fixed modification, and 
oxidized methionine, protein N-acetylation, N-pyroglutamate and deamidation of asparagine and 
glutamine were searched as variable modifications. Initial mass tolerances for protein 
identification on MS peaks were 5 ppm and on MS/MS peaks were 0.5 Da. Two “missed 
cleavages” was allowed. The instrument setting for the Mascot search was specified as “ESI-
Trap”. Peptide identification information was extracted from the Mascot result file into 
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EPICenter (Proxeon Biosystems)
237
. Besides the standard search engine results used for peptide 
assignment (score, expected versus calculated fragment ions, delta mass), additional empirical 
information was computed by the EPICenter peptide validation module to assist in the 
assignment
237
.  Peptides satisfying the following four criteria were accepted for identification. 1) 
Peptides for which MS
2
 score were above the 99
th
 percentile of significance (Mascot score > 32); 
2) Fully tryptic peptides with sequence length 7 or longer; 3) Peptides for which delta scores (the 
difference in score between 1st and 2nd scoring peptide) were at least 5.0; and 4) Peptides for 
which y-ion or b-ion score was at least 50.0. The Mascot result file was also imported into 
MSQuant, open source software available at http://msquant.sourceforge.net, and the MS
3 
score 
was calculated automatically. Finally the protein identification list was created by accepting the 
peptides (which passed our criterion mentioned before) and consolidating them as per the 
following method. Proteins with at least two peptides and a MS
2
 score of at least 64 were 
counted as identified proteins. This protein identification criterion corresponds to the confidence 
of p = 0.0001 if both peptide identifications are considered independent. For proteins identified 
by a single peptide, we required the presence of an MS
3
 spectrum and a combined score for MS
2
 
and MS
3
 of above 52 which corresponding to a level of false positives of p = 0.0001. EPICenter 
automatically assigns identified peptides to proteins and organizes all proteins with shared 
peptides
 
into a single group (protein group). EPICenter selects the protein with
 
most of the 
peptides an anchor protein and marks proteins that are identified by at least one distinct and 
separate peptide as conclusively identified proteins. We counted proteins as identified only when 
a protein conclusively identified as described above or a protein group consisted of only isoforms 
or overlapping database entries.  
 
6.2.6 Enrichment analysis of Gene Ontology (GO) categories 
BinGO
238
 - the Cytoscape
239
 plugin for finding statistically over or under represented Gene 
Ontology (GO) categories, was used for the enrichment analysis of our liver proteome dataset. 
The 3T3-L1 proteome dataset was compared against a reference set of complete mouse proteome 
(IPI mouse v 3.07) GO annotations. A custom GO ontology file for the reference set of the whole 
IPI version 3.13 mouse dataset was created by extracting the GO annotations available for mouse 
IPI IDs from EBI GOA Mouse 22.0 (containing 32,776 protein annotations). The analysis was 
done using the “HyperGeometric test” and we selected all GO terms which were significant with 
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p < 0.001, after correcting for multiple term testing by “Benjamini & Hochberg False Discovery 
Rate”. The analysis was done separately for GO biological process and molecular function 
categories, and fold enrichment for every over-represented term in the two GO categories were 
calculated. In the following we discuss the fold enrichment calculation for GO biological process 
and the same procedure applies for the molecular function category. Suppose the set of over-
represented biological process GO terms is called GOB . For each term iBGO  in set GOB  the fold 
enrichment measure was calculated by following formula:
)(%
)(%
)(
iBIPIMouse
iBAdipocyte
iBfold
GO
GO
GO
. 
Where 
)_____(
)___(
)(%
processBioGOinannotatedAdipocyteCount
iBwithannotatedAdipocyteCount
iBAdipocyte GOGO  and, 
)_____(
)___(
)(%
processBioGOinannotatedIPIMouseCount
iBwithannotatedIPIMouseCount
iBIPIMouse GOGO . 
 
 
6.2.7 InterPro domain enrichment for insights into protein function 
InterPro (release 13.0) annotations were used for finding statistically enriched protein domains in 
our dataset. We used the Cytoscape
239
 plugin BiNGO
238
 for domain enrichment analysis. For 
domain enrichment we needed three components: 1) the test dataset of identified 3T3-L1 
proteome; 2)The InterPro ontology which was built by parsing the “interpro.xml” file (for release 
13.0) available at ftp://ftp.ebi.ac.uk/pub/databases/interpro/ using in-house scripts; and  3) the 
reference set of InterPro annotation for the complete mouse proteome, which was created by 
parsing the “ipi.MOUSE.IPC” file that contains all the InterPro matches for IPI mouse 3.19 
database, available at ftp://ftp.ebi.ac.uk/pub/databases/IPI/current/ as part of IPI 3.19 release. 
The test set of 3T3-L1 proteome was compared against the InterPro annotations of the IPI mouse 
reference set using the custom InterPro ontology as the reference. The enrichment analysis was 
done using the “HyperGeometric test” and we selected all InterPro domains which were 
significant with p < 0.001, after correcting for multiple term testing by “Benjamini & Hochberg 
False Discovery Rate”. The set of over-represented InterPro terms is called enrichI . 
For each term kIenrich  in set enrichI  the fold enrichment measure was calculated by the following 
formula: )(%
)(%
)(
kIIPIMouse
kIAdipocyte
kIfold
enrich
enrich
enrich
. 
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Where )___(
)___(
)(%
InterproinannotatedAdipocyteCount
kIwithannotatedAdipocyteCount
kIAdipocyte enrichenrich
 and,  
)___(
)___(
)(%
InterproinannotatedIPIMouseCount
kIwithannotatedIPIMouseCount
kIIPIMouse enrichenrich
. Subsequently these enriched 
InterPro domains were grouped in functional categories as per their representative biological 
functions. 
 
6.2.8 Proteome mRNA concordance analysis for 3T3-L1 adipocytes 
To estimate the depth of the proteome we covered in our survey, we compared our identified 
proteome list with the microarray dataset for normal 3T3-L1 adipocyte available at the DGAP 
site (http://www.diabetesgenome.org/chipperdb/expt.cgi?id=60). The available dataset is in 
triplicates for Affymetrix MG_U74A, B and C array types. We used only MG_U74A (containing 
12,654 probe sets) data for analysis because of practical limitations in data analysis. This was 
primarily because of the difference among the probe-sets for these 3 platforms, which makes 
comparison difficult. We used “DCHIP” software for the analysis of the microarray data 
(http://biosun1.harvard.edu/complab/dchip/). The analysis was carried out in two steps. In the 
first step we estimated the basal expression of the 3T3-L1 adipocyte transcriptome and in second 
we mapped our 3T3-L1 adipocyte proteome dataset on the trascriptome data. The expression of 
probe-sets on the triplicates was calculated using “PM-only model”, and was further normalized 
using “invariant set normalization” method165. The expression values were then converted to 
log2 scale. The data was further filtered based on the Present (P) verses Absent (A) call 
percentage which are widely accepted measure of micro array data quality. We used a criterion 
of 66% P call for accepting a probe set as expressed i.e. a probe-set was accepted if it had a P 
call in two out of three samples. Only 5,148 probe sets out of 12,654 met this criterion and they 
were taken as surrogate for basal 3T3-L1 mRNA expression. Subsequently we mapped our 
proteome list on the estimated basal expression set. We used Ensembl MartView 
(http://www.ensembl.org/Multi/martview) release 39 and the “Mus musculus genes NCBIM36” 
dataset, to map adipocyte IPI IDs to their Ensembl counterparts. The Ensembl IDs were then 
used to retrieve the MG_U74A probe-sets ids using Affymetrix‟s NetAffx Analysis Center 
(http://www.affymetrix.com/analysis/index.affx). Thus we could map 3,287 IPI identifiers to 
2,113 MG_U74A probe-sets. Finally the overlap of the adipocyte basal (5,148) probe-sets and 
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our survey (2,113) probe-sets was calculated. This gave us a final number of 1,755 probe-sets 
which were found in both datasets. Hence these 1,755 probe-set data were regarded as the genes 
which we could identify and remaining 3,393 probe sets were used as the not-identified set. We 
use this consolidated information to calculate the average mRNA expression for the identified 
verses non-identified proteome using the expression levels of 5,148 probe-sets.  
 
6.2.9 Protein prioritization analysis 
The recently reported software application for the computational prioritization of genes - 
Endeavour
8
 was used for protein prioritization. 3T3-L1 proteins (IPI IDs) were mapped to human 
orthologs (Ensembl Gene ids) using Ensembl MartView  release 39 and   the “Mus musculus 
genes NCBIM36” dataset. In total 2,990 IPI protein ids were successfully mapped to human 
Ensemble gene ids. The training set ( TrainingS ) was created by choosing  29 genes involved in 
vesicular trafficking in insulin signaling pathway as shown in Figure 6C. The mapped 3T3-L1 
proteome Ensembl list was taken as candidate test set ( TestS ). The following data sources were 
used for ranking: 1) literature (abstracts in EntrezGene); 2) functional annotation (Gene 
Ontology); 3) microarray expression (Atlas gene expression); 4) EST expression (EST data from 
Ensembl); 5) protein domains (InterPro); 6) pathway membership from KEGG(Kyoto 
Encyclopedia of Genes and Genomes); 7) cis-regulatory modules (TOUCAN); and  8) sequence 
similarity (BLAST) data. The model for “vesicular trafficking” genes was created in Endeavour 
using the above mentioned data sources. Finally the candidate test set ( TestS ) genes were ranked 
for their putative role in vesicular trafficking in insulin pathway by measuring their similarity 
with genes in training set ( TrainingS ).  
 
6.2.10 Annotating hypothetical proteins using orthology based annotation transfer 
To assign putative functions to 335 “hypothetical protein” IDs we used Blast2GO240 tool 
(http://www.blast2go.de/) which assigns GO annotation to an unknown protein based on its 
sequence similarity (orthology) to other protein sequences in a pre-selected database. The GO 
annotations are assigned based on a four-tier annotation mapping procedure as described in the 
original paper (ref
240
). We used Swiss-Prot database for this analysis as it serves as the most 
comprehensive experimentally validated protein database.   
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6.2.11 Hierarchical clustering of cellular compartment profiles of the adipocyte proteome  
A cellular compartment distribution matrix was created for the 3,287 IPI ids that we identify in 
our analysis. Briefly suppose C is the 3,287 by 4 cellular compartment matrix corresponding to 
3,287 proteins and 4 compartments (nuclei, mitochondria, membrane, cytosol). For a particular 
IPI say i, 3287,1i  and a particular compartment column j, 4,1j  if the IPI was observed 
with k unique peptides in the compartment, we place C[i, j] = k. Else if the IPI i was not observed 
in compartment column j  then we place C[i, j] = 0. This 3287 by 4 matrix was called cellular 
compartment distribution matrix.  The matrix was further converted to a probability distribution 
matrix probC  of same dimensions (3287 by 4) with each element calculated by the following 
formula:
4
1
,
,
,
j
prob
jiC
jiC
jiC . The matrix probC  was then used for one dimensional hierarchical 
clustering using Genesis
241
 software. The distance metric used was “Euclidean” and the 
clustering was done using “Average Linkage clustering” technique. Subsequently the data from 
earlier large scale studies
242,243
 was overlaid on the clustered dendrogram to ascertain the 
proteome concordance and depth of our fractionation and sub-cellular identification. Also, the 
available GO cellular component terms corresponding to the 4 compartments were extracted for 
the 3,287 IPIs and overlaid on the clustered dendrogram. 
 
6.2.12 Pathway mapping of identified proteins in subcellular compartments  
We used the recently developed functional mapping tool GenMapp version 2.1 
(http://www.genmapp.org)
244
 to map our 3T3-L1 adipocyte dataset on publicly available mouse 
MAPPs.  IPI IDs were mapped to their MGI counterparts using IPI Protein cross reference 
information as available for IPI mouse version 3.13. Overall 3,124 IPI IDs (95.0% of the total) 
could be mapped to their respective MGI ids. Subsequently we created a compartment wide list 
for the mapped MGI ids based on the presence/absence of a particular protein in either of four 
compartments and the data was mapped to latest available mouse MAPPs. 
 
 
In-depth analysis of the adipocyte proteome by mass spectrometry and bioinformatics 
     
 
63 
 
6.3 Results 
 
6.3.1 High confidence protein identification of mouse adipocyte organelles 
In order to reduce the complexity of the proteome and obtain compartment specific information 
in adipocytes, we performed differential ultracentrifugation from differentiated 3T3-L1 
adipocyte cells. The proteome of four compartments (nuclei, mitochondria, membrane and 
cytosol) were examined using the workflow depicted in Figure 6.1.  As shown in Figure 6.2, 
purity of subcellular compartments was excellent as visualized by Western blots of organellar 
markers across the four fractions.   
 
Figure 6.2 Distribution of known organelle markers in subcellular fractions isolated from 3T3-L1 
adipocytes 
 
To further reduce sample complexity and dynamic range in protein abundance levels, proteins in 
each compartment were separated on 1D-SDS-PAGE, and 11 or 12 bands were excised and 
subjected to in-gel tryptic digestion. In total, 45 fractions were analyzed by liquid 
chromatography (LC) on-line coupled to electrospray mass spectrometry. We employed a hybrid 
mass spectrometer consisting of a linear ion trap coupled to a high resolution Ion Cyclotron 
Resonance (LTQ-FTICR) instrument. The mass spectrometer was programmed to perform 
survey scans of the whole peptide mass range, select the three most abundant peptide signals and 
perform narrow range, selected ion monitoring (SIM) scans for high mass accuracy 
measurements. Simultaneously with the SIM scans, the linear ion trap fragmented the peptide, 
obtained an MS/MS spectrum and further isolated and fragmented the most abundant peak in the 
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MS/MS mass spectrum to yield the MS
3
 spectrum
236
. Figure 6.3A shows a mass spectrum (MS) 
of eluting peptides (see ref
42
 for an introduction to peptide sequencing). A selected peptide was 
measured in SIM mode and fragmented (MS
2
) (Figure 6.3B). The most intense fragment in the 
MS
2
 spectrum was selected for the second round of fragmentation (Figure 6.3C). As can be seen 
in the figure, high mass accuracy, low background level and additional peptide sequence 
information obtained from MS
3
 spectra yield high confidence peptide identification. Total cycle 
time for the analysis described above was approximately five seconds. To obtain the protein 
„parts list‟ of adipocytes, high confidence protein identification and reporting were essential. We 
applied a stringent multistep filter to minimize false-positive identifications while maintaining 
favorable detection of lower-abundance and lower-molecular weight proteins (See Section 
6.2.5). In addition to standard search engine results i.e. the Mascot probability score
106
, MS
3
 
score and additional empirical information (y-ion and b-ion score, number of sibling peptides 
and proline score)
237
 were employed for peptide and protein identification. Proteins were 
identified with criteria corresponding to an estimated probability of false positives of p = 0.0001. 
We also performed a decoy database search
245
 to test the experimental level of false positive rate 
in our data set. After applying the stringent criteria mentioned above, we found no false positives 
for protein identified with two or more peptides and only two false positive protein hits with one 
peptide. These results indicate a false-positive identification rate of 2/3287 or 0.06%, at the 
protein level. Thus we conclude that our data set contains no or very few false positive 
identifications. Determining the identities of proteins from sequenced peptides is complicated 
because the same peptide
 
sequence can be present in multiple different proteins or protein
 
isoforms
246
. Standard search engines such as Mascot report proteins even when they do not have 
distinct peptides with their sequence specific to these proteins. Thus, sharing information on 
identified peptides was  
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Figure 6.3 High confidence peptide identification by two consecutive stages of mass spectrometric 
fragmentation (MS3). The precursor of a peptide, YVISAIPPVLTAK (A), was selected for fragmentation 
from a full scan of mass to charge ratio range (shown in red). A fragment of the above, y7 ion (B), was 
subsequently fragmented. A characteristic pattern for charge-directed fragmentation is observed in the 
MS3 spectra (C) and confirms the identification of the above peptide. 
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checked by EPICenter
237
 and manually verified. EPICenter organizes all entries with shared 
peptides
 
into a single group (protein group). The protein that contains
 
most of the peptides is 
selected as an anchor, and all group
 
members that are identified by at least one distinct and 
separate peptide
 
are marked as conclusively identified. We counted proteins as identified only 
when a protein had at least one distinct peptide. If a protein group consisted of only isoforms or 
overlapping database entries indistinguishable by MS, then only the anchor protein was counted, 
thus the number of identified proteins is a lower boundary of the actual value.  
 
From 45 LC-MS/MS/MS runs, 182,271 MS/MS spectra were submitted to Mascot database 
search and 52,585 MS/MS spectra satisfied the criteria for peptide validation. Among these, 
22,706 represent unique sequences in the four cellular fractions. A total of 3,287 proteins were 
identified from four fractions with 8,953 unique peptides. Of all proteins, 20.4% were identified 
with single peptide identification and two stages of peptide fragmentation. Interestingly, 71.3% 
of the total was identified within only one cellular fraction whereas 16.7%, 7.8% and 4.2% were 
identified within 2, 3 and 4 fractions, respectively. This confirms the relatively high quality of 
organellar separation as already suggested by marker analysis in the western blotting 
experiments in Fig. 2. In two previous studies analyzing several mouse tissues each similarly 
separated into four subcellular compartments, protein overlap among compartments was deeper 
and fewer than 50% of total identified proteins were specific to one compartment
243,247
. 
 
6.3.2 Depth and Coverage of the 3T3-L1 Adipocyte Proteome assessed by Comprehensive 
Bioinformatics 
 
6.3.2.1 Qualitative comparison with earlier studies 
We compared our proteome dataset with the recently published mouse liver organelle proteome 
map
242
 and the above mentioned study of six mouse tissues (brain, heart, kidney, liver, lung and 
placenta)
243
. As shown in Figure 6.4A, more than two third of the proteins identified by us in 
adipocytes overlapped with these other proteome.  These proteins are candidates for the 
„household proteome‟, i.e. proteins performing general cellular functions and therefore present in 
different cell lines and tissues. However, the proportion of proteins specific to adipocytes in our 
study (28.7%) is also relatively high. In contrast, in a previous study that compared six human 
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cell lines, specific proteins (proteins that were exclusively found in a single cell line) account for 
only 6% to 36% of all identified proteins
248
. As shown in Figure 6.4B, nearly half of our 
cytoplasm proteins overlapped with the combined cytoplasmic proteins from six human cell 
lines
248
. Secreted proteins were enriched approximately 3.5 fold in identified cytoplasmic 
proteins from adipocyte compared with cytoplasmic proteins from the six cell line proteome.  
 
Figure 6.4 Two-thirds of adipocyte cell line proteins are also found in recent mouse organelle studies. 
(A) Mouse proteins reported recently in membrane-enclosed organelles of mouse liver (Foster et al.242) 
and a study of six mouse tissues (but without fat tissue) (Kislinger et al.243) were BLASTed against 
identified proteins in the current study by ProteinCenter (Proxeon Bioinformatics). Only proteins with at 
least 95% identity were considered to match. (B) The adipocyte cytoplasmic proteins were "BLASTed" 
against the combined cytoplasmic six-cell line proteome (Schirle et al.248). Only proteins with at least 
80% sequence identity were considered to match. 
 
Figure 6.4 clearly shows our proteome dataset contains many proteins which were not identified 
in previous large-scale proteome analysis using both tissues and cell lines. Our result may reflect 
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the depth of high-confidence analysis now possible and/or the specificity of adipocyte for their 
critical role in energy balance and whole body homeostasis. 
 
6.3.2.2 Microarray comparison precludes any abundance related bias in proteome 
identification 
Previously microarray studies have been undertaken to unravel various aspects of 3T3-L1 
adipocyte differentiation, development and function
249-252
 and they serve as a useful resource for 
gaining insights into mRNA expression and cellular dynamics. Moreover microarray studies 
provide an estimate of the transcriptome in a particular biological state at any given time, and we 
wished to use this data as a reference for estimating the coverage and depth of our large-scale 
proteome study. We analyzed the gene expression levels of normal 3T3-L1 adipocyte from 
Affymetrix microarray data generated in the Diabetes Genome Anatomy Project (DGAP). The 
available dataset was in triplicates for each of the MGU_74A, B, C Affymetrix array types. We 
combined the three array type datasets for our analysis. In total they contain 37,886 probe sets of 
which 7,656 were deemed „present‟ by using the 66% Present (P) call criterion (see section 
5.2.8). Out of these 7,656 probes, 2182 could be mapped to our identified proteome. We then 
divided the genes judged to be expressed in 3T3-L1 according to the microarray data into two 
groups: those identified in our study and those not identified (Figure 6.5A).  If proteomics was 
biased to detect only high abundance proteins, we would expect a large difference in mRNA 
signal between the two groups. Remarkably, the distribution of mRNA expression levels was 
less than 2-fold higher for the genes whose products were detected in our proteomic analysis as 
compared to those that were not identified. To further substantiate this finding, we also compared 
our proteome data with the Gene Atlas V2 mouse microarray data for adipose tissue
253
. Again we 
observed that the distribution of mRNA expression level was less than 2-fold higher for the 
genes whose products were detected in our proteomic analysis as compared to those that were 
not (Figure 6.5B). This suggests that proteomics experiments, despite  remaining limitations in 
complex mixture analysis
254
, have become quite comprehensive and able to detect low-
abundance proteins in cellular proteomes. Our previous study on mouse tissue mitochondria, in 
contrast, still showed a substantial tendency of mass spectrometry to preferentially detect 
products of high abundance messages
57
. 
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Figure 6.5 Cumulative probability distribution of the mRNA levels of identified versus not identified 
proteins. (A) Proteins identified in adipocytes were mapped onto DGAP 3T3-L1 mRNA data. The 
cumulative probability distributions of mRNA abundance for the genes whose protein products were 
detected (green) or not detected (pink) by proteomics are shown. The mean expression levels for both 
groups are indicated. (B) Proteins identified in adipocytes were mapped to GNF mouse atlas V2. The 
cumulative probability distributions of mRNA abundance for the genes whose protein products were 
detected (green) or not detected (red) by proteomics are shown. 
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6.3.2.3 Coverage of proteome in terms of pathways and annotated complexes 
We then analyzed the coverage of our proteome in terms of protein complex and pathways 
known to be present in adipocytes. We mapped identified proteins onto KEGG pathways
255
.  As 
shown in Figure 6.6A and 6.6B, almost all of the known proteins in the ribosome and 
proteasome complexes were identified. It is interesting that in the membrane fraction only the 
core 20S proteasome and not the 19S (PA700) and 11S (Psme1-3) regulatory complex were 
identified (Figure 6.6A).  
Figure 6.6 Pathway mapping of identified proteins in the four subcellular fractions. Proteins identified 
in four cellular compartments (cytosol, membrane, mitochondria, and nuclei) were mapped to known 
pathways using GenMAPP. (A) Proteasome degradation; (B) Cytoplasmic ribosomal proteins; (C) Insulin 
signaling pathway. The compartments are represented by four different colors for each gene symbol. 
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Figure 6.6(B) Continued 
 
The precise distribution of 20S and 19S complex at the cellular organelle level has not been 
reported in the literature. However, in agreement with our observations, Brooks et  al  reported  
20S, 11S and 19S complexes localized predominantly in the cytosol and also localized in nuclear 
and membrane fractions prepared from rat liver
256
. The function of the 20S proteasome at the 
adipocyte membrane is unknown and would be interesting to elucidate in future studies. In 
contrast, less than half of the known proteins in the insulin pathway map were identified (Figure 
6.6C). Coverage of kinases and transcription factors was low, while we detected more than half 
of the proteins related to vesicular trafficking. Interestingly, in the analysis of 3T3-L1 microarray 
data half of the key components of the insulin signaling pathway were also flagged as not 
expressed (i.e. filtered out by microarray quality measures when using the Present P calls > 66% 
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criterion).  This suggests that the limitation of detection of low abundant proteins/genes such as 
kinases and transcription factors are no worse for MS based proteomics then for other high-
throughput “omics” technologies. 
 
Figure 6.6(C) Continued 
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6.3.3 Visual interpretation of proteome sub-cellular localization by hierarchical clustering 
and its concordance with earlier studies and genome wide annotations 
In order to compare our subcellular fractions and detection coverage we benchmarked our data 
against previously reported large-scale proteomic analyses of mouse organelles
242,243
 and Gene 
Ontology annotations. For our proteome, we built a cellular compartment distribution matrix 
(3,287 proteins by 4 fractions) by first counting peptides of each protein in each fraction. Then 
we normalized the data to arrive at a probability matrix for the distribution of each protein in the 
four compartments (see Section 5.2.11). Hierarchical clustering of this matrix shows that more 
than 70% of the proteins localized to four clusters with propensity for one specific fraction 
(Figure 6.7). A fifth cluster contained proteins for which there was no clear pattern of 
distribution. Additionally, we overlaid the data of the two large-scale mouse tissue experiments 
as well as cellular compartment annotations from Gene Ontology on the clustered dendrogram. 
As seen in the figure, most of the adipocyte cytosolic proteome showed high concordance with 
the experimental studies. Similarly, the membrane cluster shows good agreement. For the 
miotochondral and nuclear fractions there is excellent correlation, however the depth of our 
study was much greater. (Only the top part of our clusters detected counterparts in the other 
studies.) The GO annotations agreed well for the mitochondrial and nuclear specific clusters. No 
major enrichment is seen for the membrane and cytoplasmic fractions, which seem to be less 
well annotated in GO.  
 
6.3.4 Protein Domain Enrichment for Insights into Protein Function 
Classification of proteins based on their amino acid sequence or three-dimensional structure is 
one of the most established practices in protein science and also adopted by current large-scale 
structural genomics endeavors
257
. Moreover knowledge of independently folding protein 
domains can provide useful pointers into the complex interplay of proteome interactions and 
regulation by post translational modifications
258
. In order to obtain an additional perspective of 
the adipocyte proteome we performed InterPro domain enrichment analysis using our adipocyte 
proteome data set and the proteome data sets obtained from six mouse tissues
243
 and extracted 
InterPro domains enriched only in the adipocyte proteome (Figure 6.8).  
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Figure 6.7 Concordance among subcellular location of our study, recently published mouse organelle 
datasets, and Gene Ontology annotation. One-dimensional hierarchical cluster dendrogram for the 
3T3-L1 adipocyte cellular compartment profiles overlaid with data from recently reported large scale 
proteomics studies and GO cellular compartment terms is shown. The dark blue color represents the 
3T3-L1 adipocyte proteome; light blue corresponds to the mouse tissue proteome study data by 
Kislinger et al.243; light green corresponds to the liver organelle protein study data by Foster et al.58, 
yellow corresponds to the gene ontology (GO) cellular compartment annotations for the four 
compartments (nuclei, mitochondria, membrane, and cytosol) in our study 
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Figure 6.8 Significantly over-represented InterPro domains for the set of identified adipocyte proteins. 
Significantly over-represented InterPro terms with p < 0.001 and not also over-represented in the mouse 
tissue analysis are shown. For each InterPro term the bar shows the enrichment -fold ratio for the 
identified 3T3-L1 proteome in our survey with respect to the InterPro annotations of the entire mouse 
proteome. The InterPro terms are further grouped by representative biological function shown with text 
in blue. SH3, Src homology 3; FKBP, FK506-binding protein. OB, oligosaccharide/oligonucleotide-binding 
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The function of these enriched domains were mainly related to signal transduction, redox system,  
protein transport, translation, transcription, protein degradation, fatty acid metabolism, phospho 
lipid biosynthesis, in agreement with the enriched GO terms described before. Enrichment of 
redox related domains, such as the thioredoxin domain is interesting, because it has been 
suggested that the reduced redox state encourages triglyceride synthesis, adipocyte 
differentiation, and the development of adipose tissue
259
 while an increase in the markers of 
systemic oxidative stress has been associated with obesity and metabolic syndrome
260
. Similarly 
the domains related to vesicular protein transport, such as Ras small GTPase, Rab type, t-snare, 
Longin-like and a domain Zinc finger, Tim10/DDP-type which is related to protein import into 
mitochondrial inner membrane were substantially enriched.  
 
Domains related to transcription and translation were also enriched, specially three domains of 
aminoacyl-transfer RNA synthetases, namely Aminoacyl-tRNA synthetase, class 1a, anticodon-
binding, Aminoacyl-transfer RNA synthetase, class II, and Aminoacyl-tRNA synthetase, class I. 
Transcription and translation are basic functions of the cell, thus proteins related to such 
functions are generally thought to be housekeeping proteins. This observed enrichment may not 
reflect basic adipocyte biology but simply the fact that a rapidly growing cell line needs to 
express more proteins than the comparatively more inert tissue. Further insights may be obtained 
by quantitative study of protein expression in different cell lines and tissues, and by creating a 
protein expression atlas similar to a gene expression atlas
261,262
. 
 
6.3.5 An integrative genomics approach for protein prioritization analysis of vesicular 
trafficking in adipocytes 
One of the important features of adipocytes is insulin regulated glucose uptake. In adipocytes, 
the majority of this glucose uptake results from the translocation of the glucose transporter 4 
(GLUT4) to the cell surface membrane. Since the cloning of GLUT4 in 1989 in several 
laboratories
263-267
 numerous studies have attempted to elucidate the molecular basis of insulin 
receptor-signaling pathway and membrane-trafficking processes. One of the unresolved 
questions is the connection between Akt activation and GLUT4 translocation. GO term 
enrichment analysis revealed that protein transport was enriched in the adipocyte proteome (see 
above) and some of the identified vesicular trafficking proteins are known to be involved in the 
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insulin signaling pathway (Figure 6C). As 26%, 35% and 36% of identified proteins in our study 
were not annotated by Gene Ontology molecular function, biological process and cellular 
component categories, respectively, we tried to predict candidate proteins involved in GLUT4 
translocation using a bioinformatics approach. Very recently, an algorithm termed Endeavour 
was developed for gene prioritization to rank genes involved in human diseases and biological 
processes
8
. The concept of prioritization by Endeavour is that candidate test genes are ranked 
based on their similarity with a set of known training genes. The similarity measure is in turn 
calculated by integrating functional, process, gene ontology (GO), pathway and sequence 
similarity information obtained from diverse data sources. As training genes we choose 29 genes 
involved in vesicular trafficking which are on the map of Figure 6C. We used 2,990 proteins 
which were identified and mapped to human Ensembl gene Identifiers in our study as test genes. 
For 41 gene products we obtained highly significant values (p < 0.0002) for association with our 
set of proteins known to be involved in vesicular traffic (Table 6.1). Candidate proteins highly 
ranked by Endeavour contain many ras-related GTP-binding proteins (Rabs) and soluble N-
ethylmaleimide-sensitive factor attachment protein receptors (SNAREs). While it is not 
surprising that these proteins are involved in vesicular trafficking, they do serve as a positive 
control of the algorithm. We found that proteins recently associated with insulin signaling or 
GLUT4 translocation were ranked high in the candidate proteins. For example, Rab10, Rab14, 
Rab2, vesicle transport through interaction with t-SNAREs 1B homolog, vacuolar protein sorting 
45, vesicle-associated membrane protein 8 and syntaxin 12 are known to be contained in GLUT4 
vesicles
268,269
. Rab2, Rab10 and Rab14 were identified as targets of Akt substrate of 160-kDa 
(AS160) whereas Rab4 was reported to be involved in insulin-induced GLUT4 translocation
270
. 
ADP-ribosylation factor 5 (Arf5) was observed to exhibit modest re-distribution to the plasma 
membrane in response to insulin
271
 and cdc42, a Rho GTPase family member mediates insulin 
signaling to glucose transport in 3T3-L1 adipocytes
272
.  The above examples show that the 
protein prioritization by Endeavour is reasonable. By extension, candidates in Table 6.1 with no 
obvious connection to insulin signaling and GLUT4 are now excellent candidates for further 
functional study in this context.  
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TABLE 6.1 Putative proteins involved in the vesicular trafficking in insulin signaling predicted by the 
method of gene prioritization 
IPI Description
Gene 
symbol p-value
IPI00116770 RAB18, member RAS oncogene family Rab18 2.57E-06
IPI00221615 ADP-Ribosylation factor 5 Arf5 3.82E-06
IPI00271059 RAB4B, member RAS oncogene family Rab4b 4.77E-06
IPI00132276 vesicle-associated membrane protein 3 Vamp3 6.03E-06
IPI00113849 cell division cycle 42 homolog Cdc42 6.83E-06
IPI00331663 unnamed protein product Arf4 7.24E-06
IPI00122965 RAB3A, member RAS oncogene family Rab3a 8.52E-06
IPI00114560 RAB1, member RAS oncogene family Rab1 9.91E-06
IPI00137227 RAB2, member RAS oncogene family Rab2 1.07E-05
IPI00132410 RAB5A, member RAS oncogene family Rab5a 1.13E-05
IPI00118217 Syntaxin-7. Stx7 1.24E-05
IPI00453589 Vesicle-associated membrane protein 8 (VAMP-8) Vamp8 1.43E-05
IPI00126042 RAB14, member RAS oncogene family Rab14 1.49E-05
IPI00230011 Rab6 protein Rab6 1.61E-05
IPI00137647 synaptobrevin like 1 Sybl1 1.71E-05
IPI00321581 GS32 protein Snap29 1.90E-05
IPI00124291 vacuolar protein sorting 45 Vps45 2.35E-05
IPI00331128 cell line NK14 derived transforming oncogene Rab8a 2.36E-05
IPI00116729 Ras-related protein Rab-22A (Rab-22) (Rab-14) Rab22a 3.24E-05
IPI00125880 protein kinase C and casein kinase substrate in neurons 2 Pacsin2 4.34E-05
IPI00111416 syntaxin 12 Stx12 4.87E-05
IPI00469799 splice isoform 2 of golgi autoantigen, golgin subfamily A member 3 Golga3 4.91E-05
IPI00416303 aminopeptidase-like 1 Npepl1 5.52E-05
IPI00224219 sec1 family domain containing 1 Scfd1 6.32E-05
IPI00109506 unnamed protein product Stx6 6.79E-05
IPI00224518 Ras-related protein Rab-5C Rab5c 7.15E-05
IPI00225581 Dedicator of cytokinesis protein 1(Fragment) Dock1 7.19E-05
IPI00134941 c-K-ras2 protein Kras 9.95E-05
IPI00116558 ras homolog gene family, member G Rhog 9.96E-05
IPI00121335 thymoma viral proto-oncogene 2 Akt2 1.09E-04
IPI00116688 RAB3D, member RAS oncogene family Rab3d 1.09E-04
IPI00378015 Drebrin-like protein (SH3 domain-containing protein 7) Dbnl 1.17E-04
IPI00130118 RAB10, member RAS oncogene family Rab10 1.28E-04
IPI00378145 RAB6B, member RAS oncogene family Rab6b 1.30E-04
IPI00453776 early endosome antigen 1 Eea1 1.40E-04
IPI00453771 prenylated SNARE protein Ykt6 Ykt6 1.41E-04
IPI00132685 blocked early in transport 1 homolog Bet1 1.41E-04
IPI00229483 SEC24 related gene family, member C Sec24c 1.43E-04
IPI00131445 Dynamin-2 (Dynamin UDNM) Dnm2 1.49E-04
IPI00331284 vesicle transport through interaction with t-SNAREs 1B homolog Vti1b 1.50E-04
IPI00130554 SNAP-associated protein Snapap 1.94E-04
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6.4 Discussion  
Adipocytes are central players in energy metabolism and the
 
obesity epidemic, yet their protein 
composition remains largely
 
unexplored. Elucidating the protein composition of this versatile 
cell type is the first step towards understanding its role in various cellular processes and disease 
pathophysiologies. Our adipocyte proteomics study using enriched cellular compartments and 
state of the art mass spectrometry, involving very high mass accuracy and two stages of mass 
spectrometric fragmentation, allowed us to establish a high-confidence set of adipocyte proteins 
consisting of 3,287 proteins. Our analysis provides one of the largest and most confident set of 
proteins present in any cell line or tissue. Not only the identified protein list, but also the data on 
putative proteins - involved in vesicular trafficking in insulin signaling reported here should 
serve as a useful reference for more extensive experimental characterization of adipocyte 
functions. In order to share the data presented in this study, we have made the adipocyte 
proteome accessible at the Max-Planck Unified Proteome database (MAPU database, 
http://proteome.biochem.mpg.de/adipo/)
273
. While the MS technologies are already in place to 
elucidate comprehensive proteomes of model organisms
64
, continuing advances in the sensitivity 
and automation of MS-based proteomics will soon make acquisition of complex cellular 
proteomics routine. The analytical and bioinformatics analysis framework applied here can then 
serve as the template for processing and data mining of such cellular proteomes.
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7. Comparative proteomic phenotyping to assess functional 
differences between primary hepatocyte and the Hepa1-6 cell line 
 
This work is included in a manuscript accepted for publication in Molecular Cellular 
Proteomics: 
 
Cuiping Pan
φ
, Chanchal Kumar
φ
, Sebastian Bohl, Ursula Klingmueller, Matthias Mann 
Comparative proteomic phenotyping of cell lines and primary cells to assess preservation 
of cell type specific functions 
φ
 These authors contributed equally to this work 
 
7.1 Introduction 
The development of tissue culture techniques and establishment of cell lines has been 
indispensable for biological research for several decades
274
. However, disadvantages of cell lines 
are that they are usually derived from tumors and have adapted to growth in culture. Although 
cell culture tries to create a close-to-physiology milieu by adding appropriate amounts of salt, 
glucose, amino acids, vitamins, and serum, the lack of tissue architecture and heterogeneous 
population of cell types often abolishes cell-cell interaction, secretion, and other functions based 
on tissue context. Cells in culture are prone to genotypic and phenotypic drifting. Thereby cell 
lines can lose tissue specific functions and acquire a molecular phenotype quite different from 
cells in vivo. Acceptance of cell lines as model for biological function varies between fields. Cell 
biological studies on basic mechanisms, such as the cell cycle are routinely and overwhelmingly 
carried out in long-established cell lines
275
. This is particularly the case for microscopy studies, 
including large-scale siRNA screens with imaging read out. In contrast, there is substantial 
controversy of how well cell lines – which are often established from late stage cancer – preserve 
aspects of the disease and whether or not they should be used in cancer drug development
276-278
. 
Thus animal experiments or studies in primary cell lines are often preferred despite their added 
complexity. Accurate molecular phenotypes to determine if the function to be investigated is 
preserved in cell lines would enable a rational choice of the most appropriate experimental 
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system
279
. In biotechnology and the pharmaceutical industry this goal obtains added urgency in 
light of efforts to reduce animal experimentation to a minimum. 
In this work we ask how primary cells and cell lines differ in their functions. This question has 
been addressed by comparing gene expression profiles at the transcriptome level in a substantial 
body of literature (for recent examples see
280,281
). However, transcriptome studies are not 
quantitative with respect to changes at the proteome level. Ideally, the different molecular 
phenotypes should be assessed by quantitatively comparing the proteomes of the primary cells 
vs. the cell lines. Here we report such a study and develop an algorithm to extract functional 
phenotypes from the resulting differential protein distributions. 
 
7.2 Material and Methods 
 
7.2.1 Materials and reagents 
Mouse hepatoma cell line Hepa1-6 was obtained from American Type Culture Collection 
(ATCC). L-arginine, L-lysine, L-
13
C6
15
N4-arginine and L-
13
C6
15
N2-lysine were purchased from 
Sigma-Aldrich. Chemicals for the „in solution‟ and „in gel‟ digests were purchased from Sigma-
Aldrich, Endoproteinase Lys-C was obtained from Waco and sequencing grade modified trypsin 
was from Promega. 
 
7.2.2 Isolation of mouse primary hepatocytes  
Isolation and culture of mouse hepatocytes was performed according to standard operation 
procedures
282
. For biological and analytical reproducibility, primary hepatocytes were isolated 
from two mice and processed separately. After cultivation for 14 hours, the cells were placed on 
ice and the medium was removed. The cells were lysed in RIPA buffer.  
 
7.2.3 SILAC labeling of mouse hepatoma cell line Hepa1-6 
Hepa1-6 cells were grown in SILAC “light” (L-arginine and L-lysine) and “heavy” (L-13C6
15
N4-
arginine and L-
13
C6
15
N2-lysine) conditions for 8 passages before the experiment. This period 
lasted around 3 weeks. Unless stated otherwise, cell culture medium contained 4.5 g/L glucose 
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by following the standard culture condition from ATCC.  Other cell culture conditions were 
essentially the same as described
35
. 
 
7.2.4 Fluorescence microscopy 
Primary hepatocytes were isolated and seeded at a density of 2 10
5
 cells per well in collagen I 
coated 12-well plates. Hepa1-6 cells were grown to a density of 2 10
5
 cells per well in 12-well 
plates. Cells were stained for 15min with 15nM Mitotracker Orange CMTMRos (Invitrogen) and 
1:5000 Hoechst 333342 (Sigma-Aldrich) at 37°C in the corresponding cultivation medium. After 
three washing steps in cultivation medium cells were viewed with a ZeissAxioVert 200M 
fluorescence microscope using a 40  LD-Plan Neofluor objective (n.a. 1.5). Cells were viewed 
under visible light, or excited with 345nm (Hoechst 333342) or 550nm (Mitotracker). 
 
7.2.5 Protein harvest, digestion  
Primary hepatocytes and Hepa1-6 cells were lysed in a buffer containing 1% NP-40, 0.1% 
sodium deoxycholate, 150 mM NaCl, 1mM EDTA, 50 mM Tris, pH 7.5, 1 mM sodium 
orthavanadate, 5 mM NaF, 5 mM beta-glycerophosphate and protease inhibitors (Complete 
tablet, Roche Diagnostics). The lysates were centrifuged in cold with 17,000g for 15 minutes to 
pellet cellular debris. Supernatant was collected and a Bradford method was used to determine 
the protein concentrations. Equal amount of the proteins from the primary hepatocyte sample and 
Hepa1-6 sample were mixed, resulting in 100 µg proteins in total.  
Protein mixtures were added with four volumes of methanol, one volume of chloroform and 
three volumes of distilled water in a sequential manner. The addition of each solvent was 
followed by a short vortex. After centrifugation of 20,000g for 1 minute, proteins were focused 
between organic and inorganic phases. The aqueous phase was discarded. Four starting volumes 
of methanol were added to the protein pellet followed by a short vortex. After spinning at 
20,000g for 2 minutes, methanol was removed and the protein pellet was air-dried. 
Precipitated proteins were redissolved in a buffer containing 6 M urea, 2 M thiourea, 10 mM 
Hepes, pH 7.5. Proteins were reduced with 1 mM dithiothreitol for 1 hour, alkylated with 5.5 
mM iodoacetamide for 45 minutes in dark, and digested for four hours with endoproteinase Lys-
C (1/50 w/w). After diluting four times with 20 mM ammonium bicarbonate, samples were 
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digested overnight with sequencing grade modified trypsin (1/50 w/w). The digestion was 
quenched by adding trifluoroacetic acid to reach pH <3.  
 
7.2.6 Peptide preparation for mass spectrometry 
Peptides were separated based on their isoelectric points in the Agilent 3100 OFFGEL 
Fractionator (Agilent, G3100AA) and the 3100 OFFGEL Low Res Kit, pH 3-10 (Agilent, 5188-
6424) according to the manufacturer. Peptides were focused for 20 kVh at maximum current of 
50A and maximum power of 200 mW. Each peptide fraction was mixed with 10 µl solvent 
containing 30% acetonitrile, 5% acetic acid and 10% trifluoroacetic acid. The resulting solution 
was loaded into C18 reverse phase StageTips
235
.  Peptides were eluted from the StageTips by 
applying 80% acetonitrile, 0.5% acetic acid. Samples were dried down to 3 µl and mixed with 
equal volume of solvent containing 2% acetonitrile and 1% TFA. 5 µl samples were applied for 
LC-MS/MS analysis.  
 
7.2.7 Mass spectrometry and data analysis 
Samples were injected via autosampler into a 15-cm fused silica emitter (75- m inner diameter; 
Proxeon Biosystems) packed in-house with reverse-phase ReproSil-Pur C18-AQ 3- m resin
84
 
and eluted with nanoflow in Agilent 1200 liquid chromatography system (Agilent Technologies, 
Waldbronn, Germany). The gradient induced a linear increase of 4-40% acetonitrile in 0.5% 
acetic acid over 90 minutes. Eluted peptides were sprayed into a 7-T LTQ-FT or LTQ-Orbitrap 
mass spectrometer (Thermo Electron, Bremen, Germany) via a nanoelectrospray ion source 
(Proxeon Biosystems, Odense, Denmark) and analyzed as described previously
84
. Raw MS 
spectra were processed using in-house developed software MaxQuant (version 1.0.7.4)
2,283
 which 
performs peak list generation, SILAC- and extracted ion current-based quantitation, posterior 
error probability (PEP) and false discovery rate (FDR) based on search engine results, peptide to 
protein group assembly , and data filtration and presentation
283
.  The derived peak list was 
searched with the Mascot search engine (version 2.1.04, Matrix Science, London, UK) against a 
concatenated database combining 52,326 proteins from International Protein Index (IPI) mouse 
protein database version 3.24, 27 commonly observed contaminants (forward database) and the 
reversed sequences of all proteins (reverse database). Carbamidomethylation was set as fixed 
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modification. Variable modifications included oxidation (M), N-acetylation (protein), pyro (N-
term QC). Full tryptic specificity was required and up to three missed cleavages were allowed. 
Initial mass deviation of precursor ion and fragment ions were up to 10 ppm and 0.5 Da, 
respectively. Maximum peptide PEP was set to 0.1 and peptide FDR and protein FDR were set to 
0.01. 
  
7.2.8 Gene Ontology and KEGG enrichment analysis based hierarchical clustering 
In the primary against cell line study the quantified proteome was divided into 5 quantiles 
corresponding to probability cutoffs of 0, 0.15, 0.25, 0.75, 0.85, and 1. The enrichment analysis 
for gene ontology (GO) biological process and cellular component were done separately for 
these quantiles with respect to the whole quantified proteome by conditional hypergeometric test 
available in the GOstats package
284
 in the R statistical environment
285
. For hierarchical clustering 
we first collated all the categories obtained after enrichment along with their p-values, and then 
filtered for those categories which were at least enriched in one of the quantiles with p-value < 
0.05. The categories which did not have a defined p-value after collation in any quantile because 
the reference category members were missing were provided a p-value of 1. This filtered p-value 
matrix was transformed by the function x = –log10 (p-value).  Finally these x values were 
transformed to z-score for each GO category by using the transformation . These z-
scores were then clustered by one-way hierarchical clustering using “Euclidean distance” as 
distance function and “Average Linkage clustering” method available in Genesis241. KEGG 
pathway enrichment analysis was done in the same way, except that the hypergeometric test was 
employed and the reference set was complete mouse KEGG annotation. 
 
7.3 Results 
 
7.3.1 Quantitative analysis of Hepa1-6 against primary hepatocytes 
To characterize phenotypic differences between cell lines and primary cells, we SILAC-
labeled
9,286
 a murine hepatoma cell line, Hepa1-6
287
, and compared its proteome to that of 
primary hepatocytes prepared according to standard operating procedures(SOP) established by 
the German systems biology competence network HepatoSys
282
 (Figure 7.1). We used high 
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resolution MS to identify 3,400 proteins while quantifying more than 3,350 of them (see Section 
7.2.7). We repeated the experiment with hepatocytes from another mouse and obtained excellent 
reproducibility (Pearson correlation coefficient 0.95; Figure 7.2). We then combined the two 
datasets and analyzed them together using stringent and unified criteria. At a false positive rate 
of less than one percent, a total of 4,063 proteins were identified and quantified between the two 
cell populations.  
 
 
Figure 7.1 Strategy for comparing primary cells with immortalized cell lines. Primary hepatocytes were 
isolated and grown for 14 h. The Hepa1-6 cell line was completely SILAC-labeled with 13C6
15N4-arginine 
and 13C6
15N2-lysine. Cell extracts were combined and analyzed by online high-resolution MS on a linear 
ion trap Fourier transform instrument (LTQ-FT).  
 
The primary and cell line proteomes overlap qualitatively but are very different quantitatively, 
with more than half of the proteome changing at least two-fold between the two conditions 
(Figure 7.3A,7.3B). Many proteins are expressed at much lower levels in the immortalized cell 
line than in the primary cells whereas comparatively few were up-regulated in Hepa1-6. This is 
surprising since cancer cells are thought to be de-differentiated and to express many genes 
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inappropriately. It is usually recommended to cultivate Hepa1-6 cells in high glucose medium 
(38 mM). Therefore we asked whether some of the observed phenotypic changes are attributable 
to this circumstance. To address this experimentally, we performed another SILAC experiment 
comparing cells cultured in high glucose against physiological glucose levels in mice (8 mM) for 
three weeks (Figure 7.4A).  
 
Figure 7.2 Replicate experiments of comparing Hepa1-6 cell line with primary hepatocytes from two 
mice achieved very high degree of reproducibility at both identification and quantitation level (about 
4,000 proteins quantified; Person correlation coefficient 0.95). 
 
In this experiment, there were hardly any overall changes in the proteome and 96% of the 
proteins were of constant abundance within a factor of two. This was also confirmed in a 
replicate experiment (Figure 7.4B). These results rule out a dominant role of the 
superphysiological glucose level in the proteome differences between primary cells and cell 
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lines. Furthermore, they demonstrate excellent quantitative accuracy of our experiment on a 
proteome-wide basis. 
 
 
Figure 7.3 Fold-change distributions of the proteome (A) Quantitative comparison of the primary 
against the Hepa1-6 cell line proteome. The distribution was divided into five quantiles as follows. High 
relative expression in primary cells (0-15%, at least four-fold down-regulation), mostly expressed in 
primary cells (15-25%, -4 to -1.5 fold regulation), not highly regulated proteins (25-75%; - 1.5 to +2.8), 
mostly expressed in Hepa1-6 (75-85; 2.8 to 3.6 fold), highly expressed in Hepa1-6 (85-100%, more than 
3.6 fold change). Color coding of these categories is indicated at the top of the panel. (B) Biological 
replicate of the experiment showing excellent reproducibility 
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Figure 7.4 Quantitative comparison of the Hepa1-6 proteome cultured in high glucose (38 mM) and 
physiological glucose concentration (8 mM). Two independent comparisons (A) and (B) were performed 
starting from cell culture and SILAC labeling. 
 
 
7.3.2 A novel bioinformatics method for proteomic phenotyping 
To functionally understand the differences between the two cell populations, we divided the fold-
change distribution between primary hepatocytes and the Hepa1-6 cell line into five quantiles 
according to relative protein expression (Figure. 7.3A, 7.3B). Each quantile was assessed 
separately for overrepresented pathways, biological processes and cellular components with 
Gene Ontology (GO) and KEGG pathway analysis
49,288
  (Figure 7.5; Section 7.2.8). We retained 
each functional category that reached at least 95% statistical significance in one of the quantiles 
and then performed one-way unsupervised clustering of the p-values of the resulting categories 
(Fig. 7.6). This analysis differs from the more familiar clustering of overrepresented genes 
themselves, which is frequently employed in microarray-based experiments. It integrates the 
strength of statistical testing (taking p-values as input for clustering) with the intuitive simplicity 
of hierarchical clustering. By automatically classifying related processes and pathways based on 
their up or down-regulated protein measurements, it provides an unbiased global portrait of 
representative biological functions, enabling visual interpretation of the phenotype in terms of 
aggregate functional modules on a systems level.  
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Figure 7.5 Bioinformatics workflow for proteomic phenotyping (detail in section 7.2.8) 
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We verified the robustness of these functional assignments by comparing the shared p-value 
matrix of the replicate experiments against each other. This correlation was 0.86 for KEGG, 0.85 
for GO biological process and 0.92 for GO cellular compartment. 
 
Figure 7.6 Functional phenotyping of the proteome. The five quantiles (see Figure 7.2) were separately 
analyzed for enriched KEGG pathways and clustered for the z-transformed p -values. The color bar on 
top represents the quantiles. Representative pathways enriched in the protein population of each 
quantile are annotated. 
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7.3.3 Proteomic differences between Hepa1-6 and primary hepatocytes revealed by 
systematic bioinformatics 
The most prominent cluster of proteins expressed at higher levels in Hepa1-6 relates to cell 
division and encompasses categories such as cell cycle (p < 10
-9
) (Figure 7.7), DNA synthesis (p 
< 10
-4
) and RNA polymerase (p < 10
-3
). This cluster consists of 10 enriched pathways, of which 
at least five relate to increased cell proliferation. Biologically, this is not surprising since 
hepatocytes in the liver and in our primary culture are largely arrested in the GO phase of the cell 
cycle, whereas Hepa1-6 cells double every 18 hours. Nevertheless, the fact that this phenotypic 
trait is so clearly grouped in the cluster analysis makes it an excellent positive control.  
 
Figure 7.7 KEGG pathway mapping of cell cycle. The color bar on top represents the quantiles. Proteins 
that are marked with two colors are likely to represent isoforms 
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One of the most enriched categories in the quantile most expressed in primary cells is the P450 
family of enzymes (p < 10
-16
). These enzymes are mainly involved in metabolizing endogenous 
substances and xenobiotics
289
, a prototypical function of the liver. We identified 32 different 
P450 proteins and 25 of them were down-regulated at least tenfold in the cell line. Furthermore, 
the flavin monooxygenase (FMO), UDG-glucuronosyltransferase (UGT), sulfotransferase 
(SULT), and glutathione S-transferase (GST) - additional prominent drug metabolizing enzyme 
families (DMEs) - were also severely down-regulated in Hepa1-6 (Table 7.1).  
 
Table 7.1 Protein ratios for Cytochrome P450s drug metabolizing enzymes 
 
Only three P450s were up-regulated. Two of them (CYP1A1 and CYP2S1) are known to be 
regulated by the aryl hydrogen receptor
290,291
. This receptor was also more highly expressed in 
Protein 
Names
Uniprot 
ID
# of 
peptides
# of unique 
peptides
Ratio H/L 
Normalized
Ratio H/L 
Count
CYP1A2 P00186 9 5 0.07 3
CYP27 Q9DBG1 13 13 0.02 23
CYP2A12 P56593 24 21 0.04 29
CYP2A4 P15392 5 1 0.07 4
CYP2B19 O55071 6 1 0.01 3
CYP2B20 Q62397 16 11 0.09 17
CYP2C29 Q64458 11 6 0.04 12
CYP2C37 P56654 9 1 0.05 4
CYP2C40 P56657 6 6 0.03 10
CYP2C44 Q3UEM4 3 3 0.14 2
CYP2C54 Q6XVG2 9 2 0.01 1
CYP2C70 Q91W64 17 17 0.07 9
CYP2D10 P24456 12 4 0.02 16
CYP2D26 Q8CIM7 16 12 0.02 22
CYP2D9 P11714 10 6 0.02 7
CYP20 Q05421 10 10 0.03 7
CYP2F2 P33267 22 22 0.03 31
CYP2J5 O54749 3 3 0.03 3
CYP39A1 Q9JKJ9 3 3 0.07 3
CYP3A11 Q64459 4 4 0.04 3
CYP3A13 Q64464 6 6 0.06 12
CYP4A12 Q91WL5 11 11 0.07 8
CYP4F13 Q99KY6 2 2 0.18 2
CYP4F14 Q9EP75 2 2 0.02 2
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Hepa1-6, providing a ready explanation for the up-regulation. The third up-regulated P450 
protein (RIKEN clone E130013F06) has only been characterized on the basis of sequence 
homology and may have functions different from traditional P450 enzymes. Reduction of DME 
activity is a notorious difficulty in toxicological assays in cell lines. Toxicologists therefore 
attempt to stimulate liver cell lines with the aim of boosting DME activity
292
. Quantitative 
knowledge of the changes in the profile of DME could provide a rational basis to adapt cell 
systems to more closely mimic hepatocytes in vivo. 
 
Another prominent and cell-specific function of hepatocytes is production of plasma proteins. 
Figure 3 reveals that „complement and coagulation cascade‟ is specific for the primary cells (p < 
10
-2
). Inspection of the pathway involved shows that major liver-produced factors, such as C3, 
C4, MBP-C, F2, F5, A2M, Serpin A1/C1 and apolipoproteins are down-regulated more than 
five-fold in Hepa1-6. Thus, loss of tissue context allows the cell line to shut down this function, 
which is nonessential for propagation in culture. The cellular compartments most 
overrepresented in the primary cells are mitochondria (p < 10
-62
) (Figure 7.8A) and extracellular 
matrix (p < 10
-18
). Apparently, the cell line under-expresses proteins related to communication 
with stroma and with tissue maintenance. Our proteome contained a total of 479 proteins 
annotated as mitochondrial in GO. Of these, 69% were in the asymmetric tail of the distribution, 
indicating they were expressed several fold lower in Hepa1-6 cells than in primary hepatocytes. 
We independently confirmed this observation by DAPI and Mitotracker staining (Figure 7.8B). 
Indeed, primary hepatocyte nuclei were smaller whereas in these cells mitochondria were more 
abundant with respect to Hepa1-6.  Concurrent with this, fatty acid metabolism was drastically 
down-regulated according to enrichment analysis of KEGG pathways (Figure 7.9A). Likewise, 
„oxidative phosphorylation‟ (p < 10-29; Figure 7.9B), „urea cycle‟ (p < 10-4) and „steroid 
biosynthesis‟ (p < 10-2 ; Figure7.9C) were statistically significantly enriched in the quantile most 
expressed in primary hepatocytes. These down-regulated metabolic functions at least partially 
take place in mitochondria. Conversely, parts of the glycolysis pathway were up-regulated in 
Hepa1-6 (Figure 7.9D). Together, our results portray a drastic metabolic rearrangement, away 
from oxidative metabolism in the mitochondria and towards less efficient anerobic metabolism. 
These findings provide evidence for the Warburg hypothesis, that cancer cells shift towards 
glycolytic metabolic pathways
10
.  
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Figure 7.8 Phenotypic proteome comparison at the cellular component level. (A) The quantiles resulting from 
quantitative proteome comparison in Figure 7.3 were separately analyzed for enriched Gene Ontology Cellular 
Components and clustered for the z-transformed p-values. The color bar on top represents the quantiles. 
Representative categories enriched in the protein population of each quantile are annotated. Prominent 
mitochondria related categories for the primary cells are highlighted in red and prominent nucleus related 
categories in blue. (B) Nuclear (DAPI) and mitochondrial (Mitotracker) staining of primary hepatocytes and Hepa1-
6 cells. Most primary hepatocytes are binuclear
293
. 
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Figure 7.9 KEGG pathway mapping (A) Almost the entire fatty acid metabolism module is 
downregulated several-fold in Hepa1-6. Proteins are color-coded according to their relative expression 
in the two cell types according to the scheme in Figure 7.3. Proteins that are marked with two colors are 
likely to represent isoforms. (B) Oxidative phosphorylation, legends as in (A) 
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Figure 7.9 (C) Biosynthesis of steroids, legends as in Figure 7.9(A) 
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Figure 7.9 (D) Glycolysis pathway, legends as in Figure 7.9(A) 
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In the category containing the 50% of proteins with the least change, many household functions 
and organelles including ribosome (p < 10
-2
), proteasome (p < 10
-3
), splicing (p < 10
-4
) and Golgi 
apparatus (p < 10
-3
) are significantly enriched. Interestingly, several signaling pathways are also 
preferentially located in this quantile. These include the ErbB and PI3K signaling pathways 
(Figure 7.10).  
 
Figure 7.10 Phenotypic proteome comparisons at the pathway level. KEGG pathway mapping of ErbB 
and PI3K signaling pathway shows that they are equally present in primary cells and the cell line. 
 
This finding is in agreement with the requirement of growth factor containing serum for the 
maintenance of most cell lines. Conversely, TGFβ-mediated signaling is more highly represented 
in the Hepa1-6 cell line and the canonical members TGFβ R1, Smad2/3, Smad4, p107 and p15 
are all up-regulated significantly (Figure 7.11). This was unexpected because TGFβ is usually 
associated with growth inhibition whereas Hepa1-6 has an increased proliferation rate compared 
to primary hepatocytes. However, the biological actions of TGFβ are complex and it is thought 
to shift from a growth inhibitory to a growth promoting role during cancer development
294
. Thus 
up-regulation of this pathway suggests that in the Hepa1-6 tumor cells, TGFβ may have growth 
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promoting effects. Taken together, our data indicate that biological functions related to many 
important signaling pathways are well preserved in Hepa1-6.  
 
Figure 7.11 Proteomics phenotyping at the pathway level. KEGG pathway mapping shows that TGFβ 
signaling pathway is predominantly present in the cell line. 
 
Some categories shared by both cell types and enriched when analyzed using the  KEGG 
database represent  non-liver functions (such as „long term potentiation‟) or even non-animal 
functions (such as „CO2 fixation‟).  However, the enzymes found in these categories function 
both in liver tissue as well as in neurons or plants. Therefore, overrepresentation of these 
categories reflects the still evolving state of annotation of pathway databases rather than a 
limitation of our technology.  
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7.4 Discussion 
Taking advantage of the ability of SILAC to compare the levels of thousands of proteins in 
different cellular states
2,283
 and a novel bioinformatics approach, we have, for the first time, 
compared the proteomes of primary cells to cell lines. The overall picture that emerges is that 
Hepa1-6 has lost many of the specific functions typical of hepatocytes in vivo. Examples are the 
DMEs, complement production and synthesis of extracellular matrix. Conversely, the cell line 
shifts more of its resources into functions associated with proliferation, but maintains important 
cell signaling pathways. This phenotype is „rational‟ for rapidly dividing and not nutrient limited 
cells and may partly reflect Darwinian selection of cell clones.  
 
Our technology is accurate, relatively rapid and should now allow selection of the appropriate 
cell system based on a global and unbiased profile according to desired biological function. 
Furthermore, it can be used to manipulate the cell line system to better reflect the in vivo 
situation at the proteome level. While we have based our analysis on protein expression levels, it 
could just as well be applied to assess fidelity of signaling pathways in cell lines using SILAC-
based quantitative and global phosphoproteomics
65
.  
 
Our bioinformatics analysis differs in important points from the more familiar measurement of 
mRNA levels by microarray and its associated bioinformatics
295
. Even though reproducibility of 
microarray chips has become much better during recent years, the data is not quantitative with 
respect to the final, desired parameter – the global change in protein levels. Furthermore, results 
of any specific transcript on the chip generally have to be validated by RT-PCR and then by 
quantitative immunoblotting. This is impractical for large numbers of proteins. In contrast, 
quantitative proteomics inherently contains the fold-change for each protein, and increasingly 
also that of specific isoforms. The quantitative nature of our results also made it possible to 
directly group overrepresented functions and processes instead of the genes themselves. 
 
Here we have analyzed interesting, but relatively general phenotypic traits of two cell 
populations. While many of the resulting observations can be immediately rationalized in terms 
of biological function, they have never been quantified in a global and unbiased way. Our data 
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furthermore contains a wealth of functional leads that could not be explored in depth here. The 
combination of very high quantitative accuracy at the proteome level with increasingly accurate 
pathway databases should allow even richer assessment of the phenotypic state of any cell 
population in the future.  
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8. A systems view of the cell cycle by quantitative phospho-
proteomics  
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8.1 Introduction 
The cell cycle is a highly regulated and evolutionarily conserved process that results in the 
duplication of the cell's content and involves a large number of dedicated protein complexes and 
signaling pathways. Deregulation of key players that coordinate this process is implicated in 
tumorigenesis
296,297
. Global analyses of the cell cycle have so far been limited to microarray 
studies of the transcriptome
298
. However, regulated protein phosphorylation and protein 
degradation both play pivotal roles in controlling the cell cycle, but these are not always directly 
reflected by mRNA changes. Recent advances in proteomics technology, in particular high-
resolution mass spectrometry (MS), now allow large-scale quantitation of the proteome and the 
phosphoproteome. For example, we have recently quantified more than six thousand 
phosphorylation sites in response to cell stimulation
65
 using a metabolic labeling technique 
termed SILAC
9
. Here we combine this technology with global proteome quantitation to obtain a 
systems-biology view of protein and phosphorylation dynamics during the human cell cycle. We 
SILAC-encoded three HeLaS3 cell populations using light, medium and heavy stable isotopic 
versions of arginine and lysine. Light and heavy populations were synchronized in six different 
stages of the cell cycle and mixed with medium labeled asynchronously growing cells (Figure 
8.1A). Because of their different molecular weights, peptides from the three populations are 
separated in the mass spectrometer and are directly quantifiable against each other.  
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Figure 8.1 Quantitative proteomic analysis of the human cell cycle. (A) HeLa S3 cells were SILAC labeled 
with three different isotopic forms of arginine and lysine. Three individual populations of heavy and light 
SILAC cells were pre-synchronized using a thymidine-block and then collected at six different time-points 
across the cell cycle following release from the thymidine arrest. Two samples were collected after an 
additional nocodazole-arrest and release. Cells were lysed and mixed in equal amounts using an 
asynchronously growing cell population (medium SILAC) as the internal standard allowing normalization 
between experiments. Three independent experiments were performed to cover six cell cycle stages. (B) 
Immunoblot analysis of known cell cycle marker proteins in the different cell populations. (C) 
Fluorescence Activated Cell Sorting (FACS) profiles of the individual synchronized HeLa S3 populations. 
Cells were fixed, collected by centrifugation after which the DNA content of the cells was determined 
using propidium iodide. 
A systems view of the cell cycle by quantitative phosphoproteomics 
     
 
105 
 
This results in relative quantitation of the proteome and the phosphoproteome during the cell 
cycle in three experiments with the asynchronous population present in each experiment for 
normalization. Following harvesting, cells from the three experiments were combined and 
processed as described in section 8.2 for proteome and phosphoproteome analyses. We 
monitored synchronization of SILAC cell cultures by Western blotting and FACS analyses 
(Figure 8.1B and 8.1C). 
 
8.2 Materials and Methods 
8.2.1 Cell culture and sample preparation 
HeLa S3 cells were SILAC labeled as previously described using three different isotopic 
versions of lysine and arginine
9
. Cells were synchronized in G1/S overnight using a thymidine 
block at a concentration of 4 mM (Sigma, St. Louise, MO). Cells were then released from 
thymidine block and subsequently collected at four different time points; 0 h (G1/S-phase), 2.5 h 
(Early S-phase), 5.5 h (Late S-phase) and 7.5 h (G2-phase) after removal of thymidine. Two sets 
of cells were arrested overnight using nocodazole following the 7.5 hours release from 
thymidine. The next morning these cells were released for either 0.5 h (M-phase) or 3 h (G1-
phase). Western blotting and FACS analyses were performed to monitor the efficiency of the 
cell-cycle arrest (Fig. 8.1B,C).  
 
8.2.2 Fluorescence-activated Cell Sorting Analysis  
Cell suspensions were fixed with 80% ethanol, permeabilized by treatment for 5 min with 0.25% 
Triton X-100 in PBS, and incubated with 0.1% RNase and 10 µg/ml Propidium Iodide. Cellular 
DNA content was determined by flow cytometry using FACSCalibur (BD Biosciences Clontech, 
San Jose, CA) system and CellQuest software (Becton-Dickinson, Lincoln Park, NJ). 
 
8.2.3 Western blotting 
Cells were washed once with ice-cold PBS containing 1 mM phenylmethylsulfonyl fluoride, 
scraped off the plate, and resuspended in ice-cold HEPES lysis buffer (50 mM HEPES, pH 7.4, 
150 mM NaCl, and 0.5% Triton X-100) containing 1 mM DTT, 30 µg/ml RNase A, 30 µg/ml 
DNase, protease, and phosphatase inhibitors. After 15 min on ice, lysed cells were centrifuged at 
13,000 rpm for 15 min at 4°C. Protein concentrations in the cleared lysate were determined using 
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the Dc protein assay (Bio-Rad), and equal protein amounts were loaded on SDS-PAGE gels. 
Separated proteins were transferred to nitrocellulose membranes (Whatman Schleicher and 
Schuell). For Western blot analysis, rabbit anti-cyclin D (St. Cruz Biotechnology), mouse mAb 
anti-cyclin E (clone HE-12 tissue culture supernatant), goat anti-cyclin A (St. Cruz 
Biotechnology), mouse anti cyclin-B (BD Transduction Laboratories), mouse mAb anti-α-
tubulin (Sigma-Aldrich), rabbit anti-Geminin (gift from Roland A. Lasckey), rabbit mouse anti-
Bub1 (clone 61–22–2, tissue culture supernatant), rabbit anti-Eg5299, mouse anti-Aurora B (BD 
Transduction Laboratories), mouse anti-Plk1 (clone PL2, tissue culture supernatant), mouse anti-
securin (Abcam), mouse anti-TPX2 (Abcam), rabbit anti-Kif20A (gift from Thomas U. Mayer), 
mouse anti-pT210 Plk1  (BD Transduction Laboratories), anti-pT14 Cdk1, rabbit and rabbit anti-
pS10 Histone 3 (Upstate Biotechnology) were used and detected by ECL Supersignal (Pierce 
Chemical) using a digital Fujifilm LAS-1000 camera attached to an Intelligent darkbox II 
(Raytest).  
Arrested cells were lysed in modified RIPA buffer
65
 after which protein extracts were clarified 
by centrifugation to pellet chromatin and other insoluble material. This insoluble pellet was 
redissolved in 8M urea/1% N-octylglucoside supplemented with phosphatase inhibitors and 
benzonase. The soluble proteins in the RIPA extract were precipitated overnight at -20 °C by 
adding 4 volumes of ice-cold acetone. Following centrifugation, precipitated proteins were 
redissolved in 8M urea/1% N-octylglucoside supplemented with phosphate-inhibitors. The 
protein concentration of all the fractions was determined using the Bradford assay. Protein 
extracts derived from the different cell-cycle arrest stages were then mixed 1:1:1 accordingly 
using an asynchronous cell population as the internal standard. 20% of the protein mixtures were 
separated by 1D-SDS PAGE, sliced in 20 gel-plugs and digested with trypsin in-gel
300
. 30% of 
the extracted peptide mixtures were used for quantitative proteome analysis by LC-MS, whereas 
the other 70% of the extracted peptides were subjected to titanium dioxide enrichment in the 
presence of 2,5-DHB
38
 and analyzed by LC-MS. The remaining 80% of protein mixtures were 
not fractionated by 1D SDS PAGE but directly reduced with DTT, alkylated using 
iodoacetamide and subsequently digested with endoproteinase Lys-C and trypsin as described
65
. 
The resulting peptide mixtures were either directly subjected to titanium oxide enrichment or 
first fractionated by strong-cation chromatography followed by titanium dioxide enrichment. 
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8.2.4 Mass Spectrometry 
All experiments were performed on an LTQ-Orbitrap instrument connected to an online 
nanoflow HPLC (Agilent 1100 system) via a nanoelectrospray ion-source (Proxeon Biosystems). 
The tryptic peptide mixtures were autosampled onto a 15 cm long 75 µm ID column packed in-
house with 3-um C18-AQUA –Pur Reprosil reversed-phase beads (Dr. Maisch) and eluted with a 
linear gradient from 8% to 40% MeCN in 2 hrs. The separated peptides were electrosprayed 
directly into an LTQ-Orbitrap mass spectrometer (Thermo Fisher Scientific), which was operated 
in the data-dependent acquisition mode to automatically switch between one orbitrap full-scan 
and five ion trap tandem mass spectra. The tandem mass spectra were acquired with the multi-
stage activation enabled for neutral loss of phosphoric acid (32.66, 48.99 and 97.97 amu)
301
. All 
full-scan spectra were recalibrated in real-time using the lock-mass option
86
. 
 
8.2.5 Data processing and analysis  
Mass spectrometric data were analyzed using the in-house developed software MaxQuant 
version 1.0.12.0
2
. Which performs peak list generation, SILAC- and XIC-based quantitation, 
estimation of false discovery rates for search engine results, peptide to protein group assembly, 
as well as data filtering and presentation. The MS/MS spectra were searched against the human 
International Protein Index sequence database (IPI version 3.37) supplemented by frequently 
observed contaminants, concatenated with reversed versions of all sequences. Mascot (version 
2.2.04) was used for the database search. Enzyme specificity was set to trypsin, allowing for 
cleavage N-terminal to proline and between aspartic acid and proline. Carbamidomethyl cysteine 
was set as fixed and oxidized methionine, N-acetylation, loss of ammonia from N-terminal 
glutamine as well as phosphorylation of seine threonine and tyrosine as variable modifications. 
Spectra determined to result from medium or heavy labeled peptides by pre-search MaxQuant 
analysis were searched with the additional fixed modifications Arg6 and Lys4 or Arg10 and 
Lys8, respectively, while spectra with a SILAC state not determinable a priori were searched 
with Arg10 and Lys8 as additional variable modifications. A maximum of three missed 
cleavages and three labeled amino acids (arginine and lysine) were allowed. The required false 
discovery rate was set to 0.01 at the peptide and at the protein level and the minimum required 
peptide length to 6 amino acids. If the identified peptide sequence set of one protein was equal to 
or contained another protein‟s peptide set, these two proteins were grouped together by 
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MaxQuant and not counted as independent protein hits. Protein SILAC ratios are reported as the 
median of the ratios derived from SILAC triplets assigned to the protein. For phosphopeptides 
the phosphorylation site(s) were assigned by using a modified version of the PTM score
65
 in 
MaxQuant. All high-confidence phosphosites (FDR<0.01) together with their cell cycle 
dependent ratios were uploaded to Phosida (http://www.phosida.com), which is a freely 
accessible phosphorylation site repository
302
. 
 
8.2.6 Peak time index calculation for (phospho)-proteomic temporal profiles 
The workflow of the analysis is shown in Figure 8.3. The fold ratios (r1 through r6) for each 
protein over the 6 time points (t1=1 through t6=6) were scaled between range [0, 1]. Then for 
each protein we calculated a time peak index (tpeak) by weighted mean of the expression ratio of 
maximal expression (i.e. ri=1) at time point ti with respect to its adjacent time points (ti-1 and ti+1). 
In order to maintain the cyclicity we made two assumptions: (a) if the maximal expression was at 
t1 (i.e. r1 = 1) then t1 was preceded by t0=0 with expression r6, and (b) if the maximal expression 
was at t6 (i.e. r6 = 1) then t6 was followed by t7=7 with expression r1. The equations for the peak 
time (tpeak) calculation are as follows: 
 
The protein expression profiles were subsequently ordered in increasing order to get a temporal 
map of cell cycle. For the purpose of rendering according to their increasing tpeak the original 
(unscaled) expression profile for each protein was z-transformed prior to rendering as in Figure 
8.4.  
 
8.2.7 Cyclic angular peak calculations based on peak time index of (phospho)-proteomic 
temporal profiles 
The time peak measure for any protein j, tpeak(j) was further converted to an angular peak measure 
θpeak(j)  in the range [0,360°] by following equation: 
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Thus, the time peak measures tpeak(j) were converted to a polar coordinate system with the radial 
coordinate r=1  and the polar angle θpeak(j). By definition the polar coordinate system has an 
anticlockwise orientation with 0° ray as the polar axis. However, in order to represent and 
analyze our proteomics data according to the standard cell cycle stages beginning with “Mitosis” 
we further wished to choose a transformed polar coordinate system having clockwise orientation 
with 90° ray as the polar axis. In such a polar coordinate space θpeak(j) has to be transformed by 
following equation:   .These  values were used to render the 
z-transformed protein profiles in the transformed polar coordinate space as shown in Figure 8.8.  
 
8.2.8 Enrichment analysis for Gene Ontology Cellular Component (CC) based on circular 
statistics 
For each of the Gene Ontology
288
  cellular component category C the circular peak angles of the 
complete protein set (N proteins) was used to derive a 1×N vector θC  such that its j
th
 entry was 
 if protein j was annotated with C else “NA”. This θC vector was tested for non-
homogeneous distribution across the unit circle in the transformed polar coordinate system (θ*) 
by using the “Rayleigh test”303. Only categories which had a p-value < 0.05 were considered 
significant. The mean(θC) provided mean direction of enrichment for the category C and was 
used to render the category at particular angles in Figure 8.8.  
 
8.2.9 Comparison with cell cycle microarray dataset  
The microarray dataset of ref
298
 experiment no. 4 (Thy-Noc) was chosen for comparison with our 
proteomics dataset as the experimental conditions therein paralleled our study. The complete 
microarray dataset was categorized into changing (1,100 probes) and non-changing (39,484 
probes). The complete identified proteome was divided into regulated (2,857 IPIs) and non-
regulated (3,169 IPIs) proteins. The IPI identifiers of the proteomics data were mapped to the 
microarray probes using common EntrezGene identifiers. Some of the IPIs could be mapped to 
more than one EntrezGene identifiers and hence were multiplicatively mapped for each identifier 
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thereby resulting in 11,826 probe entries in common. This final mapped dataset was categorized 
into 4 classes as shown in following contingency table:  
 
These set of clusters were then analyzed using GO based clustering method for enriched 
biological processes (BP) by a method similar to the one described in section 8.2.11. 
  
8.2.10 Comparison with steady-state HeLa microarray data 
We used a recently published microarray data set
304
, which employed the Affymetrix HGU133A 
GeneChip with 22,283 probe sets that map to 12,999 Entrez gene identifiers. We downloaded the 
data from the four control data sets representing the normal HeLa transcriptome. In accordance 
with practice in our proteomics experiment, we defined a transcript as present if the MAS5 p-
values were at least 0.01 in three out of the four experiments (the MAS5 probability values are a 
standard measure of the presence of a transcript, and they are calculated from the signals of the 
different elements in each probe set). We then mapped the 8,161 probe sets with a “present call” 
on the Affymetrix probe set to 5,791 unique Entrez gene identifiers. Our quantified proteome of 
6,026 IPI entries was mapped to 5,455 unique Entrez gene identifiers. Subsequently the overlap 
between the two datasets was calculated by common Entrez gene identifiers. Figure 8.2 shows 
their overlap with the proteomic HeLa data set.  
 
8.2.11 Gene Ontology and KEGG pathways enrichment based clustering for protein groups 
based on peak time 
The enrichment analysis for Gene Ontology (GO)
288
 Biological Process(BP) and Cellular 
Component(CC) were done separately for each of the peak clusters (M peak, G1 peak, G1/S 
peak, Early S peak, Late S peak, G2 peak) derived from peak time index clustering (Figure 8.4) 
with respect to the whole quantified proteome by the ”conditional hypergeometric test” available 
in the GOstats
284
 package in the R statistical environment
305
. For further hierarchical clustering 
based on GO terms we first collated all the categories obtained after enrichment along with their 
Regulated Non-regulated
Cycling Cluster A(311) Cluster B(226)
Non-cycling Cluster C(5,493) Cluster D(5,796)
Proteins
m
R
N
A
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p-values, and then filtered for those categories that were at least enriched in one of the clusters 
with p-value < 0.05. This filtered p-value matrix was transformed by the function x = –log10 (p-
value). Finally these x values were z-transformed for each GO category. These z-scores were 
then clustered by one-way hierarchical clustering (Euclidean distance, Average Linkage 
clustering) using Genesis
241
. KEGG pathway
306
 enrichment analysis was done in the same way, 
except that the „hypergeometric test‟ was employed and the reference set were the complete 
human KEGG annotations. 
 
8.2.12 Analysis of kinase–substrate relationships during phases of the cell cycle  
In order to predict kinase-substrate relationships all identified class I serine and threonine 
phosphorylation sites (pS/T) were scored with NetPhosK
307
. We found that the overall score 
distribution of the cycling pS/T is significantly different from the score distribution of the non-
cycling counterparts (P < 10
-10
, Chi-square test). For each time point in the cell cycle we 
investigated which kinases contribute most to the observed differences in score distributions 
compared to non-cycling pS/T. This was plotted with the “heatmap” package in R (the time 
points in the cell cycle were z-score scaled) (Figure 8.11C).  
 
8.2.13 New candidates in the DRR network 
We found 479 pS/T sites in the data set that matched the pS/T-Q DNA Damage Repair (DDR) 
kinase consensus motif.  Out of these sites we defined a dynamic subset that was regulated on 
multiple levels. This subset consisted of 13 sites regulated on phosphorylation (high confidence) 
and protein levels as well as 8 sites regulated on phosphorylation (intermediate confidence) and 
mRNA levels. We next used the NetworKIN algorithm
308
 to classify which upstream kinases 
target the particular phosphorylation sites and found that 15 pS/T-Q sites in 14 proteins were 
contextually linked to ATM or DNA-PK. 
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8.3 Results 
 
8.3.1 High throughput identification of proteome changes during the cell cycle  
LC-MS/MS data from 144 gel slices for the quantitative proteome and 300 fractions for the 
phosphoproteome were together analyzed using the MaxQuant software
2
 applying unified 
statistical criteria. At a false discovery rate of one percent this resulted in the identification of 
6,695 proteins, of which 6,281 were directly associated to 5,878 unique Ensembl genes. For 
6,027 proteins, quantitative profiles were obtained. About 70% of the proteome was 
phosphorylated (4,795) and a total of 23,765 phosphorylation sites were identified – again at a 
false discovery rate of one percent. We could confidently assign 18,037 unique phosphorylation 
sites in the peptide sequences (Class I sites
65
). As our phosphoproteome measurement is 
extensive but still not complete, our data suggests that the majority of all human proteins are 
phosphorylated to some degree.  
 
8.3.2 Coverage of the proteome 
To assess if our measured HeLa cell proteome is biased against „difficult‟ protein classes such as 
low-abundance regulatory proteins or membrane proteins and determined to which extent we 
covered these categories and well-known protein complexes. Typically we identified at least 
70%, suggesting the HeLa cell proteome contains at least 10,000 proteins of which we quantified 
a majority. Classical cell-cycle proteins, such as cyclins, CDKs and components of the anaphase 
promoting complex/cyclosome (APC/C) were measured essentially completely. This is the 
largest quantified proteome to date, similar in size to typical dynamic transcriptome profiles of 
human cell lines (see section 8.2.10, Figure 8.2). The quality of the proteome-wide quantitation 
is demonstrated by the dynamic MS-based profiles for the marker proteins shown by Western 
blotting in Figure 8.1B and other key cell-cycle proteins. Expression levels of a fifth of the 
proteome changed by at least four-fold over the cell cycle.  A four-fold change also best 
accounted for the dynamics of already described cell-cycle components. A recently published 
global study using RNAi identified a cell-cycle phenotype for more than 1,000 proteins
309
. Both 
numbers are large compared to the number of known central cell-cycle actors.  
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Figure 8.2 Comparison of steady state HeLa transcriptome with the quantified proteome. The 
microarray data for four samples of unsynchronized HeLa cells taken from the dataset of Carson et al. 
were analyzed as explained in section 8.2.10. The Venn diagram shows the overlap between two 
datasets based on common Entrez gene identifiers. In total 3,433 entries were common between the 
two datasets with a similar number of entries identified exclusively by only microarray or MS-based 
proteomics.  
 
8.3.3 Analyzing proteome time course by novel bioinformatics approach  
In order to discover the patterns of expressions across 6 time points we devised a new metric 
taking into account the maximal expression of proteins with respect to its peaking time and 
called it “peak time index” (Figure 8.3; Section 8.2.6). Ordering the proteins according to their 
“peak time index” revealed distinct up- and down-regulated clusters corresponding to each cell-
cycle stage (Figure 8.4). Key players of cell cycle stages were found to show clearly discernible 
and already established kinetics as marked in Figure 8.4. The peak patterns were then divided 
into six sub-clusters (M peak, G1 peak, G1/S peak, Early S peak, Late S peak, G2 peak) 
depending on the concerted proteome peaking in respective cell cycle stages (annotated by blue 
gradient coloring in Figure 8.4). Each of these sub clusters were analyzed by a proteomic 
phenotypic approach using KEGG and Gene Ontology (GO) as annotational resources to reveal 
distinct functional characteristics and cellular contexts. 
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Figure 8.3 Bioinformatics workflow to cluster and circularize proteome and phosphoproteome changes. The proteome time profiles were first 
scaled in range [0,1] and then assigned a time peak index (section 8.2.6). The complete proteome was then clustered as per the increasing time 
peak index as shown in step (C).The time peak index was further transformed into an angular peak measure (section 8.2.7) in the range [0,360] 
degrees. This angular peak measure was used to render the z-transformed proteome profile as shown in step (D). Subsequent bioinformatics 
analysis was done using circular statistical methods on the polar coordinates of these proteins. 
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Figure 8.4 Dynamics of the proteome during the cell cycle. Proteins that were found to be regulated at 
least four-fold during the cell cycle were clustered in all cell-cycle stages by calculating a time peak index 
by weighted mean of the expression ratio of maximal expression. For each cell cycle stage, there are 
clear patterns of up and down-regulation. 
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Figure 8.5 KEGG pathway enrichment analysis applied to the individual clusters derived from the cell 
cycle regulated HeLa proteome (marked in Figure 8.4 with blue gradient colors).  
 
KEGG pathways enrichment based clustering provided a systems level peek into the diverse role 
of these proteins ranging from pivotal signaling pathways (p53, insulin, mTOR, GnRH), disease 
(Glioma, AML, Type II diabetes mellitus), and metabolic networks (OXPHOS) (Figure 8.5).  
A systems view of the cell cycle by quantitative phosphoproteomics 
     
 
117 
 
Figure 8.6 Gene Ontology (GO) enrichment analysis of biological processes (BP) applied to the individual 
clusters derived from the cell cycle regulated HeLa proteome (marked in Figure 8.4 with blue gradient 
colors) 
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Figure 8.7 Gene Ontology (GO) enrichment analysis of cellular components (CC) applied to the individual 
clusters derived from the cell cycle regulated HeLa proteome (marked in Figure 8.4 with blue gradient 
colors) 
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Analysis of these clusters using GO biological process revealed clear functional enrichment of 
categories that would be expected in these cell cycle clusters; for instance M-phase, cell cycle, 
mitotic chromosome condensation among others were clearly enriched in the “M peak” cluster 
(Figure 8.6), and additionally many novel functions relevant to each of the six clusters shown in 
figure 8.4. Similarly, analysis of GO cellular components highlighted enrichment of distinct 
cellular compartments that are clearly defined sites of many of the biological processes and 
pathways found to be enriched in those clusters thereby substantiating the results found in 
previous analysis (Figure 8.7). 
8.3.4 Directional statistics based enrichment of protein profiles reveal co-regulated 
complexes  
To determine when in the cell-cycle specific proteins and protein groups peaked we circularized 
the clustered proteins on a cell-cycle timeline by mapping the peak times onto a transformed 
polar coordinate system
310
 (Figure 8.8). Subsequently directional statistics based on the 
“Rayleigh test” was used to find enriched GO cellular components and complexes (see Section 
8.2.7). Co-regulation of subunits within cell cycle regulated complexes namely APC/C (P < 
0.02), Mediator complex (P < 1E-05), DNA replication factor A complex (P < 0.007) was 
observed (Figure 8.8). Likewise, proteins from sub-cellular organelles were found to be co-
regulated, for example, mitochondrial proteins (P < 1.6E-25), nucleolar proteins (P < 0.01) and 
ER-Golgi components (P < 0.001). 
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Figure 8.8 Dynamic cell cycle proteome rendered in cyclic order along with enriched gene ontology 
(GO) cellular compartments and complexes. The data shown in Figure 8.4 was circularized to determine 
the angle in the cell cycle where particular proteins peak. Around the circle co-regulated protein 
complexes and organellar proteins for particular cell cycle stages are indicated. 
 
A systems view of the cell cycle by quantitative phosphoproteomics 
     
 
121 
 
8.3.5 Proteome transcriptome comparison reveals similar depth of coverage and weak 
expression correlation 
We next compared the dynamics of the proteome to a published cell-cycle transcriptome that 
made use of the same cell type and a related experimental procedure for cell synchronization
298
. 
Detected proteome and transcriptome overlapped to 63% and covered the expressed genome to 
similar depth (Figure 8.2). Steady-state message levels did not correlate well with steady state 
protein levels as estimated by summed peptide intensities (R=0.38, Figure 8.9A; R=0.46 when 
correcting for protein length, Figure 8.9B). This is not surprising since different transcripts and 
proteins have different half-lives.  
 
Figure 8.9 Transcriptome versus proteome comparison reveals an uncorrelated behavior (A) Summed 
peptide intensity vs. mRNA expression on log2 scale (B) Corrected summed peptide intensity vs. mRNA 
expression on log2 scale 
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However, 59% of the genes that significantly changed at the transcriptome level and that were 
quantified as proteins changed significantly (ratio-change >4) at the proteome level as well. We 
found that 21% of all observed proteins significantly change in abundance during the cell cycle, 
whereas only 10% of the transcriptome was reported to change
298
. This most likely reflects 
differences in the statistical analyses and experimental setup as well as the contribution of post-
transcriptional regulation. Reassuringly, Gene Ontology (GO) analysis confirmed a cell-cycle 
function for proteins regulated at both the mRNA and the protein level, whereas proteins 
regulated at neither of the levels are preferentially involved in homeostasis and basic metabolic 
processes (Figure 8.10). The only functional class of proteins that are specifically regulated at the 
protein level but not at the mRNA level is the transcriptional machinery. 
8.3.6 Analysis of cell cycle phosphorylation by ensemble bioinformatics approach 
To determine phosphorylation sites that show dynamic profiles due to changes in 
phosphorylation state rather than due to changes in protein abundance, we normalized the 
measured phosphopeptide ratios by the corresponding protein changes. Subsequently we 
clustered the phosphoproteome time course data by increasing peak time index (section 8.2.6). 
The phosphoproteome is three times as large as that of our group‟s recent growth factor signaling 
study
65
. It encompasses 70% of those sites and was distributed across cellular compartments as 
observed before. Interestingly, the level of phosphorylation of more than half of the 
phosphorylation sites changed at least two-fold over the cell cycle; of these again about half were 
maximally phosphorylated in M-phase (Figure 8.11A). Compared to single-stimulus studies, this 
is a much larger proportion, highlighting the involvement of many more signaling processes in 
the cell cycle. Inspection of known cell-cycle-regulated phosphorylation sites showed the 
expected kinetics, as exemplified for the activation loop phosphorylation site  (pT161) and the 
inhibitory sites (pT14 and pY15) of CDK1, which show opposing kinetics (Figure 8.11B). 
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Figure 8.10 Comparison of mRNA and protein dynamics during the cell cycle. Measured protein 
dynamics were correlated to mRNA data published by Whitfield et al. (3). Proteins were grouped on the 
Y-axis in four categories from top to bottom: unchanging mRNA and protein, changing mRNA and 
unchanging protein, changing mRNA and unchanging protein and changing mRNA and changing protein. 
In addition, proteins were clustered on the X-axis according to their gene ontology. 
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8.3.7 Kinase substrate relationship prediction and novel insights into phosphorylation 
mediated cellular processes 
 
Next we used NetPhosK to predict kinase-substrate relationships and constructed a heat map 
based on the dynamic phosphoproteome
307
. For each stage of the cell cycle this map indicates the 
degree of over- or under-representation of substrates of different kinase groups (Figure 8.11C).  
Figure 8.11  Dynamics of the phosphoproteome during the cell cycle. A. Clustering of regulated phosphorylation 
sites in all cell cycle stages as described for the proteome in Figure 8.4. More than half of all identified regulated 
phosphorylation sites peak in mitosis. B. Dynamic profile of two CDK1 phosphopeptides during the cell cycle. The 
activating site T161 clearly peaks in mitosis, whereas the inhibitory sites T14 and Y15 are down-regulated in 
mitosis. C. Heat map of cell-cycle-regulated kinase substrates. The NetPhosK algorithm was used to construct a 
heat map based on the cell cycle phosphoproteome and reveals overrepresentation of particular kinases during 
different stages of the cell cycle as shown. Strikingly, ATM and DNAPK kinases were found to be globally active 
during S phase. 
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As expected, predicted CDK substrates are most highly phosphorylated in M-phase.  PKB/AKT-
related signaling is most active in G1 whereas PKC-related substrates are preferentially 
phosphorylated in G1/S, which presumably reflects their growth-associated roles
311
.  
Interestingly, substrates of the DNA damage response (DDR) kinases ATM/ATR and DNA-PK 
are significantly overrepresented in S phase, which is most likely due to the coupling between 
DNA replication and repair. While this has been reported for individual phosphoproteins, our 
data show that it is a general phenomenon since 124 sites that match the ATM/ATR and DNA-
PK kinase motifs peak in S phase. Many of these phosphoproteins are known to be involved in 
DNA repair, such as RAD50, MDC1, TP53BP1 and ERCC6. A recent phosphoproteomic study 
of DNA damage also identified some of these sites
312
.  
Figure 8.12 Regulation of mini-chromosome-maintenance (MCM) complexes in response to DNA 
damage. (A) Tandem mass spectrum of a phosphopeptide derived from MCM6 that contain the pS13. 
(B) Left panel, MCM2-7 is one of several complexes involved in initiation of DNA replication. In response 
to DNA damage, the subunits MCM2 and MCM3 are phosphorylated on S108 and S535, respectively. We 
identify a novel pS-Q phosphorylation site (S13) on the MCM6 subunit, which is phosphorylated during 
S-phase. Right panel, during the elongation phase of DNA replication, only the subcomplex MCM4/6/7 is 
part of the replication fork. The novel phosphorylation site on MCM6 provides a plausible mechanism by 
which the DDR kinases can halt ongoing DNA replication in response to DNA damage. 
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The DDR kinases
313
 coordinate cell-cycle checkpoints and DNA repair mechanisms and almost 
exclusively phosphorylate substrates with linear sequence motifs that match pS/T-Q
314
. Out of 
479 pS/T-Q sites in the data set we selected 21 sites in proteins that are regulated at multiple 
levels. These were analyzed with the NetworKIN algorithm, which increases the accuracy in 
classifying kinase-substrate relationships by combining prediction of kinase substrate motifs with 
contextual information
308
.  This analysis tied 14 substrates to ATM and DNA-PK, of which five 
are known to be part of the DDR apparatus. The DDR kinases also phosphorylate the MCM2 and 
MCM3 subunits of the hexameric mini-chromosome-maintenance (MCM) complex
315
, which is 
essential for initiation of DNA replication. In agreement with this, we show that S108 of MCM2 
is most highly phosphorylated during S-phase. However, this does not explain how the DDR 
kinases can halt ongoing DNA replication in response to DNA damage, since only the 
MCM4/6/7 helicase subcomplex is involved in the elongation process
316
. We identify a novel pS-
Q site within this subcomplex (S13 of MCM6, Figure 8.12A) which is phosphorylated 
specifically during S-phase and hence provides a plausible mechanism by which DDR kinases 
could inhibit ongoing DNA replication (Figure 8.12B). 
8.3.8 Systematic study of cell cycle control regulation by integrating proteome, 
phosphoproteome and transcriptome 
Apart from regulated phosphorylation, targeted protein degradation is a key regulatory 
mechanism in cell-cycle control. To analyze our data with respect to degradation motifs, we 
integrated the different levels of signal processing and gene expression at the protein and 
transcriptome levels. Degradation signals are significantly overrepresented in proteins that are 
cell-cycle regulated; this is true both for transcriptional regulation (KEN boxes, P < 10
-18
; PEST 
regions, P < 0.002), regulation of protein levels (KEN boxes, P < 0.002; PEST regions, P < 0.02) 
and periodic phosphorylation (KEN boxes, P < 10
-4
; PEST regions, P < 0.001). As expected, 
proteins that are regulated at multiple levels are more enriched in degradation signals than the 
individual sets; for example, proteins that are regulated by phosphorylation and transcription 
show a 2.6-fold enrichment for KEN boxes, whereas phosphorylation alone leads to a 1.4-fold 
enrichment only.  
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If gene products that are regulated at the phosphoproteome or proteome level are highly enriched 
for proteins that have important functions during the cell cycle, then knock-down of these 
proteins should result in cell-cycle defects. Indeed, of 39 genes that show a cell-cycle phenotype 
in a siRNA pilot study
317
, 14 were regulated at the phosphoproteome in M-phase, and 29 at the 
proteome level (Table 8.1).  
Table 8.1 Comparison of our cell cycle regulated proteome and phospoproteome to RNAi phenotype 
study by Neumann et al.317 
Gene name RNAi phenotype observed in study by Neumann et al. 
[Nature Methods  2006. 3(5) 385-390]
Timing of 
phenotype
Proteomics Max 
Difference
M-phase specific 
Phosphorylation?
RGPD5 Medium mitosis and apoptosis phenotype Early onset 2.23 -
NU153 NUP153 - Medium mitosis and apoptosis phenotype Early onset 1.55 -
SYNE2 Medium mitosis, shape and apoptosis phenotype Early onset 1.5 -
RAD21 Medium mitosis and apoptosis phenotype Medium onset 1.76 -
ANC1 medium all Early mitosis 1.96 -
NUP62 Medium shape Late 1.64 -
SEH1L Medium mitosis and apoptosis phenotype Early onset 1.37 -
CDC27 Weak mitosis and medium apoptosis phenotype Early onset 1.38 -
ANC2 Medium all Late onset 1.93 -
NUP37 Medium shape Late 1.23 -
NU107 NUP107 - Medium mitosis & apoptosis phenotype Early onset 1.15 -
MD2L1 Medium shape Late onset 1.38 -
NUMA1 NUMA1 - Medium mitosis and apoptosis phenotype Early onset 1.01 -
ANC5 medium all Early mitosis 1.19 Yes
LMNA Weak mitosis and medium apoptosis phenotype Late onset 0.95 Yes
SUV42 Weak mitosis and medium apoptosis phenotype Late onset 1.45 Yes
APC10 Weak mitosis and medium apoptosis phenotype Late onset 1.16 Yes
POM121 Medium mitosis and apoptosis phenotype Early onset 0.99 Yes
CBX1 Weak mitosis and medium apoptosis phenotype Medium onset 0.16 Yes
CBX3 Medium mitosis and apoptosis phenotype Medium onset 0.13 Yes
DUS3 medium shape, early onset 0.82 -
COPB Strong apoptosis Early 0.17 Yes
CAPG Medium mitosis and shape Medium 0.25 Yes
SEC13 Medium all early 0.27 Yes
MP2K3 Medium shape Late 1.5 -
CBX5 Weak mitosis and medium apoptosis phenotype Medium onset 0.16 Yes
CDK7 Medium shape Medium onset 0.75 -
EGFR Weak mitosis and medium apoptosis phenotype phospho? 0.37 Yes
H2AY Weak mitosis and medium apoptosis phenotype Medium onset 0.85 -
CENPH Weak mitosis and medium apoptosis phenotype Medium/Late 0.61 Yes
CENPB Medium mitosis and apoptosis phenotype Late onset 0.7 Yes
KIF11 Strong mitosis phenotype Early 1.82 -
KIF23 Medium all, stronger mitosis Early 2.3 -
AURKB Medium mitosis, shape and apoptosis phenotype Early onset 1.69 -
DUS14 Medium shape, weak mitosis and apoptosis Early 3.28 -
TPX2 Medium mitosis, shape and apoptosis phenotype Early onset 2.83 -
SMC4 Weak mitosis and medium apoptosis phenotype Early onset 3.11 -
PLK1 Strong mitosis phenotype Early 4.48 -
CCNB2 Weak mitosis and medium apoptosis phenotype Late onset 3.05 -
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We found 27 gene products that exhibit periodic regulation of phosphorylation states, protein 
levels, and transcription (Table 8.2).  
Table 8.2 Protein regulated at multiple levels during the cell cycle. The table contains the HGNC name, 
the IPI identifier, the number of detected phosphorylation sites (with the number of periodic 
phosphorylation sites in parenthesis) and the presence/absence of degradation motifs (D for D-box, K 
for KEN box and P for PEST region) for each of the 27 proteins. 
Among these are two genes, LMNB1 (Lamin B1) and TMPO (Lamina-associated polypeptide 2), 
which encode lamina-related proteins that influence nuclear envelope stability. TMPO contains a 
Lamin-B-binding domain that mediates its interaction with LMNB1
318
. This interaction is 
HUGO IPI id Phosphorylation sites
Degradation 
signal
DSP IPI00013933 40(9) D/K/P
BIRC2 IPI00013418 8(1) -
GMNN IPI00026309 9(1) K/P
UNG IPI00011069 6(2) P
TROAP IPI00029680 8(1) P
BRIP1 IPI00012500 10(1) D/P
NUSAP1 IPI00000398 15(4) K
KIF23 IPI00293884 17(1) K/P
ZNF24 IPI00306446 5(5) P
LMNB1 IPI00217975 22(4) P
GPSM2 IPI00642575 8(1) D
RAD18 IPI00024579 6(2) K/P
TMPO IPI00030131 14(1) D/P
GAS2L3 IPI00185219 5(2) P
MKI67 IPI00413173 3(3) P
ATAD2 IPI00170548 11(2) -
NUP35 IPI00329650 26(12) -
C4A IPI00032258 5(4) D/P
PLK1 IPI00021248 3(1) -
RRM2 IPI00011118 5(1) K
SHCBP1 IPI00168691 6(1) P
CASP2 IPI00291570 2(2) -
PRR11 IPI00305822 8(3) D/K/P
TACC3 IPI00002135 12(1) K/P
SFRS12 IPI00375462 4(1) -
TPX2 IPI00008477 10(1) D/K
KPNA2 IPI00002214 16(7) -
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disrupted by phosphorylation of TMPO in mitosis
319
. Our data now identifies the M-phase-
specific site of phosphorylation (S306), which is located within the Lamin-B-binding domain of 
TMPO, as being responsible for this disruption. Other lamina-related gene products, LMNA 
(Lamin A), LMNB2 (Lamin B2), and LBR (Lamin B Receptor) were also found to cycle at 
multiple levels. Very recently, it was shown that the regions that surround lamina-associated 
chromosomal domains contain binding sites for certain transcription factors
320
. Most of these are 
E2Fs and other G1/S transcription factors, which is intriguing since TMPO has been shown to 
regulated cell-cycle progression via the Rb–E2F pathway321. Thus it is tempting to speculate that 
lamina-related proteins regulate G1/S transcription both by interacting with known G1/S 
transcription factors and by binding close to their downstream target genes. 
8.4 Discussion 
In this work we present the first global and unbiased analysis of proteome and phosphoproteome 
dynamics during the cell cycle at a depth of about 6,000 proteins and the quantitation of more 
than 18,000 unique phosphorylation sites. Our quantitative proteomics dataset provides a 
valuable resource for large-scale studies of in vivo phosphorylation dynamics at a systems-
biology level. Complemented with novel bioinformatics analysis and the inferences gathered 
therein we provide a global compendium of cell cycle related pathways, functions and 
components. We expect it to be useful for the cell-cycle and cancer communities as it directly 
connects gene expression changes with protein regulatory information at a proteome-wide level. 
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9. Protein localization assignment in brown and white adipose tissue 
mitochondria by multiplexed quantitative proteomics and 
systematic bioinformatics approach 
 
The bioinformatics approach for mitochondrial protein localization discussed in this project is 
part of the work included in a manuscript under submission:  
 
Francesca Forner, Chanchal Kumar, Christian A. Luber, Martin Klingenspor and Matthias 
Mann 
Pathway analysis of mitochondria in brown versus white adipocytes by quantitative 
proteomics 
 
9.1 Introduction  
The imminent goal of understanding a cell at the „systems level‟ hinges on the accurate 
knowledge of the dynamic, spatial and temporal aspects of its sub-cellular components including 
RNAs, proteins and metabolites. One definitive step towards this is mapping the sub-cellular 
localization of proteins which provides key insights into their cellular function and interaction 
with other entities
62
. Until now systematic experimental studies of subcellular localization of 
proteins have been performed with the help of cellular fractionation or fluorescent microscopy. 
The first proteome wide localizome study of budding yeast using green fluorescent protein (GFP) 
fusion proteins has been published
322
. In more complex eukaryotes and mammalian systems GFP 
based methods face numerous challenges, and has been recently shown to result in experimental 
artifacts such as translocation to nucleus causing spurious localization
323
. Alternatively, 
antibodies or other affinity reagents have been successfully used to visualize protein sub-cellular 
localization. While this method has several advantages over GFP based methods, one of its 
largest drawbacks is the lack of availability of comprehensive antibody inventory to probe the 
protein localization on a global and high-throughput scale. One of the most comprehensive 
studies based on fluorescently labeled antibodies coupled with confocal microscopy has recently 
reported the localization of 1,899 human gene products
324
.  
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Additionally, numerous bioinformatics methods for protein localization prediction have been in 
use for many years and have provided pointers towards function of hypothetical or novel and 
uncharacterized proteins
325-327
. As they are mainly based on sequence features they can be 
applied for genome wide studies of protein localization predictions for organisms which have 
already been sequenced. But because of the underlying algorithms and the input constraints, they 
are very specific for particular class of proteins (eukaryotic vs. prokaryotic, secretory, 
mitochondrial, nuclear, chloroplast) and therefore limited or specialized in application
328-331
. 
Moreover, they provide mere indications towards protein localizations which need to be 
ultimately verified by cell-biological or biochemical methods. 
 
Proteomics methods specifically applied to characterization of sub-cellular organelle proteomes 
has been referred in literature as Organellar Proteomics and refers to the ensemble of innovative 
experimental methods, MS techniques and specialized bioinformatics algorithms employed for 
characterization of organelle proteomes
332,333
. Organellar proteomics methods have been 
successfully applied to unravel the proteomes of various organelles including mitochondria, 
nucleolus, isolated synaptic vesicles, clathrin coated vesicles, endosomes, phagosomes, 
endoplasmic reticulum, and Golgi apparatus, as well as Golgi-derived COPI vesicles
58,333-336
. 
Quantitative proteomics methods add another dimension to organellar proteomics thereby 
facilitating study of the dynamics of organelles and their constitutive proteomes under various 
cellular states
45
. SILAC is a valuable method for quantitative proteomics and has found 
numerous applications in basic and translational research. Recently organellar proteomics 
methods based on SILAC have been successful employed to map the dynamics of protein 
trafficking in human nucleolus and to model the phagosome maturation process
337,338
 
 
As protein localization is contingent upon many factors which are at play in a given cellular 
context, a dynamic picture of protein localization calls for a special approach and methodology. 
Following this idea we devised a comprehensive framework and workflow for assigning 
simultaneous protein localization in two sub-cellular organelles, compartments and fractions by 
integrating SILAC, organelle enrichment, quantitative mass-spectrometry analysis and a novel 
probabilistic bioinformatics approach. Given the limitations of obtaining totally purified 
organelles and the fact that in any fractionation method a part of the protein population is always 
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present as contaminant in different sub-fractions, we reasoned that a probabilistic approach of 
localization assignment in separate fractions is more rational. The workflow described is suited 
for simultaneous protein localization assignment in two sub-cellular compartments or fractions 
and could easily be extended to more fractions.  
 
9.2 Materials and Methods 
 
9.2.1 Preparation of SILAC reference 
3T3-L1 and brown preadipocytes were sub-cultured and differentiated in DMEM supplemented 
with 10% dialyzed fetal bovine serum (Gibco) and antibiotics in 5% CO2 at 37°C. SILAC 
labeling was performed as described
339
 with L-Lysine-13C6,-15N2 and L-Arginine-13C6,-15N4. 
3T3-L1 preadipocytes were grown and differentiated as described previously (Kratchmarova et 
al. 2002). Brown preadipocytes were obtained from C.R. Kahn‟s laboratory and differentiated as 
described
340
. Cells were harvested with Trypsin (Gibco), diluted with DMEM supplemented with 
protease inhibitors (Roche) and centrifuged at 1000 g for 10 min. Cells were then resuspended 
with 250 mM sucrose, 10 mM Hepes pH 7.4, 0.1 mM EGTA supplemented with protease 
inhibitors (Roche) and washed twice. The suspension was homogenized on a 7 ml Dounce 
homogenizer. Mitochondria and nuclei were isolated as described below. The crude 
mitochondrial fraction was purified on a 30% Percoll self-forming gradient. Equal amounts of 
brown and white adipocyte mitochondria were mixed 1:1 based on the protein amount and 
served as the internal standard (am-IS). The post mitochondrial fraction (PMF) was the 
supernatant obtained after the first centrifugation at 10000 g (see below). The PMF was 
concentrated by with 5000 MWCO membranes (Millipore).  
 
9.2.2 Preparation of mitochondrial sample 
Interscapular brown adipose tissue and epididymal white adipose tissue from C57BL/6 mice (5 -
10 weeks) were excised, immersed in HBSS, cleaned free of connective tissue under a binocular 
microscope, minced and digested with 1 mg/ml collagenase A (Roche) at 37°C for 30 min. After 
digestion, the slurry was passed through 250 μm mesh opening fiber material (Sefar) and 
centrifuged at 500 g for 1 min. The floating adipocytes were removed with a plastic pipette and 
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centrifuged three additional times in HBSS. No visible stromal vascular fraction was present 
after the fourth centrifugation. Floating adipocytes were homogenized using a 10 µm clearance 
cell homogenizer (Isobiotec) pre-cooled in ice. Membrane disruption was checked with Trypan 
blue staining. The tissue homogenate was centrifuged twice at 800 g for 10 min at 4°C to pellet 
the crude nuclear fraction. The supernatant was centrifuged at 10000 g for 10 min at 4°C. The 
crude mitochondrial pellet was resuspended in 250 mM sucrose, 10 mM Hepes pH 7.4, 0.1 mM 
EGTA  supplemented with protease inhibitors (Roche). The suspension was further centrifuged 
at 7000 g for 10 min at 4°C and purified with the protease treatment as described
341
. For the 
localization study, mitochondria from the brown and from the white adipose tissues were mixed 
1:1 with post mitochondrial (PMF) and nuclear fractions (N) isolated from the SILAC-labeled 
brown adipocytes or 3T3-L1 respectively (see section 9.2.1). For quantitative proteomics, 
mitochondria from the brown and from the white adipose tissues were each mixed 1:1 with the 
am-IS based on protein amount (Bradford).   
  
9.2.3 Protein fractionation and mass spectrometric analysis of proteins and relative 
quantitation.  
Protein samples were separated on 1D gels, trypsin-digested and extracted as described
342
. 
Peptides were desalted and concentrated on C18 stage tips as described
235
 and analyzed by LC-
MS/MS on a LTQ-Orbitrap mass spectrometer (Thermo Fischer Scientific) connected to an 
Agilent 1200 nanoflow HPLC system via a nanoelectrospray source (Proxeon Biosystems). MS 
full scans were acquired in the orbitrap analyzer by using internal lock mass recalibration in real-
time. MS full scans were acquired in two different m/z ranges (350-1000 and 1000-1800). 
Tandem mass spectra of the 6 most intense ions of the lower mass range and of the 4 most 
intense ions of the higher mass range were simultaneously recorded in the linear ion trap. 
Peptides were identified from MS/MS spectra by searching them against the IPI mouse database 
(version 3.24) using the Mascot search algorithm (www.matrixscience.com) and SILAC pairs 
were quantified by MaxQuant
47
. 
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9.2.4 Finite Mixture modeling and Bayesian approach for protein localization 
 
The section explains the Bayesian inference methodology of localization probability assignment 
for brown adipocytes experiment shown in Figure 9.1A. The same approach was applied to the 
3T3-L1 white adipocytes experimental setup. Below we discuss the two cases namely case 1: 
mitochondrial (Mito) vs. post mitochondrial fraction (PMF), and case 2: mitochondrial (Mito) vs. 
nuclear fraction (Nuc).  
Case 1: We used the statistical method of finite mixture modeling to model the abundances of 
the
Mito
PMF
2log ratios based on the assumption that the “Mito” and “PMF” protein ratios originate 
from two different Gaussian distributions MitoMitoxf ,; and PMFPMFxf ,; respectively. To 
estimate these distributions we used expectation maximization (EM) algorithm
343
 with an initial 
assignment of the protein ratios
Mito
PMF
x 2log  to either the mitochondrial class (CMito) or the PMF 
class(CPMF) by the criteria: 
PMF
Mito
Cxxif
Cxxif
),5.1(
),5.1(
. The cutoff -1.5(on log2 scale) was chosen as it 
corresponds to ~ 3 fold up/down ratios and enables a preliminary separation of the dataset as 
observed from manual inspection. The EM algorithm iteratively finds the best estimates for the 
Gaussian distributions for the two classes given the SILAC ratios for all the proteins identified in 
that experiment. The class membership (or localization) probability for each protein was 
calculated by the equations defined below. Briefly, given a protein ratio
Mito
PMF
x 2log , the 
following two equations calculate the class membership probability PMito and PPMF of its 
membership to mitochondrial class (CMito) and PMF class(CPMF) respectively.  
    
)(*)|()(*)|(
)(*)|(
)|(
PMFPMFMitoMito
MitoMito
MitoMito
CPCxRatioPCPCxRatioP
CPCxRatioP
xRatioCPP  
And,  
 
Where, 
 
   
 
)(*)|()(*)|(
)(*)|(
)|(
PMFPMFMitoMito
PMFPMF
PMFPMF
CPCxRatioPCPCxRatioP
CPCxRatioP
xRatioCPP
MitoMitoMito xfCxRatioP ,;)|(
PMFPMFPMF xfCxRatioP ,;)|(
Protein localization by multiplexed quantitative proteomics and systematic bioinformatics 
     
 
136 
 
Case 2: As in case 1 expectation maximization (EM) algorithm was used to model the 
abundances of the
Mito
Nuc
2log ratios based on the assumption that the “Mito” and “Nuc” protein 
ratios originate from two different Gaussian distributions MitoMitoxf ,; and NucNucxf ,;
respectively. The initial assignment of the protein ratios
Mito
Nuc
x 2log  to either mitochondrial 
class (CMito) or nuclear class(CNuc) was done by the criteria 
Nuc
Mito
Cxxif
Cxxif
),5.1(
),5.1(
 similar to case 
1. The EM algorithm iteratively finds the best estimates for the Gaussian distributions for the two 
classes given the SILAC ratios for all the proteins identified in that experiment. These estimates 
for the two class distributions were in turn used to assign the class membership probabilities. 
Given a ratio, 
Mito
Nuc
x 2log , the following two equations calculate the membership probability 
PMito and PNuc of its membership to mitochondrial class (CMito) and nuclear class(CNuc) 
respectively.  
)(*)|()(*)|(
)(*)|(
)|(
NucNucMitoMito
MitoMito
MitoMito
CPCxRatioPCPCxRatioP
CPCxRatioP
xRatioCPP  
And,  
  
Where, 
 
  
 
This complete analysis was done using “MCLUST” version 3 package344 in the R statistical 
environment
345
. 
 
 
 
 
 
 
 
)(*)|()(*)|(
)(*)|(
)|(
NucNucMitoMito
NucNuc
NucNuc
CPCxRatioPCPCxRatioP
CPCxRatioP
xRatioCPP
MitoMitoMito xfCxRatioP ,;)|(
NucNucNuc xfCxRatioP ,;)|(
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9.2.5 Categorization of proteins in discrete classes based on probability cutoff 
The proteins were finally assigned to separate categories based on the localization probability 
values. Below we discuss the two cases pertaining to our study of brown adipocytes, namely case 
1: mitochondrial (Mito) vs. post mitochondrial fraction (PMF), and case 2: mitochondrial (Mito) 
vs. nuclear fraction (Nuc). A similar approach was employed for classifying proteins in the 3T3-
L1 white adipocyte experimental setup 
 
Case 1: Based on the PMito and PPMF membership probabilities for each protein, we categorized 
the proteins in 3 exclusive categories by the following criterion: (a) MITO: if (PMito >= 0.75), (b) 
BORDER: if((PMito < 0.75)  AND (PPMF < 0.75)), and (c) Non-MITO: if (PPMF >= 0.75). 
 
Case 2: Based on the PMito and PNuc membership probabilities for each protein, we categorized 
the proteins in 3 exclusive categories by the following criterion: (a) MITO: if (PMito >= 0.75), (b) 
BORDER: if((PMito < 0.75)  AND (PNuc < 0.75)), and (c) Non-MITO: if (PNuc >= 0.75). 
 
9.2.6 Gene Ontology based localization concordance matrices 
The accuracy metrics for our localization approach were defined with respect to known GO 
cellular compartment annotations available for IPI version 3.24 downloaded from the EBI GOA 
website (version gene_association.goa_mouse.32.gz). As the premise of our approach was 
to identify mitochondrial proteins we specifically choose the available annotation pertaining to 
“mitochondrion” (GO:0005739) for each of the four dataset( two each for BAT and WAT). The 
percentage of true-positive and false-negative mitochondrial proteins assigned by this approach 
were quantified by two metrics namely True Localisation Percentage (TLP) and False 
Localization Percentage (FLP) as defined below: 
 
  
 
 
 
 
(Proteins  in MITO class)  AND  (Annotated as Mitochondrial (GO:0005739)) 
TLP  *  100
All Proteins Annotated as Mitochondrial(GO:0005739) in dataset
(Proteins  in Non-MITO class)  AND  (Annotated as Mitochondrial (GO:0005739)) 
FLP  *  100
All Proteins Annotated as Mitochondrial(GO:0005739) in dataset
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9.3 Results 
 
9.3.1 Multiplexed proteomics approach to obtain mitochondrial localizations in Brown and 
White Adipose Tissue 
 
Mitochondria (Mito) from brown adipose tissue (BAT) and white adipose tissue (WAT) were 
purified by density gradient centrifugation. In separate experiments nuclear (Nuc) and the post-
mitochondrial fractions (PMF) were isolated from SILAC-labelled brown adipocytes and 3T3-
L1. We then mixed BAT mitochondria with (1) SILAC-labeled brown adipocyte PMF and (2) 
with SILAC-labeled brown adipocyte Nuc in a 1:1 ratio (Figure 9.1A). Likewise, we mixed 
WAT mitochondria with (1) SILAC-labeled 3T3-L1 PMF and (2) with SILAC-labeled 3T3-L1 
Nuc in a 1:1 ratio (Figure 9.1B). The four samples were separated in 40 fractions on 1D gels and 
measured by high resolution mass spectrometry. 
 
The PMF/Mito and Nuc/Mito protein ratios provided the relative protein abundance over the 
three subcellular fractions, based on the assumption that relatively high PMF/Mito or Nuc/Mito 
ratios designated non-mitochondrial proteins (higher abundance in the PMF or Nuc fraction) 
whereas relatively low PMF/Mito or Nuc/Mito ratios designated mitochondria-associated 
proteins. Plotted ratio distributions were more distinctly bimodal for brown adipocytes/BAT than 
for 3T3-L1/WAT. Manual inspection of the datasets confirmed that the left tails (lower ratios) 
were highly enriched in mitochondrial proteins, as expected from the lower PMF/Mito or 
Nuc/Mito ratios. In total 3,689 proteins were identified with quantified SILAC ratios in at least 
one of the four experiments.  
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Figure 9.1 Workflow of mitochondrial protein localization based on quantitative proteomics and bioinformatics analysis (A). Mitochondria 
were enriched from the brown fat and mixed on one to one ratio with nuclear and post-mitochondrial enriched fractions obtained from SILAC 
labeled cell line of brown adipocytes. Plotted protein ratios distributions appeared bimodal and were interpolated with the expectation 
maximization algorithm (EM) to calculate the probability of mitochondrial localization. (B) The procedure described in (A) was repeated with 
mitochondria enriched from white adipocytes, whereas nuclear and post-mitochondrial fractions were enriched from SILAC-labeled 3T3-L1. 
Protein localization by multiplexed quantitative proteomics and systematic bioinformatics 
     
 
140 
 
9.3.2 Probability based localization assignment of mitochondrial proteins 
Our next goal was to establish core mitochondrial proteomes from this rich dataset. One of the 
simplest empirical methods could have been to choose an arbitrary cut-off of PMF/Mito and 
Nuc/Mito ratios and then categorise the proteins as mitochondrial, PMF or Nuclear. This 
criterion is very inconsistent for multiple datasets of similar origin but with distinct features like 
the one here, as in each case we would have to define a separate cut-off. Moreover this approach 
is not amenable to automation and depends on manual curation, validation, individual expertise 
and bias. We wanted to avoid all of these above pitfalls in our data analysis and sought to devise 
a generic bioinformatics approach which could be consistently applied to any such dataset. Given 
the data in hand and the nature of the problem to be solved we adopted a probabilistic model 
based on Bayesian inference to assign probabilities to the proteins based on their SILAC ratios. 
Bayesian methods have found myriad applications in bioinformatics and have been successfully 
applied to sequence analysis, microarray data analysis, network inference and systems 
biology
346
. Our proposed analysis methodology is a two step process. In the first step we model 
the abundances of the protein ratios based on the assumption that the ratios would originate from 
two different Gaussian distribution functions pertaining to (a) Mitochondrial proteins, and (b) the 
PMF or Nuclear proteins, under the given experimental strategy. Expectation Maximization 
(EM) algorithm
343
 was employed to model these Gaussian distributions. In the second step we 
use these estimates to assign a probabilistic measure of locality (PMito, PPMF/PNuc) using sets of 
Bayesian equations (for details see section 9.2.4).  
 
9.3.3 Grouping of proteins in organelle classes based on Bayesian probabilities 
For each experiment we categorized the proteins as “MITO”, “BORDER” and “Non-MITO” 
based on conservative probability values (see section 9.2.5 and Figure 9.2). The rationale behind 
defining a BORDER class was twofold - on a computational level these are proteins which could 
not be confidently assigned to either of the two categories based on their obtained probability 
values and so they are borderline cases, and from a biological perspective these could be proteins 
which are present on the interface of the two organelles (like proteins associated with the outer 
membrane) or proteins which have more tightly coupled dynamics between the organelles. 
Moreover, GO annotations for these BORDER proteins revealed that they contained some 
interesting mitochondrial proteins in each case. Finally, we applied a very conservative threshold  
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of PMito > 0.75 to define core mitochondrial proteome in each experiment. Though the BORDER 
proteins were not included in the core set, in subsequent discussion we show the implication of 
their inclusion or exclusion on our results assessment metrics. Figure 9.2 provides the summary 
of results obtained by our categorization approach for the two experiments against the backdrop 
of their quantitative proteomics ratios (PMF/M or N/M) and the estimated Gaussian 
distributions. The number of proteins in each category is represented with the class labels. It is 
evident that setting an arbitrary cut-off would have been difficult and completely arbitrary to 
categorize the data. Interestingly, in each set of experiments the combined set of MITO and 
Border class together contained (1) 97% and 94% of GO annotated mitochondrial proteins for 
WAT and (2) 95% and 97% of GO annotated mitochondrial proteins for BAT respectively; 
thereby demonstrating the power of our method in sorting out true mitochondrial proteins from 
non-mitochondrial ones. As a first step towards validation we checked for the classification of 
known mitochondrial residents (e.g. respiratory chain subunits, Krebs cycle enzymes, fatty acid 
oxidation enzymes, translocases of the outer membrane) and cytoplasmic/mitochondrial isoforms 
of a certain protein (e.g. aspartate aminotransferase) were correctly classified. 
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Figure 9.2: Categorization of proteins in three classes (MITO, Border, and Non-MITO) based on the 
calculated localization probability values. (A) The number of proteins categorized in BAT experiments 
against the backdrop of quantitative proteomics ratios (in black bars) and the estimated Gaussian 
distributions (enveloped by colored areas). In each plot the left distribution pertains to estimated 
mitochondrial population. The ratio cutoffs corresponding to the categorization criterion are shown as 
vertical blue lines and the number of proteins in each class is provided in parentheses. (B) The number 
of proteins categorized in WAT experiments. The details of the legends are as in (A) 
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9.3.4 Concordance of probabilistic localization with Gene Ontology annotations  
To provide a quantitative measure to the accuracy of our method we defined two metrics. True 
Localisation Percentage (TLP) and False Localization Percentage (FLP) which would be 
respectively analogous to true-positive and false-negative rates in machine learning vocabulary 
but defined with respect to Gene Ontology(GO) annotations
48
 (see section 9.2.6 for definition). 
GO annotations have been used as the benchmark in many studies on localization predictions, 
therefore we decided to use GO as the reference for calculating the (true/false) localization 
percentages for each dataset
214,347
. We compared our localization assignments with the GO 
cellular compartment annotations available for IPI Mouse 3.24 database from GOA website 
(Figure 9.3).  
Figure 9.3 Localization concordance results for the mitochondrial localization experiments (A) Localization 
concordance results for the BAT mitochondrial localization. The black bars show the True Localization 
Percentage (TLP) and the grey bars represent False Localization Percentages (FLP) for MITO class proteomes 
(PMito>= 0.75). The error bars TLP show the gain % in TLP when Border proteins are included in the MITO set. 
The number on top of the green bars denotes the TLP for the core proteome sets with the increased TLP in 
parentheses (with a green arrow).  The error bars on FLP shows the decrease % in FLP when multiply localized 
mitochondrial proteins are removed from FLP calculations. The number on top of the red bars denotes the 
FLP for the core proteome sets with the decreased FLP in parentheses (with a red arrow). (B) Localization 
concordance results for the WAT mitochondrial localization. The details of legends are as in (A) 
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9.3.4.1 High accuracy of mitochondrial localization in brown adipose tissue (BAT) 
Figure 9.3A shows the results for TLP and FLP of the core mitochondrial proteomes for the two 
BAT experiments. For the PMF vs. Mito experiment we get TLP of 93% and FLP of 5% while 
for the Nuc vs. Mito experiment we get TLP of 93% and FLP of 9%. The relatively lesser TLP 
and relatively higher FLP for the Mito vs. Nuc experiments (as compared to PMF vs. Mito ones) 
may be due to the fact that there exists a strong trafficking of  proteins between nucleus and 
mitochondria as suggested by large body of literature on mitochondrial-nuclear 
communication
348
. This is further substantiated by our observation on the increase in TLP when 
we included GO annotated mitochondrial BORDER proteins in the core proteome set. In the 
PMF vs. Mito experiments the TLP increased to 95 % (an increase of 2%) but in the Nuc vs. 
Mito exp the increase was 97 % (an increase of 5%). This higher gain in the latter case could be 
a reflection of the dynamics of nuclear-encoded mitochondria-targeted proteins in the particular 
cellular contexts during our experimentation. As the highest FLP in this case was 9% and though 
it was comparable w.r.t the experimental and computational localization assignment methods, 
but still we sought to probe the reason behind this. After careful study of the GO annotations for 
the proteins which accounted for FLP calculation we observed that most of them indeed had 
multiple localizations besides mitochondria, so they were not exactly “false-negatives” in the 
true sense and could be localised to other compartments. Therefore to get a more logical statistic 
we recalculated the FLP by removing proteins which had any other GO localization that could be 
part of PMF(peroxisome, membrane, lysosome, ER, cytoplasm) or Nuclear fractions 
(nucleus,nucleolus), in addition to mitochondrial annotations. Thereby the corrected-FLP was 
now 4%( a decrease of 1%) for the BAT(PMF/Mito) and 3%(a decrease of 6%) for 
BAT(Nuc/Mito) ( Figure 9.3 A). In total we could confidently assign mitochondrial localization 
to 650 proteins across these 2 experiments. 
 
9.3.4.2 High accuracy of mitochondrial localization in white adipose tissue (WAT) 
Figure 9.3B shows the results for TLP and FLP of the core mitochondrial proteomes for the two 
WAT experiments. For the PMF vs. Mito experiment we get TLP of 93% and FLP of 3% while 
for the Nuc vs. Mito experiment we get TLP of 84% and FLP of 6%. As in the case of BAT the 
relatively lesser TLP and relatively higher FLP for the Mito vs. Nuc experiments (as compared to 
PMF vs. Mito ones) may be due to the fact that there exists a strong trafficking of proteins 
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between nucleus and mitochondria. Similarly, we observed a remarkable increase in TLP when 
we included GO annotated mitochondrial BORDER proteins in the core proteome set. In the 
PMF vs. Mito experiments the TLP increased to 97 % ( an increase of 4%) but in the Nuc vs. 
Mito exp the increase was 94 % ( an increase of 10%). This was again similar to the results in 
case of BAT localizations. Again, similar to the BAT case, we recalculated the FLP by removing 
proteins which had any other GO localization that could be part of PMF (peroxisome, membrane, 
lysosome, ER, cytoplasm) or Nuclear fractions (nucleus,nucleolus), in addition to mitochondrial 
annotations. Thereby the corrected-FLP was now 1.5% (a decrease of 1.5%) for the 
WAT(PMF/Mito) and 5%(a decrease of 1%) for WAT(Nuc/Mito) ( Figure 9.3B). In total we 
could confidently assign mitochondrial localization to 1,512 proteins across these two 
experiments. 
 
9.3.5 Integration of multilevel sub-cellular localization information to elucidate 
mitochondrial proteome of mouse adipose tissue 
The two parallel localization experiments for each of the adipose tissue types i.e. BAT and WAT 
(Figure 9.1) provides us with two levels of confidence for a protein to be localized in either 
mitochondrion versus its post mitochondrial fraction or nuclei. Subsequently, as described in 
section 9.3.3 and illustrated in figure 9.2, for each experiment we categorize each protein as 
either being MITO, BORDER or Non-MITO by using conservative probability cutoffs (section 
9.2.5). Furthermore, we used this dual localization evidences for each tissue type to define the 
core mitochondrial proteome of that tissue type. The classification contingency matrix along 
with the numbers of proteins identified as mitochondrial or non-mitochondrial are illustrated in 
Figure 9.4. In BAT we putatively assign 650 proteins to mitochondria (out of 1,753) and in WAT 
we assign 1,512 proteins to mitochondria (out of 3,345). Though in terms of the numbers the 
BAT mitochondrial proteome is approximately one-third of the WAT mitochondrial proteome, 
this disparity diminishes when we look at the percentage coverage of BAT and WAT 
mitochondrial proteome w.r.t the quantified proteome in each tissue type.  BAT mitochondrial 
proteins cover roughly 37% of the total tissue specific organelle proteome while WAT covers 
45%. Lastly, we use the union of these two tissue type mitochondrial proteomes to arrive at 
1,517 putative mitochondrial proteins in adipose tissue of mouse.  
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Figure 9.4 contingency matrixes for combining evidence from two parallel experiments each in BAT and 
WAT to define core-mitochondrial proteome of adipose tissue (WAT). The class assigned (Mito, Border, 
Nuc/PMF) in each experiment ( Nuc vs. Mito and PMF vs. Mito; Figure 9.1) were combined to assign a 
final class to the proteins as shown in the matrix. Blue boxes contain the mitochondrial protein numbers 
in BAT (upper matrix) and WAT (lower matrix). In total we obtained 1,517 core mitochondrial proteins.  
 
 
9.4 Discussion 
Protein localization studies in sub-cellular organelles have become a mainstay in current systems 
biology enterprises, and are definitely the first steps towards realizing their promises and 
goals
147,349
. In recent years many proteomics methods based on MS technology have been 
reported for establishing the protein localization and organelle localizomes332-334. The most 
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effective of these methods combine elaborate cellular fractionation, mass-spectrometry and 
quantitative proteomics. Protein Correlation Profiling (PCP) and Localization of Organelle 
Proteins by Isotope Tagging (LOPIT) are the representative approaches in this category
104,350
. 
While they provide definite results they also require simultaneous analysis of many fractions and 
are limited by the efficiency of fractionation, most importantly they require prior knowledge of 
organelle marker proteins. We devised a simpler and generic approach whereby we build upon 
the strengths of quantitative proteomics and SILAC and do away with multiple fractionations. 
Furthermore we use a probabilistic localization method with simplest computational assumptions 
(or model) and do not require prior knowledge of organelle marker proteins. As a proof of 
concept we use this framework to assign putative localization to proteins identified from BAT 
and WAT mitochondria.  
 
Mitochondria have been one of the most widely studied sub-cellular organelles and they play 
pivotal roles in myriad biological processes including growth, division, energy metabolism and 
apoptosis
351-353
. Due to their expansive role in cellular processes they are also implicated in 
myriad diseases including obesity, diabetes, cancer, neurodegenerative and cardio-vascular 
disorders
354,355.  The advent of high throughput “omics” disciplines has helped tremendously in 
generating parts list of mitochondria at various levels of organization including genome, 
proteome, metabolome and interactome; thereby providing valuable insights into its biology and 
cellular function
356
. The study of mammalian mitochondrial proteomes is a challenge owing to 
its dynamic constitution, and the complexity of the cellular milieu in these systems. In the recent 
past proteomics and functional genomics approaches have been employed for establishing the 
mitochondrial proteome of mouse and humans
57,59,342,357
. According to the latest estimates there 
are ~1500 mitochondrial proteins in humans
358
. While recent systemic analysis approaches are 
trying to enumerate the complete mitochondrial proteome in model organisms
359
, there is still 
clear consensus that many more mitochondrial proteins remain to be discovered and 
characterized
360
. Moreover, study of the tissue specific organellar proteome is of immense value 
as it correctly portrays the physiology which is often not captured by studying cell lines of 
similar origin
342
. Therefore we sought to explore the mitochondrial proteome from brown and 
white adipose tissue of mouse as a model system for humans
361
.   
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In two sets of parallel experiments we were able to quantify and elucidate 650 (BAT) and 1,512 
(WAT) putative mitochondrial proteins according to very high probability scores obtained by our 
bioinformatics approach. These proteins show very high concordance with the known Gene 
Ontology mitochondrial localizations. Furthermore, by combining the localization evidences 
from these two separate tissue specific experiments we were able to derive a set of 1,517 putative 
mitochondrial proteins in mouse adipose tissue. This candidate mitochondrial catalogue was 
further used in a setup for systems level analysis of in vivo quantitative profiling of 
mitochondrial proteome of BAT and WAT. Figure 9.5 shows the schematic of this experiment; 
briefly tissue mitochondria were isolated and quantified against mitochondria isolated from 
SILAC labeled cognate cell types (3T3-L1 and brown adipocytes). The mitochondrial proteome 
identified and quantified in this experiment was filtered against the candidate mitochondrial 
catalogue established in earlier steps to arrive at high confidence in vivo quantitative BAT vs. 
WAT mitochondrial proteome of 978 proteins. The relative ratios of proteins in two tissue types 
provided a quantitative landscape of the differences in BAT versus WAT mitochondrial proteins, 
which were further shown to be involved in many biological processes and pathways. One of the 
key findings therein was that there is considerable specialization and divergence of key 
mitochondrial pathways in the two tissue types as shown in Figure 9.6. For instance, strongly up-
regulated pathways in BAT mitochondria were ubiquinone biosynthesis (p=2.8E-12), oxidative 
phosphorylation (p=7.6E-28), and citrate cycle (p=8.6E-10). In WAT mitochondria up-regulation 
of pathways was less pronounced, and significantly up-regulated pathways were 
androgen/estrogen metabolism (p=3.8E-3), fatty acid synthesis (p=2.4E-3), pyruvate metabolism 
(p=1.6E-4), and metabolism of xenobiotics (p=8.4E-2).  
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Figure 9.5 Strategy of quantitative proteomic analysis of mitochondria in BAT vs. WAT. Mitochondria 
isolated from brown and white adipocytes were mixed with SILAC labeled mitochondria isolated from 
bat and 3T3-L1 cells that served as internal standards. In vivo relative protein levels of BAT versus WAT 
were obtained from the “ratio of ratios” of peptide levels measured by mass spectrometry. The final 
dataset was the WB-mitochondrial core proteome. Proteins were qualified into one of five protein 
categories obtained by subdividing the BAT/WAT distribution in percentiles (10%, 25%, 75%, and 90%). 
The categories were named vH-BAT, H-BAT, 1to1, H-WAT, and vH-WAT to express their relative 
abundance in BAT versus WAT. 
Protein localization by multiplexed quantitative proteomics and systematic bioinformatics 
     
 
150 
 
Figure 9.6 Map of metabolic pathways in primary adipocyte mitochondria from the systematic analysis of quantitative proteomic data. Relative activity of 
pathways in BAT and WAT mitochondria were inferred from the protein ratios obtained from quantitative proteomics(Figure 9.5).  Proteins were subdivided 
into five categories (see Figure 2) and color-coded based on their BAT/WAT protein ratios: vH-BAT (red), H-BAT (orange), 1to1 (grey), H-WAT (green), vH-WAT 
(dark green). Non-filled boxes represent proteins that were not identified in our proteomic survey or that were non-mitochondrial based on our localization 
assignment. A tentative localization of MCC-32 with its putative interaction partners as obtained from our preliminary experiments is also shown.
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In summary our framework adds to the growing toolkit of organellar proteomics and is very 
generic in terms of applicability. The simplicity and flexibility of our approach makes it 
amenable for global-study of other organelle proteomes and opens newer vistas towards creation 
of organelle cellular maps
334
. The framework and the mitochondrial database generated will be 
of great value to the ongoing systems biology and „omics‟ endeavors. 
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10. Conclusions, challenges and perspective 
 
Mass spectrometry based proteomics is now a multidisciplinary scientific endeavor with 
extensive applications and far-reaching impact. This transition from a previous niche domain to 
one of the strongest stakeholders of post-genomics science has been propelled by technological 
advances in mass spectrometry instrumentation complemented by experimental and 
bioinformatics innovations. A simple comparison of PubMed indexed publications appearing in 
last 15 years (starting from 1994 when the term “proteomics” was coined) in the field of 
proteomics and genomics reveals that proteomics is now as widely entrenched in contemporary 
biomedical research as genomics (Figure 10.1). This in itself is a testimony to the power and 
importance of this relatively young discipline in current scientific ecosystem.  
 
Figure 10.1 Number of publications in PubMed with title or abstract containing term “Genomics” or 
“Proteomics” from 1, January 1994 till 30, September 2008. The graph shows the extrapolated values for 
the end of the year 2008 based on the number of publications till 30, September 2008. The trend 
illustrates the pervasiveness of proteomics in post genomics biomedical research.  
 
Analogous to every emerging paradigm, proteomics too has brought in its unique set of 
challenges that are of varying constitution - scientific, technological, experimental and 
computational. The very nature, scale and novelty of these challenges have attracted serious 
attention from the stakeholders of proteomics community. Concerted scientific and technical 
efforts are now underway to harness the untapped potential of proteomics.  
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Modern high resolution mass spectrometry instruments can produce gigabytes of data per run 
and a large proteomics project may employ several stages of upfront protein or peptide 
fractionation and consist of hundreds of runs. As proteomics endeavors become more ambitious 
and more comprehensive, the analytical challenges are further compounded. The high 
dimensionality and complexity of MS data pose novel computational, analytical and 
infrastructural challenges hitherto unseen by biomedical informatics researchers.  
 
Proteomics in its current form requires extensive informatics support, therefore computational 
proteomics and bioinformatics have become key constituents of this field. While computational 
proteomics helps in extracting protein identity and quantity information from mass spectra, 
bioinformatics subsequently serves in discovering knowledge models, verifying hypothesis and 
providing biological insights. Throughout my PhD studies I have concentrated on this latter 
aspect of proteomics dataset analysis by bioinformatics. As proteomics progresses towards 
achieving the same kind of depth and comprehensiveness as genomics
2,64
 it cannot be 
overemphasized that the analysis of current proteomics datasets necessitates elaborate 
bioinformatics infrastructure and support. Proteomics has opened up newer vistas for 
bioinformatics researcher and now drives a major part of current biomedical informatics research 
initiatives. In that context I have adopted two approaches towards proteomics data analysis: (1) 
adapting functional genomics databases, tools and algorithms for obtaining insights into 
proteomics dataset and, (2) developing novel analysis algorithms, frameworks and workflows for 
proteomics dataset. Taking specific examples of typical datasets that are being currently 
generated in our laboratory (beginning with qualitative catalogues to quantitative multi-time 
course datasets), I have tried to showcase the diversity of analysis which is needed in typical 
proteomics experimental scenarios. In this thesis I have discussed some of the novel analytical 
workflows and algorithms we have developed in our group for functional analysis of high 
throughput proteomics data using bioinformatics algorithms, tools and databases. All of the 
projects discussed in this work also showcase the importance of collaborative and 
interdisciplinary science wherein active dialogue and synergy is required between bioinformatics 
and experimental biological scientists.  
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Current trends in proteomics data analysis also indicate that the present bioinformatics resources 
and approaches will not be sufficient or adequate to mine proteomics datasets, and novel 
algorithms and approaches will have to be developed to integrate these datasets with disparate 
“omics” datasets for knowledge discovery. In that direction novel data mining, analytical and 
visualization software needs to be developed to harness the uniqueness of such dataset. At the 
same time one of the biggest challenges faced by current proteomics researcher is the relative 
scarcity of protein centric annotational knowledgebases. Still today most of the annotational 
databases are “gene” centric, and while they have been of immense value to researchers they still 
do not meet the numerous and at times unique demands of the proteomics community. Therefore 
more scientific investments are required to have a unified and comprehensive proteomics 
database on the lines of GenBank or Ensemble.  
 
Modern proteomics technologies and its applications span a broad spectrum of biological 
explorations on various levels of cellular organization. These investigations cover nearly all 
aspects of cellular composition and architecture including, elucidation of structural, spatial, 
temporal and relational constitution - at the proteome level. The availability of such data types 
has in turn infused vigor into the ongoing bioinformatics efforts towards assimilating this 
important piece of information into the broader framework of systems biology
59,362,363
. Future 
bioinformatics activities in proteomics will focus more and more on integrative systems biology, 
as there are still many open ended questions which can only be answered by adopting this 
approach. For instance, we still do not have a comprehensive understanding of how protein 
expression is controlled and regulated as a function of regulatory mechanisms at epigenetic, 
transcriptional, translational and post-translational levels
215
. Current debates in biomedical 
informatics research are replete with many such questions.  
 
In the post-genomic era proteomics along with other “omics” disciplines provides the 
foundations on which future promises of systems biology will be realized and delivered. The 
next steps in this direction is consolidation and integration of datasets and information across 
different layers of the “omics” hierarchy364(Figure 10.2), ultimately leading to physiologically 
exact and clinically relevant in silico models of biological processes and systems. Proteomics has 
Conclusions, challenges and perspective 
     
 
156 
 
the potential of making a huge impact in this endeavor by providing comprehensive and 
quantitative data of constituent proteomes for the systems of interest.  
Figure 10.2. The Wheel of Biological Understanding. System biology strives to understand all aspects of 
an organism and its environment through the combination of a variety of scientific fields (image adapted 
from Joanne Fox article URL:  http://bioinformatics.ubc.ca/about/what_is_bioinformatics/) 
 
One of the ultimate litmus tests for proteomics is to be able to generate data of the nature and 
scale which is necessary for incorporation into multi-scale simulation and modeling 
frameworks
365
.  Moreover, augmentation of modeling languages is needed to incorporate 
proteomics datasets and results into the framework of executable cell biology
366
. In that context 
innovative experimental strategies and scalable instrumentation capabilities have to be developed 
so that fine grained, comprehensive and quantitative datasets are generated in the future, which 
are amenable for in silico modeling and execution. Recent results indicate that proteomics is well 
equipped to handle this challenge and is poised to transform the landscape of system biology, 
thereby engendering profound changes in translational research.  
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Abbreviations 
2D: two dimensional 
3D: three dimensional 
A2M: alpha-2-macroglobulin 
AC: alternating current 
ADP: Adenosine diphosphate  
AGC: automatic gain control 
AKT: protein kinase B, or Rac (RAC-alpha serine/threonine-protein kinase). The term AKT 
originates from the transformed AKR mouse strain. 
AML: Acute myeloid leukemia 
APC/C: Anaphase promoting complex/cyclosome 
AQUA: Absolute Quantitation 
ATM: Ataxia telangiectasia mutated 
ATP: adenosine triphosphate 
BAT: Brown adipose tissue 
bis-Tris :2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol 
BiNGO: Biological Networks Gene Ontology tool  
BLAST, Basic Local Alignment and Search Tool 
CDKs: cyclin-dependent kinases 
ChIP: Chromatin innunoprecipitation 
CID: collision induced fragmentation 
DC: direct current 
DDA: DNA damage response 
DGAP: Diabetes Genome Anatomy Project 
DHB: 2,5-dihydroxy benzoic acid 
DMEs: drug metabolizing enzymes 
DMEM: Dulbecco‟s modified Eagle‟s medium 
DMSO: dimethyl sulfoxide 
DNA: deoxyribonucleic acid 
DNA-PK: DNA-activated protein kinase 
Abbreviations 
     
 
176 
 
ECD: electron capture dissociation 
ECM: extracellular matrix 
EDTA: ethylenediaminetetraacetic acid 
EGFR: epidermal growth factor receptor 
EM: Expectation Maximization 
ErbB: epidermal growth factor receptor (EGFR) family 
ER: Endoplasmic reticulum 
ESI: electrospray ionization 
EST: expressed sequence tag 
ET: Evolutionary trace 
ETD: electro transfer dissociation 
FACS: Fluorescent-activated cell sorting 
FDR: false discovery rate 
FKBP: FK506-binding protein 
FLP: False localization percentage 
FMO: Flavin monooxygenase 
FT: Fourier transform 
FTICR: Fourier transform ion cyclotron resonance 
FVA: Flux variability analysis 
GAP: GTP activated protein 
GFP: Green fluorescent protein 
GLUT4: glucose transporter 4 
GnRH: Gonadotropin-releasing hormone 
GO: Gene Ontology 
GOA: Gene Ontology Annotation 
GST: glutathione S-transferase 
GTP: guanosine triphosphate 
HPLC: high performance liquid chromatography 
ICAT: Isotope-Coded Affinity Tagging 
IMAC: immobilized metal ion affinity chromatography, 
IP: immunoprecipitation 
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IPI: International protein index 
IRMPD: infrared multiphoton dissociation 
iTRAQ: isobaric tag for relative and absolute quantitation 
KEGG: Kyoto Encyclopedia of Genes and Genomes 
LBR: Lamin B Receptor 
LDL: low-density lipoprotein 
LMNA: Lamin A 
LMNB1: Lamin B1 
LMNB2: Lamin B2 
LOPIT: Localization of Organelle Proteins by Isotope Tagging  
LTQ: linear quadrupole ion trap 
m/z: mass to charge ratio 
MALDI: matrix-assisted laser desorption/ionization 
MAPU: Max Planck Unified Proteome 
MBP-C: mannose-binding protein C 
MCM: Mini-choromosome maintenance complex 
MeCN: acetonitrile 
miRNA: micro RNA 
MS: mass spectrometry 
MGI: Mouse Genome Informatics 
mTOR: mammalian target of rapamycin 
nanoESI: nanoelectrospray ionization 
OB: Oligosaccharide/Oligonucleotide binding 
OMIM: Online Mendelian Inheritance in Man  
OXPHOS: Oxidative phosphorylation 
PBS: phosphate buffered saline 
PCA: Principal component analysis 
PCM: polycyclodimethylsiloxane 
PCP: Protein correlation profiling 
PCR: polymerase chain reaction 
PEP: posterior error probability 
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PFAM: Protein family 
piRNA: Piwi-interacting RNA 
PI3K: Phosphatidylinositol-4,5-bisphosphate 3-kinase 
PMF: Post mitochondrial fraction 
PTM: post translational modification 
QCAT: concatemer of Q peptides 
QIT: Quadrupole ion trap 
QTOF: Quadrupole time-of-flight 
Rb: retinoblastoma 
RF: radio frequency 
RMS: Root mean square 
RNA: Ribonucleic acid 
RNAi: RNA interference 
ROS: reactive oxygen species 
RP HPLC: reverse phase high performance liquid chromatography 
RT-PCR: Reverse transcription polymerase chain reaction 
SCX: strong cation exchange 
SDS-PAGE: sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SH3: Src homology 3 
siRNA: Small interfering RNA 
SILAC: stable isotope labeling by amino acids in cell culture 
SIM: selected ion monitoring 
SLD: Soft laser desorption 
Smad2/3: mothers against decapentaplegic homolog 2/3 
SNARE: soluble N-ethylmaleimide-sensitive factor attachment protein receptor 
SOP: standard operating procedures 
SORI: sustained off resonance irradiation 
Src: proto-oncogene tyrosine-protein kinase Src 
SULT: sulfotransferase 
TCA: tricarboxylic acid 
TFA: trifluoroacetic acid 
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TGFβ: transforming growth factor β 
TGFβ R1: transforming growth factor β type 1 receptor 
TMPO: Lamina-associated polypeptide 2 
TOF: Time of flight 
TLP: True localization percentage 
TrEMBL : Translated EMBL 
t-SNARE: target SNARE 
UGT: UDG-glucuronosyltransferase 
WAT: White adipose tissue 
Y2H: Yeast two hybrid
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